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Complex emergencies are characterized by insecurity and mass population 
movements. At the end of the year 2000, an estimated 135 million people 
– including refugees, returnees and internally displaced persons – were af-
fected by complex emergencies.1 More than 40 million people in Africa 
– more than 75% of them women and children – were displaced from their 
homes, either within their own countries or to neighbouring countries. The 
areas of the world whose populations are most affected by complex emer-
gencies are often those with the greatest malaria burden. Consequently, 
malaria is a signifi cant cause of death and illness in complex emergency 
situations. 
Effective malaria control programmes prevent malaria transmission by 
promoting personal protection measures and effective vector control strate-
gies, and providing appropriate case management with early diagnosis and 
effective treatment. However, malaria control in complex emergency situa-
tions is often diffi cult because of the breakdown of existing health services 
and programmes, displacement of health care workers and fi eld staff with 
malaria expertise, movement of non-immune people to endemic areas, and 
concentrations of people, often already in poor health, in high-risk, high-
exposure settings.
This interagency handbook was developed by the Roll Back Malaria 
(RBM) Technical Support Network on Complex Emergencies. It focuses 
on effective malaria control responses to complex emergencies, particularly 
during the acute phase when reliance on international humanitarian as-
sistance is greatest. It provides policy-makers, planners, fi eld programme 
managers and medical coordinators with practical guidance on designing 
and implementing measures to reduce malaria morbidity and mortality. 
Such measures must address the needs of both the displaced and the host 
1 Including Angola, Burundi, the Congo, the Democratic Republic of the Congo, Guin-
ea, Liberia, Rwanda, Sierra Leone, Somalia and Sudan. This estimate does not include 
the refugee-affected populations in the Central African Republic or in western parts 
of the United Republic of Tanzania. 
populations and must accommodate the changes in those needs as an acute 
emergency evolves into a more stable situation. 
The handbook is organized as follows:
 Chapter 1, Introduction – introduces complex emergencies and malaria 
control.
 Chapter 2, Initial assessment and planning – describes how to assess the 
burden of malaria in an emergency and how to identify those most at 
risk, as well as how to use the information collected to design an effec-
tive response. 
 Chapter 3, Surveillance – discusses the establishment of surveillance 
systems to monitor the malaria situation.
 Chapter 4, Outbreak preparedness and response – describes how to 
prepare for and respond to a sudden increase in malaria cases.
 Chapter 5, Case management – provides an overview of methods of 
diagnosis, treatment and patient care in complex emergencies. 
 Chapter 6, Prevention – describes the most useful approaches and tools 
currently available for vector control and personal protection from ma-
laria in complex emergencies. 
 Chapter 7, Community participation and health education – discusses 
how to mobilize affected communities to participate in malaria control 
interventions. 
 Chapter 8, Research and evaluation – focuses on evaluating the effec-
tiveness of prevention and treatment measures, and identifi es priority 
operational research issues for malaria control in complex emergencies. 
In addition, a glossary is provided at the beginning of the handbook. Sug-
gestions for further reading are included at the end of several chapters. 
Ideal – or “gold standard” – approaches to malaria control may not al-
ways be feasible in complex emergencies, and interventions will need to be 
adapted to the realities of each situation. Using this handbook, however, 
humanitarian agencies should be able to implement effective and concerted 
responses to the malaria problems.
As new information becomes available, updates to the handbook 
will be published. Comments and suggestions are most welcome and 
should be sent to RBM/Complex Emergencies at WHO (E-mail: 
rbmemergencies@who.int).
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The defi nitions given below apply to the terms as used in this handbook. 
They may have different meanings in other contexts.
A
acute emergency phase Begins immediately after the impact of the disaster 
and may last for up to 3 months. Characterized by initial chaos and a 
high crude mortality rate (CMR). Ends when daily CMR drops below 
1/10 000 people. 
adherence (compliance) Health-related behaviour that abides by the rec-
ommendations of a doctor or other health care provider or of an investi-
gator in a research project. 
agranulocytosis Severe defi ciency of certain white blood cells as a result of 
damage to the bone marrow by toxic drugs or chemicals.
anaemia A reduction in the quantity of the oxygen-carrying pigment hae-
moglobin in the blood. The main symptoms are tiredness, breathlessness 
on exertion, pallor and poor resistance to infection. 
Anopheles A genus of widely distributed mosquitoes, occurring in tropical 
and temperate regions and containing some 400 species. Malaria para-
sites (Plasmodium) are transmitted to humans through the bite of female 
Anopheles mosquitoes. 
Anopheles, infected Female Anopheles with oocysts of malaria parasites 
on the midgut wall (with or without sporozoites in the salivary glands). 
Anopheles, infective Female Anopheles with sporozoites in the salivary 
glands (with or without oocysts in the midgut). 
antipyretic A drug that reduces fever by lowering the body temperature. 
anthropophilic Descriptive of mosquitoes that show a preference for feed-
ing on humans even when non-human hosts are available. A relative 
term requiring quantifi cation to indicate the extent of the preference. 
asymptomatic Not showing any symptoms of disease, whether disease is 
present or not. (See parasitaemia for “asymptomatic malaria”.)
attack rate The cumulative incidence of infection in a group observed over 
a period during an epidemic.
auscultation Listening, usually with the aid of a stethoscope, to the sounds 
produced by the movement of gas/air or fl uid within the body, to diag-
nose abnormalities, for example in the lungs.
B
bacteraemia Presence of bacteria in the blood.
bias Any trend in the collection, analysis, interpretation, publication or 
review of data that can lead to conclusions that are systematically differ-
ent from the truth. 
blood meal Ingestion by a female mosquito of blood obtained from a ver-
tebrate host; also, the ingested blood. 
bradycardia Slowing of the heart rate to less than 50 beats per minute.
breeding site (place) Site where eggs, larvae or pupae of mosquitoes are 
found; larval habitat. 
C 
case A person who has the particular disease, health disorder or condition 
that meets the case defi nition. 
case defi nition A set of diagnostic criteria that must be fulfi lled for an indi-
vidual to be regarded as a “case” of a particular disease for surveillance 
and outbreak investigation purposes. Case defi nitions can be based on 
clinical criteria, laboratory criteria or a combination of the two. 
case-fatality rate The proportion of cases of a specifi ed condition that are 
fatal within a specifi ed time (usually expressed as a percentage). 
census Enumeration of a population. A census usually records the identi-
ties of all persons in every place of residence, with age or date of birth, 
sex, occupation, national origin, language, marital status, income, and 
relationship to head of household, in addition to information on the 
dwelling place. 
chemoprophylaxis Administration of a chemical to prevent either the de-
velopment of an infection or the progression of an infection to active 
manifest disease. 
cluster sampling A sampling method in which each selected unit is a group 
of people (e.g. all persons in a city block, a family) rather than an indi-
vidual. 
community health worker (CHW) A member of the community who is 
integrated into primary health care programmes after a short training on 
health-related issues, and who acts as intermediary between the community 
and the health services. CHWs may be paid staff or volunteers (CHVs). 
compliance See adherence.
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confi dence interval A computed interval with a given probability (e.g. 
95%) that the true value of a variable (e.g. a mean, proportion or rate) is 
contained within that interval. 
conjunctival Relating to the conjunctiva, the thin mucosa covering the in-
side of the eyelids and the sclera (the white part of the eye).
contact (of an infection) A person or animal that has been in such associa-
tion with an infected person or animal or a contaminated environment 
as to have had opportunity to acquire the infection. 
coverage A measure of the extent to which services cover the potential 
need for these services in a community. It is expressed as a proportion 
in which the numerator is the number of services rendered and the de-
nominator is the number of instances in which the service should have 
been rendered. 
cross-sectional study (disease frequency survey; prevalence study) A study 
that examines the relationship between diseases (or other health-related 
characteristics) and other variables of interest as they exist in a defi ned 
population at one particular time. The presence or absence of disease 
and the presence or absence (or, if they are quantitative, the level) of the 
other variables are determined in each member of the study population 
or in a representative sample at one particular time. The relationship 
between a variable and the disease can be examined in terms both of 
the prevalence of disease in different population subgroups defi ned ac-
cording to the presence or absence (or level) of the variables and of the 
presence or absence (or level) of the variables in the diseased versus the 
non-diseased. A cross-sectional study usually records disease prevalence 
rather than incidence and cannot necessarily determine cause-and-effect 
relationships. 
D
demography The study of populations, especially with reference to size 
and density, fertility, mortality, growth, age distribution, migration and 
vital statistics, and the interaction of all these with social and economic 
conditions. 
district hospital A hospital with the capacity to manage fi rst-referral cases 
but with medical services usually limited to emergency obstetrical and 
surgical care and follow-up, and inpatient and rehabilitative care. In 
principle, facilities include laboratory, blood bank, and X-ray services. 
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E
effectiveness A measure of the extent to which a specifi c intervention, 
procedure, regimen or service, when deployed in the fi eld in routine 
circumstances, does what it is intended to do for a specifi ed population; 
a measure of the extent to which a health care intervention fulfi ls its 
objectives.
effi cacy The extent to which a specifi c intervention, procedure, regimen or 
service produces a benefi cial result under ideal conditions; the benefi t or 
utility to the individual or population of the service, treatment regimen 
or intervention. Ideally, determination of effi cacy is based on the results 
of a randomized controlled trial. 
effi ciency The effects or end results achieved in relation to the effort ex-
pended in terms of money, resources and time; the extent to which the 
resources used to provide a specifi c intervention, procedure, regimen or 
service of known effi cacy and effectiveness are minimized; a measure 
of the economy (or cost in resources) with which a procedure of known 
effi cacy and effectiveness is carried out; the process of making the best 
use of scarce resources. 
endemic Description applied to malaria when there is a constant measur-
able incidence both of cases and of natural transmission in an area over 
a succession of years. 
endophagy Tendency of mosquitoes to feed indoors. 
endophily Tendency of mosquitoes to rest indoors. 
epidemic Description applied to malaria when the incidence of cases (other 
than seasonal increases) in an area rises rapidly and markedly above 
its usual level or when the infection occurs in an area where it was not 
previously present.
epidemic curve A graphic plotting of the distribution of cases by time of 
onset.
epidemiology The study of the distribution and determinants of health-
related conditions or events in specifi ed populations, and the application 
of this study to the control of health problems. 
essential drugs Therapeutic substances that are indispensable for rational 
care of the majority of diseases in a given population. 
evaluation A process that attempts to determine as systematically and ob-
jectively as possible the relevance, effectiveness and impact of activities 
in relation to their objectives. 
exophagy Tendency of mosquitoes to feed outdoors. 
exophily Tendency of mosquitoes to rest outdoors. 
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F
focus group Small convenience sample of people brought together to dis-
cuss a topic or issue with the aim of ascertaining the range and intensity 
of their views, rather than arriving at a consensus. Focus groups are 
used, for example, to appraise perceptions of health problems, assess the ac-
ceptability of a fi eld study or refi ne the questions to be used in a fi eld study. 
G
gamete Mature sexual form, male or female. In malaria parasites, the 
female gametes (macrogametes) and the male gametes (microgametes) 
normally develop in the mosquito. 
gametocytes Parent cell of a gamete. In malaria parasites, the female and 
male gametocytes develop in the red blood cell. Very young gametocytes 
cannot usually be distinguished from trophozoites. 
H
haemoglobinuria The presence of haemoglobin in the urine
haemolysis The destruction of red blood cells.
health care system The organization of health care services within a desig-
nated geographical area (e.g. country, province, district, camp). 
hepatic Relating to the liver.
host A person or other living animal, including birds and arthropods, 
harbouring or providing subsistence to a parasite. In an epidemiological 
context, the host may be the population or group; biological, social and 
behavioural characteristics of this group that are relevant to health are 
called “host factors”.
host, defi nitive In parasitology, the host in which sexual maturation oc-
curs. In malaria, the defi nitive host is the mosquito (invertebrate host). 
host, intermediate In parasitology, the host in which asexual forms of the 
parasite develop. In malaria, the intermediate host is a human or other 
mammal or bird (vertebrate host). 
household One or more persons who occupy a dwelling; may or may not 
be a family. The term is also used to describe the dwelling unit in which 
the persons live. 
hypersensitivity Responding exaggeratedly to the presence of a particular 
antigen.
I
immunity, acquired Resistance acquired by a host as a result of previous 
exposure to a natural pathogen or substance that is foreign to the host. 
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incidence The number of instances of illness commencing, or of persons 
falling ill, during a given period in a specifi ed population. 
incidence rate The rate at which new events occur in a population. The nu-
merator is the number of new events that occur in a defi ned period and 
the denominator is the population at risk of experiencing these events 
during this period, sometimes expressed as person-time. 
indicator A measure that shows whether a standard has been reached. It is 
used to assess and communicate the results of programmes as well as the 
process or methods used. Indicators can be qualitative or quantitative. 
infection, mixed Malaria infection with more than one species of Plasmo-
dium. 
informed consent Voluntary consent given by a subject (i.e. person or a 
responsible proxy such as a parent) for participation in a study, immuni-
zation programme, treatment regimen, etc., after being informed of the 
purpose, methods, procedures, benefi ts and risks, and, when relevant, 
the degree of uncertainty about outcomes. The essential criteria of informed 
consent are that the subject has both knowledge and comprehension, that 
consent is freely given without duress or undue infl uence, and that the right 
of withdrawal at any time is clearly communicated to the subject. 
inpatient facility A health care institution that provides lodging, nursing 
and continuous medical care for patients within a facility and with an 
organized professional staff. 
K
knowledge, attitudes, practice (KAP) survey A formal survey, using face-
to-face interviews, in which people are asked standardized pre-tested 
questions dealing with their knowledge, attitudes and practice concern-
ing a given health or health-related problem.
knockdown Rapid immobilization of an insect by an insecticide, without 
necessarily causing early death. 
L
larva The pre-adult or immature stage hatching from a mosquito egg. 
loading dose An initial higher dose of a drug, given with the objective of 
rapidly providing an effective drug concentration. 
logistics The procurement, maintenance and transport of material, person-
nel and facilities; management of the details of an undertaking. 
M
merozoite A stage in the life cycle of the malaria parasite. Product of 
segmentation of a tissue schizont, or of an erythrocytic schizont before 
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entering a new host cell. Merozoites are found either separated from or 
contained in the original schizont. 
mesoendemicity A pattern of malaria transmission typically found among 
small rural communities in subtropical zones, with varying intensity of 
transmission depending on local circumstances. 
mobile clinic See outreach clinic.
monitoring Episodic measurement of the effect of an intervention on the 
health status of a population or environment; not to be confused with 
surveillance, although surveillance techniques may be used in monitor-
ing. The process of collecting and analysing information about the im-
plementation of a programme for the purpose of identifying problems, 
such as non-compliance, and taking corrective action. In management: 
the episodic review of the implementation of an activity, seeking to en-
sure that inputs, deliveries, work schedules, targeted outputs and other 
required actions are proceeding according to plan. 
morbidity Any departure, subjective or objective, from a state of physio-
logical or psychological well-being. Sickness, illness, and morbid condi-
tion are similarly defi ned and synonymous. Morbidity can be measured 
as: (a) persons who are ill; (b) the illnesses experienced by these persons; 
and (c) the duration of these illnesses. 
mortality rate An estimate of the proportion of a population dying during 
a specifi ed period. The numerator is the number of persons dying during 
the period and the denominator is the total number of the population, 
usually estimated as the mid-year population. 
myalgia Pain in the muscles.
N
needs assessment A systematic procedure for determining the nature and 
extent of problems that directly or indirectly affect the health of a speci-
fi ed population. Needs assessment makes use of epidemiological, socio-
demographic and qualitative methods to describe health problems and 
their environmental, social, economic and behavioural determinants. 
The aim is to identify unmet health care needs and make recommenda-
tions about ways to address these needs.
O
oedema Swelling caused by an excess of fl uid in the tissues.
oliguria The production of an abnormally small amount of urine over a 
period of time.
outpatient clinic A facility for diagnosis, treatment and care of ambulatory 
patients. 
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outreach (clinic, team) The extending of services or assistance beyond 
fi xed facilities.
P
pallor Paleness.
palmar Relating to the palms of the hands.
parasitaemia Condition in which malaria parasites are present in the 
blood. If this condition in the human subject is not accompanied by 
fever or other symptoms of malaria except for a possible enlargement 
of the spleen, it is known as asymptomatic parasitaemia, and the person 
exhibiting the condition is known as an asymptomatic parasite carrier. 
parenteral Relates to drug administration by any route other than oral, e.g. 
by injection.
paroxysms Cyclic manifestation of acute illness in malaria characterized 
by a rise in temperature with accompanying symptoms; usually caused 
by invasion of the blood by a brood of erythrocytic parasites.
Plasmodium Genus of parasites causing human malaria (Plasmodium fal-
ciparum, P. vivax, P. ovale, P. malariae). 
population structure Composition of the population, usually by age and sex.
preparedness Readiness to prevent, mitigate, respond to and cope with the 
effects of a disaster or epidemic. 
prevalence The number of instances of a given disease or other condition 
in a given population at a designated time, with no distinction between 
new and old cases. Prevalence may be recorded at a specifi c moment 
(point prevalence) or over a given period of time (period prevalence). 
prevalence rate The total number of all individuals who have a disease or 
condition at a particular time (or during a particular period) divided by 
the population at risk of having the attribute or disease at that point in 
time or midway through that period. 
prevention Actions aimed at eradicating, eliminating or minimizing the 
impact of disease and disability or, if none of these is feasible, retarding 
the progress of disease and disability. The concept of prevention is best 
defi ned in the context of levels, called primary, secondary, and tertiary 
prevention. In epidemiological terms, primary prevention aims to reduce 
the incidence of disease; secondary prevention aims to reduce the preva-
lence of disease by shortening its duration; and tertiary prevention aims 
to reduce the number and/or impact of complications. 
proportion See under ratio. 
pulmonary Relating to, associated with or affecting the lungs.
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R
random sample A sample that is arrived at by selecting sample units in 
such a way that each possible unit has a fi xed and determinate probabil-
ity of selection. Random allocation follows a predetermined plan that 
is usually devised with the aid of a table of random numbers. Random 
sampling should not be confused with haphazard assignment.
rate A measure of the frequency of occurrence of a phenomenon. In epide-
miology, demography and vital statistics, a rate is an expression of the 
frequency with which an event occurs in a defi ned population in a speci-
fi ed period of time. The use of rates rather than raw numbers is essential 
for comparison of experience between populations at different times, 
different places, or among different groups of persons. The components 
of a rate are the numerator, the denominator, the specifi ed time in which 
events occur, and usually a multiplier, a power of 10, that converts the 
rate from an awkward fraction or decimal to a whole number. 
  number of events in specifi ed period 
 rate =   x 10n
   average population during the period
ratio The value obtained by dividing one quantity by another; a general 
term of which rate, proportion, percentage, etc. are sub-sets. The impor-
tant difference between a proportion and a ratio is that the numerator of 
a proportion is included in the population defi ned by the denominator, 
whereas this is not necessarily so for a ratio. A ratio is an expression of 
the relationship between a numerator and a denominator where the two 
are usually separate and distinct quantities, neither being included in the 
other. 
recrudescence Repeated manifestation of an infection after a period of la-
tency following the primary attack. It is used particularly in the context 
of treatment failure of Plasmodium falciparum, and is often the result 
of non-adherence to the treatment regimen, especially with short-acting 
drugs such as quinine and the artemisinins.
relapse Renewed manifestation (of clinical symptoms and/or parasitaemia) 
of malaria infection separated from previous manifestations of the same 
infection by an interval greater than that related to the normal periodic-
ity of the paroxysms. The term is used mainly for renewed manifesta-
tion due to survival of exo-erythrocytic forms of Plasmodium vivax or 
P. ovale.
reservoir (of infection) Any person, animal, arthropod, plant, soil or sub-
stance, or a combination of these, in which an infectious agent normally 
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lives and multiplies, on which it depends primarily for survival, and 
where it reproduces itself in such a manner that it can be transmitted to 
a susceptible host. The natural habitat of the infectious agent. 
resistance Ability of a parasite strain to multiply or to survive in the pres-
ence of concentrations of a drug that normally destroy parasites of the 
same species or prevent their multiplication. Ability in a population of 
insects to tolerate doses of an insecticide that would prove lethal to the 
majority of individuals in a normal population of the same species; de-
veloped as a result of selection pressure by the insecticide. 
retention (in ITN programme) An indicator used to establish whether nets 
remain with the individuals to whom they were originally distributed. 
Retention alone is not an indicator of the correct use of the nets. 
risk The probability that an event will occur, e.g. that an individual will 
become ill or die within a stated period of time or by a certain age. Also 
a non-technical term encompassing a variety of measures of the prob-
ability of a (generally) unfavourable outcome. 
S
sample A selected sub-set of a population. A sample may be random or 
non-random and may be representative or non-representative. 
sampling The process of selecting a number of subjects from all the sub-
jects in a particular group, or “universe”. Conclusions based on sample 
results may be attributed only to the population from which the sample 
was taken. Any extrapolation to a larger or different population is a 
judgement or a guess and is not part of statistical inference. 
schizont Intracellular asexual form of the malaria parasite, developing 
either in tissue or in blood cells. 
sensitivity (of a screening test) The proportion of truly diseased persons in 
the screened population who are identifi ed as diseased by the screening 
test. Sensitivity is a measure of the probability of correctly diagnosing a 
case, or the probability that any given case will be identifi ed by the test. 
See also specifi city.
species Group of organisms capable of exchanging genetic material with 
one another and incapable, by reason of their genetic constitution, of 
exchanging such material with any other group of organisms. 
specifi city (of a screening test) The proportion of truly non-diseased per-
sons who are so identifi ed by the screening test. Specifi city is a measure 
of the probability of correctly identifying a non-diseased person with a 
screening test. 
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spleen rate A term used in malaria epidemiology to defi ne the frequency of 
enlarged spleens detected on survey of a population in which malaria is 
prevalent. 
splenomegaly Enlargement of the spleen. 
sporozoite The infective form of the malaria parasite occurring in a mature 
oocyst before its rupture and in the salivary glands of the mosquito. 
surveillance The process of systematic collection, orderly consolidation 
and evaluation of pertinent data with prompt dissemination of the re-
sults to those who need to know, particularly those who are in a position 
to take action. 
survey An investigation in which information is systematically collected; 
usually carried out in a sample of a defi ned population group, within 
a defi ned time period. Unlike surveillance a survey is not continuous; 
however, if repeated regularly, surveys can form the basis of a surveil-
lance system. 
systematic sampling The procedure of selecting according to some simple, 
systematic rule, such as all persons whose names begin with specifi ed 
alphabetical letters, who are born on certain dates, or who are located 
at specifi ed points on a master list. A systematic sample may lead to er-
rors that invalidate generalizations. For example, people’s names more 
often begin with certain letters of the alphabet than with other letters. A 
systematic alphabetical sample is therefore likely to be biased. 
T
target population The group of people for whom an intervention is in-
tended. 
transmission Any mechanism by which an infectious agent is spread from 
a source or reservoir to another person. 
transmission, perennial Transmission occurring throughout the year with-
out great variation of intensity. 
transmission, seasonal Natural transmission that occurs only during some 
months and is totally interrupted during other months. 
trend A long-term movement in an ordered series, e.g. a time series. An 
essential feature is movement consistently in the same direction over the 
long term. 
triage The process of selecting for care or treatment those of highest prior-
ity or, when resources are limited, those thought most likely to benefi t. 
trophozoite Strictly, any asexual and growing parasite with an undivided 
nucleus. In malaria terminology, generally used to indicate intracellular 
erythrocytic forms in their early stages of development. Trophozoites 
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may be in either a ring stage or an early amoeboid or solid stage, but 
always have the nucleus still undivided. 
V
vector Any insect or living carrier that transports an infectious agent from 
an infected individual or his/her wastes to a susceptible individual or 
his/her food or immediate surroundings. The organism may or may not 
pass though a developmental cycle within the vector. 
vector control Measures of any kind directed against a vector of disease 
and intended to limit its ability to transmit the disease. 
verbal autopsy A procedure for gathering systematic information that 
enables the cause of death to be determined in situations where the de-
ceased has not been medically attended. It is based on the assumption 
that most common and important causes of death have distinct symp-
tom complexes that can be recognized, remembered and reported by lay 
respondents. 
vulnerability Defencelessness, insecurity, exposure to risks, shock, and 
stress, and having diffi culty coping with them. The potential that when 
something destructive happens or goes wrong, people will not be able to 
handle the consequences by themselves and the ability to sustain life is 
endangered. 
Z
zoophilic Descriptive of mosquitoes showing a relative preference for non-
human blood even when human hosts are readily available. 
The foregoing defi nitions have been adapted from the following sources: 
Concise medical dictionary, 5th ed (1998). Oxford, Oxford University 
Press.
Last J (2001). A dictionary of epidemiology, 4th ed. Oxford, Oxford Uni-
versity Press.
Slee V et al. (1996). Health care terms, 3rd ed. St Paul, MN, Tringa Press.
Terminology of malaria and of malaria eradication (1963). Geneva, World 
Health Organization.
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1CHAPTER 1
Introduction
This chapter:
■ explains what is meant by a complex emergency and the different 
phases of an emergency 
■ discusses the impact of complex emergencies, explaining who is 
affected
■ provides basic information about malaria parasites, malaria 
transmission and populations at risk, and why malaria is signifi cant in 
emergency situations
■ sets out the key steps of an effective emergency response.
Complex emergencies
Defi nition and causes
A complex emergency is a situation that affects large civilian populations 
with war or civil strife, food shortages and population displacement, result-
ing in excess mortality and morbidity.
Complex emergencies can have multiple causes, requiring responses 
specifi cally designed for the needs of those affected. Most complex emer-
gencies follow disasters of human cause – for example, war between states, 
internal confl ict, political persecution of ethnic groups. These situations 
may cause large-scale population displacement or, commonly leave com-
munities stranded and isolated in their own homes unable to access assist-
ance. These settings are often characterized by breakdown of social and 
physical infrastructure, including health care systems. They can be of sud-
den onset – for example, Rwanda in 1994 or East Timor (now Timor-Leste) 
in 1999 – or may develop more slowly – for example, Afghanistan and Su-
dan. In many emergencies, both natural and human factors play a role and 
their interaction can exacerbate the situation. For instance, drought and 
heavy rains exacerbated existing complex emergency situations in Burundi, 
the Democratic Republic of the Congo (DRC), north-eastern Kenya, and 
Somalia. Manipulation of access to food supplies, water or agricultural 
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land can create famine situations in specifi c communities as happened, for 
example, in southern Sudan, or even displace entire populations.
Different phases of complex emergencies
Complex emergencies are not stable, and the situation can change rapidly 
and unpredictably. Thus there are many different descriptions of the vari-
ous phases of an emergency. Box 1.1 presents a summary version that may 
be useful, and Box 1.2 describes key characteristics of the acute phase. 
Most complex emergencies continue to shift between different phases for 
many years, until the causes of the original confl ict are resolved and order 
is restored. 
Box 1.1 The main phases of emergencies 
Acute phase Immediate: 0–4 weeks
 Stabilization: 4–10 weeks
Chronic phase Recovery: several months
 Settlement or repatriation: months or years
Box 1.2 Characteristics of the acute phase of emergencies
■ Mortality rates are usually high (over 1/10 000 population per day). 
■ Access for the affected population to effective health care is poor (the 
health infrastructure may be overwhelmed, inadequate or non-existent).
■ Appropriate response is beyond local or national capacity.
■ Normal coordination mechanisms may have broken down.
Mortality rates may remain high long after the acute phase is over, particu-
larly when there is ongoing confl ict. For example, rates have remained high 
in war-affected communities in eastern DRC since 1998. 
The impact of complex emergencies
It is important to understand how people are affected during different 
phases of emergencies, and to be aware that complex emergencies have an 
impact on resident or host populations as well as refugee and internally dis-
placed populations. The emergency response must be adapted to the needs 
of different populations, as they change over time.
Impact on displaced populations
Populations affected by complex emergencies may be driven from their 
homes to another part of their own country to become internally displaced 
3people (IDPs) or to a neighbouring country to become refugees. During 
fl ight and the acute phase of an emergency, these populations are particu-
larly vulnerable to malnutrition and disease. 
Camps for refugees and IDPs planned as “temporary” settlement areas 
during the acute phase of an emergency may ultimately become relatively 
stable communities. When displaced populations cannot return to their 
own homes or their own country for many years, camps may become 
long-term settlements. Examples are the Congolese and Burundian refugee 
camps in the United Republic of Tanzania and the Karen refugee camps in 
Thailand.  
Refugees and IDPs who are scattered among host communities, living 
with host households, are a common feature of many complex situations. 
Often, such displaced people are not registered by national or United 
Nations authorities and may not receive assistance in the same way as those 
living in offi cial camps or settlements. Consequently, because they have no 
access to basic health care, food distribution or other services, they may be 
particularly vulnerable. Access to displaced people scattered among host 
households is a challenge for emergency actors.
Impact on resident or host populations
Resident or host populations may not be directly affected by the causes of a 
complex emergency but can be severely affected by the effects of that emer-
gency. Hosting large numbers of refugees or IDPs can stretch limited local 
resources and have a detrimental effect on the local economy. Resident 
populations may also be directly affected by the causes of the emergency. If 
confl ict, political oppression or deployment of antipersonnel mines severely 
restricts people’s movement, the resident population may be unable to 
access essential materials and services, such as food, land, fi rewood, water 
and health care, and may be effectively prevented from carrying out their 
normal employment. Conditions for the resident population may deterio-
rate and result in high rates of malnutrition and disease. 
Sometimes the bulk of humanitarian assistance is delivered to the 
displaced population, who consequently have better access to essential 
services than the local population. This can create tension between the 
displaced and resident populations. The emergency response must there-
fore be designed to meet the needs of all populations affected by a complex 
emergency – refugee, IDP and resident.
CHAPTER 1. INTRODUCTION
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Mortality and morbidity rates
Complex emergencies result in high rates of death and illness, especially 
during the acute phase. Crude mortality rates (see Table 1.1) are commonly 
used to express the severity of emergencies.
Death and illness do not affect everyone equally. Certain population 
groups, such as young children, are more vulnerable to the effects of malnu-
trition and disease. Thus, while crude mortality rates provide information 
about overall mortality rates in a population, they do not help to identify 
the groups most at risk. In complex emergencies, initial assessment and 
ongoing surveillance must ensure that the most vulnerable groups are iden-
tifi ed and that their needs are met.
Over the past decade, the majority of complex emergencies have oc-
curred in African countries. In most instances only a small proportion 
of total deaths have been directly related to war trauma; most have been 
caused by diarrhoeal diseases, malaria, pneumonia, measles and malnutri-
tion, all of which are preventable. 
Table 1.1 Crude mortality rates in emergencies
 Crude mortality rate  Severity of emergency
 (deaths/10 000 population per day)
 Up to 0.5 [Normal – non-emergency]
 <1 Under control
 >1 Very serious
 >2 Out of control
 >5 Catastrophic
Malaria
Malaria is a common and life-threatening disease in many tropical and sub-
tropical areas. It is currently endemic in over 100 countries. Each year an 
estimated 300 million people fall ill with malaria, and there are more than 
1 million deaths. Malaria is caused by the protozoan parasite Plasmodium 
and transmitted by female Anopheles mosquitoes, which bite mainly be-
tween sunset and sunrise. 
Parasites
Four species of malaria parasites infect people – Plasmodium falciparum, 
P. vivax, P. malariae, and P. ovale – of which P. falciparum and P. vivax 
are the most common. Falciparum malaria can be fatal, and is a priority 
during the acute phase of an emergency. Severe falciparum malaria has a 
case-fatality rate of around 10% in reasonably well-equipped hospitals. 
5Vivax malaria is an acute but not life-threatening illness associated with 
anaemia and splenomegaly, and causes low birth weight. Unlike P. falci-
parum, the liver stages of P. vivax can give rise to relapse. Malaria caused 
by the other Plasmodium species is less severe than falciparum malaria and 
is rarely life-threatening. 
The current distribution of malaria in the world is shown in Figure 1.1.
The four human malaria species are not evenly distributed across the 
malaria-affected areas of the world and their relative importance varies 
between and within different regions. The risk of contracting malaria is 
therefore highly variable from country to country and even between areas 
in a country. P. falciparum is the commonest species throughout the tropics 
and subtropics, and predominates in sub-Saharan Africa. P. vivax has the 
widest geographical range, is present in many temperate zones but also in 
the subtropics, and coexists with P. falciparum in the Horn of Africa and 
in tropical parts of the Americas and Asia. P. ovale occurs in Africa and 
sporadically in south-east Asia and the western Pacifi c. P. malariae has a 
similar geographical distribution to P. falciparum but is far less common 
and its incidence is patchy. 
It is important to know which species are present in any particular area 
and the relative importance of each species, because this will affect the 
choice of treatment. In Afghanistan, for example, 85% of malaria is caused 
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by P. vivax and up to 15% by P. falciparum; in DRC, 95% of malaria is 
due to P. falciparum, with P. malariae and P. ovale accounting for the re-
maining 5%; in Timor-Leste, 60% is caused by P. falciparum and 40% by 
P. vivax. The relative importance of vivax and falciparum in a country may 
shift over time. In areas of signifi cantly mixed malaria infection, such as 
Timor-Leste, it is even more important that patients with suspected malaria 
should be diagnosed by laboratory methods so that appropriate treatment 
can be given for the species causing the disease. However, if microscopy 
or rapid diagnostic tests (RDTs) are not available, all cases of suspected 
malaria must be assumed to be of mixed infection and treated for both 
species. Generally, P. vivax can be treated with the same antimalarials as 
P. falciparum, with the exception of sulfadoxine–pyrimethamine (SP). In 
some specifi c circumstances, P. vivax may require additional anti-relapse 
treatment with primaquine.
Vectors
There are about 400 different species of Anopheles mosquitoes throughout 
the world, but only some 60 of these are vectors of malaria under natural 
conditions, and only 30 are vectors of major importance. Each species has 
a different behaviour pattern. Several species of Anopheles can be found 
in most malarial areas, and different species occur in different parts of 
the world. Highly effi cient species, such as A. gambiae, A. arabiensis and 
A. funestus, predominate in sub-Saharan Africa, while less effi cient vec-
tors, such as A. stephensi and A. minimus, predominate in Asian countries. 
A. dirus is an effi cient vector in the forests of south-east Asia. 
Endemicity, transmission and disease patterns (populations at risk)
Knowledge of the epidemiology of malaria in the area affected by an emer-
gency is essential, to allow appropriate prevention and case-management 
strategies to be planned.
The epidemiology varies by region, determining levels of immunity and 
risk of severe disease. In highly endemic areas, people gradually develop 
a partial immunity to the disease, and it is therefore young children who 
are most at risk from severe infection with malaria. In these areas, malaria 
in pregnancy causes maternal anaemia, as well as spontaneous abortions, 
stillbirths and low birth weight, particularly during fi rst and second preg-
nancies and in HIV-infected women. In lowland and rural areas of Africa, 
malaria endemicity may be very high, with perennial (where there is rain-
fall for more than 8 months a year) or seasonal transmission. 
7In areas of intense malaria transmission, such as Liberia and Sierra 
Leone, the population is semi-immune after childhood. Incidence of symp-
tomatic disease remains fairly constant all year round. People in these areas 
may carry malaria parasites in their blood without showing clinical symp-
toms of disease; thus the presence of parasites in a patient’s blood is not 
a clear indicator that malaria is the cause of the illness. While more than 
60% of the population is parasite-positive at any time, young children are 
at increased risk of developing severe malaria in the rainy season. 
Hilly, forested areas of south-east Asia also have high transmission, 
but severe disease is common in adults whose work obliges them to stay 
overnight in forests. In parts of Asia and the Americas where transmission 
is low to moderate, seasonal and epidemic peaks of malaria incidence are 
seen. In high-altitude and desert-fringe areas and in city centres malaria 
endemicity is usually low, with less than 10% of the population infected 
(although there is some transmission in cities of Africa and south Asia). In 
areas of unstable malaria transmission, such as the highlands of Angola, 
Burundi, Ethiopia, Kenya, Rwanda, Uganda and the United Republic of 
Tanzania and the semi-arid and desert fringes of countries in the Horn of 
Africa and the Sahel, the whole population may have low levels of immuni-
ty and outbreaks of malaria may affect all age and population groups. The 
presence of parasites in a patient’s blood indicates that malaria is highly 
likely to be the cause of the presenting illness.
Malaria may re-emerge in areas where it was once well controlled, such 
as central Asian countries since the break-up of the former Soviet Union. 
For instance, population displacement from malaria-endemic areas of Af-
ghanistan has contributed to the re-emergence of P. falciparum malaria in 
Tajikistan. 
Recognizing malaria
Malaria is an acute febrile illness with an incubation period of 7 days or 
longer. Thus, a febrile illness developing less than one week after the fi rst 
possible exposure is not malaria. 
The most severe form is caused by P. falciparum, in which variable clini-
cal features include fever, chills, headache, muscular aching and weakness, 
vomiting, cough, diarrhoea and abdominal pain; other symptoms related 
to organ failure may supervene, such as acute renal failure, generalized 
convulsions, and circulatory collapse, followed by coma and death. It is 
estimated that about 1% of patients with P. falciparum infection die of the 
disease. In complex emergencies in areas of high transmission, malaria may 
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account for up to 50% of all deaths. Prevention of progression to severe 
malaria disease and death depends on accurate diagnosis and prompt treat-
ment. An effective and usable case defi nition for malaria is critical. The 
simplifi ed malaria case defi nition agreed by WHO and partners for use in 
emergencies is summarized in Box 1.3. More detailed case defi nitions and 
classifi cation for surveillance purposes are given in Chapter 3.
In all complex emergencies it is important to use a standardized case 
defi nition for malaria, in combination with a suitable rapid triage and 
screening process to identify those cases requiring immediate diagnosis and 
treatment. Basic confi rmatory diagnostic capacity for malaria (using RDTs 
or microscopy) should be established as early as possible. 
Box 1.3 Simplifi ed malaria case defi nition for use in emergencies
Uncomplicated malaria 
Person with fever or history of fever within the last 48 hours (with 
or without other symptoms such as nausea, vomiting and diarrhoea, 
headache, back pain, chills, myalgia), where other obvious causes of fever 
have been excluded.1
 
Severe malaria
Person with fever and symptoms as for uncomplicated malaria but 
with associated signs such as disorientation, loss of consciousness, 
convulsions, severe anaemia, jaundice, haemoglobinuria, spontaneous 
bleeding, pulmonary oedema, shock. 
To confi rm case 
Demonstration of malaria parasites in blood fi lms by examining thick or 
thin smears or by rapid diagnostic test for P. falciparum.
1 In a high malaria risk area or season, all children under 5 years of age with fever 
(or history of fever) should be classifi ed as having malaria (sometimes in addition 
to another febrile illness); presumptive treatment for malaria based on the clinical 
diagnosis is justifi ed in this group given the high rate of malaria risk and the pos-
sibility that another illness might cause the malaria infection to progress. 
 In a low malaria risk area or season, children with fever (or history of fever) are 
classifi ed as having malaria and given an antimalarial only if they have no runny 
nose (a sign of ARI), no measles and no other obvious cause of fever (pneumonia, 
sore throat, etc.). Parasitological confi rmation in these children is recommended. 
Malaria in complex emergencies
More than 80% of current complex emergencies are in malaria-endemic 
areas. A survey in eastern DRC showed that, during a period when violent 
deaths increased 5.5-fold, malaria-specifi c mortality increased 3.5-fold, 
9including adult deaths (IRC, 2000). If this pattern is typical of the impact 
of sustained confl ict, the number of deaths due to malaria in countries simi-
larly affected by complex emergencies, such as Angola, Burundi, Guinea, 
Liberia, Sierra Leone, Somalia and Sudan, may be far higher than previ-
ously believed.
Populations at risk
In addition to the population groups generally at risk as identifi ed above, 
others may be at increased risk of developing severe malaria during com-
plex emergencies. The following factors all contribute to the increased ma-
laria burden in affected populations:
— collapse of health services;
— ongoing confl ict limiting access to effective treatment;
— resistance of the malaria parasites to commonly available drugs;
— lack of immunity to malaria; a population that has been displaced 
from a non-malarious area or an area of low transmission to (or 
through) an area of high transmission will have little immunity to the 
disease;
— weakened immunity because of multiple infections and malnutri-
tion;
— exposure due to poor or absent housing;
— environmental deterioration resulting in increased vector breeding; 
— population and parasite movement;
— poor knowledge among health agencies.
Some groups are particularly vulnerable, especially in the acute phase of a 
complex emergency, because they are given less priority in the distribution 
of limited resources, are marginalized socially or politically, or have greater 
diffi culty in accessing treatment and care. Depending on the situation, these 
may include minority ethnic groups, older people, people with disabilities, 
and infants and children who are already weak or sick. Groups that are 
isolated from the main focus of humanitarian assistance are also vulner-
able. For example, several hundred thousand refugees from Burundi and 
Rwanda fl ed from refugee camps around Goma, Bukavu and Uvira into 
the central forests of eastern DRC in 1997, because of fear of retribution. 
Several months passed before international assistance arrived. By this time, 
many children had died, and the prevalence of malaria and malnutrition 
was high. Tackling these issues of access can be extremely challenging. 
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MALARIA CONTROL IN COMPLEX EMERGENCIES
10
Effective emergency response
The fi ve principles of an effective emergency response, which apply both 
overall and to specifi c interventions such as malaria control, are:
• Coordination – among different partners to maximize overall capacity, 
promote linkages and complementary activities, and avoid duplication 
of effort. One emergency partner will normally take responsibility for 
coordination. This may be the ministry of health (in principle the fi rst 
choice from the viewpoint of sustainability), the United Nations or a 
nongovernmental organization (NGO) and may change according to the 
situation and the stage of the emergency.
• Accurate and timely assessment – of the emergency situation and the 
needs of those affected (see Chapter 2).
• Planning – for the emergency response, based upon the results of assess-
ment (see Chapter 2).
• Implementation – of the emergency response and specifi c interventions 
(see Chapters 3–7).
• Monitoring and evaluation – of the effectiveness of interventions by each 
emergency partner to ensure that programme activities are regularly re-
viewed and modifi ed to maximize impact. Evaluation can be conducted 
by the agency implementing the interventions or, to increase objectivity, 
by an external organization. 
Coordination among different partners
In emergencies, especially in confl ict situations, international donors often 
terminate bilateral assistance to governments and focus on the delivery of 
humanitarian aid through international organizations, including United 
Nations agencies and international NGOs. These organizations are the key 
partners in emergency situations.
Operational partnerships between a range of organizations are essential 
in complex emergencies. It is critical to work with national and local gov-
ernment agencies, emergency organizations and personnel, wherever pos-
sible, when planning and implementing an emergency response. Existing 
health facilities and national staff can play an important role in emergency 
response and, with international support, are often best placed to deliver 
emergency health care. 
Local NGOs and community groups are also important partners in the 
emergency response, usually after the acute phase, although they some-
times play a signifi cant role early on. For example, AMIKIVU, a local 
NGO based in Goma, eastern DRC, has good diagnostic laboratory capac-
11
ity. Working together with international partners, AMIKIVU diagnosed 
the fi rst cholera cases in Rwandan refugees who fl ed to Goma in July 1994, 
and has continued to play an important support role in the overall emer-
gency response since that time.
Local faith-based organizations also play a vital role in health care 
delivery in many countries. In DRC, for example, more than 80% of the 
country’s health infrastructure is managed by Catholic and Protestant or-
ganizations.
Refugees, displaced people and war-affected resident populations often 
suffer from exhaustion, malnutrition and illness in the initial phase of an 
emergency. However, they have important skills, infl uence and cultural un-
derstanding, which may be lacking among the international humanitarian 
community, and it is important to identify the capacity that exists within 
affected populations as soon as possible and to work together with these 
populations. 
Priorities and constraints
The priority in the acute phase of complex emergencies with high mortality 
rates is to establish effective life-saving interventions within the fi rst few 
days. Interventions should be based on the best available evidence – both 
from existing information and from rapid assessment of the situation. The 
information gathered during assessment is essential, not only to plan ap-
propriate interventions but also to lobby donor organizations for adequate 
funds. Emergency responses need to be tailored to the urgency of the situ-
ation, and unsustainable approaches are justifi ed in the short-term until 
mortality rates are brought under control. Once the situation is stable, 
more sustainable approaches should be introduced, as the chronic phase of 
an emergency may go on for years. 
It is important to remember that the ideal is not always possible in com-
plex emergencies, especially in the acute phase; often there are signifi cant 
constraints to delivering even basic interventions (see Box 1.4). These con-
straints affect what can be done, and organizations may have to make com-
promises in the way they manage patients, particularly inpatients. Within 
these constraints, however, every effort should be made to implement best 
practice. Poor quality interventions are never acceptable – they prolong suf-
fering and result in unacceptable loss of life. 
The international community may have to support rapid responses by 
providing expatriate staff and augmenting existing health infrastructure 
with temporary parallel facilities – such as mobile clinics and therapeutic 
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Box 1.4 Constraints in complex emergencies
The most common constraints encountered in complex emergencies are:
Health infrastructure
Local health facilities in complex emergencies are often in poor 
condition, as affected areas have frequently experienced many years 
of social and economic decline before the onset of confl ict or political 
strife. Infrastructure may be destroyed during the emergency. Modern 
intensive care facilities and equipment, and even relatively basic inpatient 
equipment and supplies such as X-ray and oxygen, are rarely available or, 
if available, cannot be maintained in emergency conditions.
Capacity, human resources 
During the acute phase of many complex emergencies, national capacity 
may be weakened and civil structures, including health and other services, 
are often unable to cope with the scale of response required. Shortages 
of skilled staff are the norm. Skilled national professionals, who have the 
means to leave, are often the fi rst to be lost in confl ict situations, further 
weakening national capacity. There is also a lack of the specifi c technical 
skills required to ensure health care delivery in diffi cult and challenging 
situations. Capacity may remain weak for many years.
Logistics
Supply, storage and distribution problems are exacerbated by poor road 
infrastructure, looting of stores, and breakdown of procurement systems 
and supply management.
Security
Poor security complicates logistics and service provision, restricts the 
access of vulnerable populations to health care, and places emergency 
teams under great stress, resulting in high staff turnover.
Funding
Delayed funding decisions, insuffi cient funding, and rapid decline in 
funding availability are key problems. Resources for training fi eld teams in 
malaria control methods may also be severely limited.
Coordination
Lack of transparency, complementarity and information sharing among 
partners can hinder effective response.
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feeding centres – to deal with additional and specifi c medical or operational 
management problems. Initial assessment should therefore include review 
of the capacity of existing health facilities in order to determine the staffi ng, 
and fi nancial and material support required for an effective response. 
Delivering effective malaria control responses
Effective malaria control in complex emergencies requires fl exibility and 
innovation to maximize the impact of available resources. Large-scale 
funding made available in emergencies that have received wide media cov-
erage may not be sustained beyond 6–12 months, and approaches used in 
the acute phase may not be feasible in the longer term. Programme design 
and strategies will need to be adapted through regular monitoring and re-
view, in response to the changing situation. 
Once mortality and morbidity rates are under control and have returned 
to pre-emergency levels, less intensive support may be required. Planning 
programme changes should be achieved through a careful process of reas-
sessment and evaluation. If funding reductions are not appropriate, agen-
cies will need to lobby donors with clear, evidence-based information to 
ensure effective health care for all those affected. 
Reference
IRC (2000). Mortality in eastern DRC: results from fi ve mortality surveys 
by the International Rescue Committee. Bukavu, International Rescue 
Committee.
Finding out more
An effective emergency response requires signifi cant technical and op-
erational skills. A list of resources and contact details is given in Annex I. 
Technical assistance and fi eld support from RBM can also be obtained 
through:
Malaria in Emergencies Network
World Health Organization
1211 Geneva 27
Switzerland
Fax: +41 22 791 4824
E-mail: rbmemergencies@who.int 
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CHAPTER 2
Initial assessment and planning
This chapter:
■ outlines what information is essential and desirable for analysing 
the malaria burden and risk in emergency situations and planning and 
implementing an effective response
■ explains what to do if this information is not available, including how to 
conduct a rapid clinic-based fever survey and a rapid community cross-
sectional prevalence survey
■ provides practical guidelines for selecting sites for displaced 
populations and managing drug supplies.
Understanding malaria
In an emergency situation, basic information about local malaria parasites, 
vectors, endemicity and transmission is desirable for the planning and im-
plementation of appropriate and effective control measures. Country malar-
ia profi les and communicable disease “toolkits” for many of the countries 
affected by emergencies can be found on the WHO/RBM web site (http:
//www.who.int/malaria/epidemicsandemergencies.html). Information on 
broader health issues is available in the country profi les generated and up-
dated by WHO’s Health Action in Crises department (www.who.int/hac). 
Country (malaria) profi les need to be regularly updated, especially from 
data generated by those working in the fi eld.
In any malaria-endemic area, the following questions should be consid-
ered:
• Is it an area of high or low malaria transmission?
• Is there malaria transmission all year round or seasonal transmission?
• Are there malaria epidemics at particular times? 
Assessment 
In a complex emergency, a general assessment is essential to:
— identify current health priorities and potential health threats;
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— assess the capacity and resources available to respond to the situa-
tion;
— collect baseline information for monitoring and evaluation of the 
effectiveness of planned interventions.
More specifi cally, it is important to determine the extent to which malaria 
is, or is likely to become, a major problem. Important questions to consider 
include:
• Is malaria a major health problem in the affected populations?
• Is the area prone to malaria outbreaks?
• Is there local transmission?
• Is malaria a major problem in the area from which the population has 
been displaced?
• Who is most at risk of malaria infection, illness and death?
Initial assessment of the situation should take less than a week, although 
this will depend on security, transport and communication. The informa-
tion collected should be shared with other international and national emer-
gency partners, so that it can contribute to the overall assessment both of 
the health situation and of wider humanitarian needs.
When conducting community malaria surveys or assessments at health 
facilities, it is essential to document both the presence of parasites (by RDT 
or microscopy) and clinical symptoms (“actual or reported fever” as a 
minimum). These data will provide useful information on both the propor-
tion of symptomatic and asymptomatic malaria cases, and the proportion 
of febrile individuals without malaria.
Guiding principles for assessment, planning and selection of malaria 
control activities are summarized in Box 2.1
Box 2.1 Guiding principles for assessment, planning and selection 
 of malaria control activities
■ Maximize the use of existing information at international, national, 
district and community levels. 
■ Carry out rapid surveys if existing information is inadequate or 
inaccessible.
■ As far as possible, match malaria control interventions to current 
effective national policies, if known. 
■ Use available local expertise to assist with the selection of malaria 
control options. 
■ Involve affected populations in decision-making and action.
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Obtaining information
Locally available data relevant to the emergency situation may be limited 
or outdated, particularly where government structures and services have 
been severely disrupted. If this is the case, it may be necessary to carry out 
rapid surveys, such as clinic-based fever surveys or cross-sectional preva-
lence surveys (details are given later in this chapter), to assess the situation 
and the relative importance of malaria. Carrying out malaria surveys at the 
same time as other rapid surveys, for example of nutritional status or vac-
cination coverage, can save time and money. In most emergency situations, 
there is uncertainty about:
— the actual malaria burden, due both to lack of mortality and morbid-
ity data from the health services and to the absence of information 
about disease trends;
— the proportion of malaria cases (suspected and confi rmed) that 
present for treatment at health facilities;
— the immune status of the refugee or displaced population, since there 
may be differences in malaria transmission in the areas that people 
have travelled through or settled in. 
Information that is essential for early planning
When information is to be collected for planning, it is important to consid-
er what information is critical and how it will be used to develop interven-
tions. Information about the overall emergency situation, the population 
affected by the emergency, the malaria situation in the resettlement area 
and local capacity to respond is essential. 
Emergency situation
Background information about the emergency situation and how it is likely 
to affect security and population movements is essential for planning in-
terventions.
Affected population
Essential information about the affected population includes:
— estimated total population and breakdown by age and sex, and ongo-
ing population movement (see Chapter 3);
— estimated mortality per 10 000 per day (see Chapter 3);
— immune status, population at risk for malaria, and emergency factors 
increasing vulnerability to malaria.
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As discussed in Chapter 1, the level of immunity in a population depends 
on malaria endemicity (see Figure 2.1). Where people have been displaced, 
it is essential to fi nd out where they have come from and whether or not 
they have travelled through malaria-endemic areas to reach the resettle-
ment area. Groups within the displaced population may have different 
places of origin: some may have come from highly endemic areas, others 
from areas with little or no malaria transmission. Different groups may 
also have travelled along different routes and may or may not have been 
exposed to malaria during their journeys. 
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Figure 2.1 Incidence of acute malaria infections (percentage by age) 
 at different endemic levels in stable indigenous populations
A Low endemicity. A person may attain adolescence before infection is acquired 
and may escape altogether.
B Moderate endemicity. Maximum incidence occurs in childhood and adolescence, 
but still not unusual for individuals to reach adulthood before acquiring infection.
C High endemicity. By late infancy or early childhood practically all are infected. Lit-
tle acute illness in adolescents and still less in adults.
D Hyperendemicity. Most individuals acquire infection in early infancy, but acute 
manifestations are less frequent in childhood and are unusual in adults.
E Unless caused by exotic parasites, epidemics can occur only in populations 
where malaria was either previously absent or persisted at low or moderate en-
demic levels. They are characterized by a high incidence in all age groups (Boyd, 
1949).
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Malaria situation in the resettlement area
Morbidity caused by malaria
In order to prioritize interventions and monitor their effectiveness, it is es-
sential to discover how much morbidity, including severe anaemia, in the 
target population is due to malaria, and which population and age groups 
are most affected. The age groups most affected will indicate pre-existing 
population immunity levels – and thus endemicity in the areas from which 
the population originated – but may also indicate age groups at particular 
risk of transmission, for example adult men who stay overnight in forested 
areas in some Asian countries where transmission is intense.
This information can be obtained from provincial, national, district and 
local levels by the following means:
• A review of past and present medical records – suspected and confi rmed 
malaria morbidity data and, if available, severe anaemia data (haemo-
globin <6 g/dl), disease trends and surveillance data) – from the affected 
locations.
• A rapid fever survey at a health facility or mobile clinic, preferably one 
that sees patients from all affected groups (i.e. host, refugee and inter-
nally displaced). Such a survey will indicate the actual proportion of 
confi rmed malaria cases among people who perceive themselves to be 
sick with a febrile disease. 
Mortality caused by malaria
Specifi c mortality data are usually unavailable or, for various reasons, are 
inaccurate. Data on case-fatality rate (CFR) could be obtained in refer-
ral hospitals or facilities that admit patients with severe disease, bearing 
in mind that such data represent only a fraction of the real mortality at 
community level and tend to refl ect the quality of case management in 
health care facilities. Surveys using questionnaires can be used in camps or 
communities to provide more accurate specifi c estimates of mortality and 
burden of disease.
Malaria endemicity and transmission
Information about the local level of malaria endemicity and patterns of ma-
laria transmission (see Chapter 1) should be obtained from data available 
either within the country or from elsewhere (e.g. WHO). It is also impor-
tant to know about geographical and climatic factors that affect endemicity 
and transmission, such as seasonal variations in rainfall and temperature. 
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Malaria outbreaks and malaria control efforts
It is essential to fi nd out whether there are any known risk factors for ma-
laria outbreaks – for example, a large infl ux of non-immune people into 
an area of high transmission, rainfall after an unusual period of drought, 
recent environmental changes that have increased suitable breeding sites 
– and whether the area has experienced earlier outbreaks. If there have been 
earlier outbreaks, it is important to fi nd out whether the numbers of people 
affected and the causes of the outbreak were documented, and to be aware 
of past and present malaria control efforts in the area, so that these efforts 
can be built on and lessons learned from past experiences.
Malaria parasite species
The malaria parasite species present in the area and the relative impor-
tance of each must be determined: this information will affect the choice 
of control measures and possibly the choice of treatment (see Chapter 1). 
Information on malaria species could be obtained from laboratory records 
or – for greater accuracy – from a cross-sectional parasitological survey.
Local vectors, vector behaviour, susceptibility to main insecticides 
and suitable breeding sites
The following questions should be considered:
• Are there malaria vectors present? 
• What vector species are they, where do they like to breed, and when and 
where do they feed? 
• Do they prefer humans or animals?
• What are the vector resting patterns?
• Where do people come into contact with the vector and under what con-
ditions?
Information about local vectors, their biting and resting habits, and their 
susceptibility to insecticides is critical (see Chapter 1 and refer to Tables 
6.6–6.9). The local vector species affect transmission patterns and conse-
quently the choice of cost-effective vector control options. It may be useful 
to fi nd out about the location of major breeding sites, for example, areas 
that are badly drained, marshy, low-lying and prone to fl ooding, and that 
are close to where people live. This information is particularly useful at the 
early stage, to avoid siting camps in high-risk areas, and later for selecting 
potential additional prevention measures.
Information on local vectors is often diffi cult to obtain but could be 
gathered from:
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— the ministry of health and the national malaria control programme, 
if accessible;
— records from previous entomological surveys (see reports or “grey” 
literature maintained in international institutions such as WHO);
— published literature such as the information on malaria vectors com-
piled by Mouchet et al. (2002).
Capacity to respond
The capacity to respond to the emergency will often depend on interna-
tional and national partners. It is important to assess the presence and ac-
tivities of other agencies and mechanisms and scope for co-ordination and 
joint planning. You also need to assess the capacity of health services and 
to review national policy and regulations regarding drugs and insecticides. 
Health infrastructure and personnel
The condition of public and private health facilities and other infrastruc-
ture should be assessed, as should the availability of personnel, particularly 
those who have worked in malaria control (see the checklist in Table 2.1). 
This assessment should include the type of health facilities, the number of 
Table 2.1 Health system condition
System Present Fee  Observations
   (Y/N) system 
    (Y/N) 
 1. Clinical diagnosis
 2. IMCIa strategy in use in country
 3. Laboratory diagnosis
 4. Treatment of uncomplicated malaria
 5. Referral system and facilities
 6. Transport facilities
 7. Management of severe malaria
 8. Previous use of insecticide-treated 
  materials among refugees and 
  host population
 9. Other vector control
 10. Monitoring and surveillance
a Integrated Management of Childhood Illness.
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health workers and their level of training, referral services, availability of 
diagnostic facilities, drugs and equipment (including blood transfusion fa-
cilities), the effectiveness of communication between different levels of the 
system, and whether or not a surveillance system exists. 
Accessibility and use of health services
It is important to fi nd out about the host population’s access to, and use of, 
existing health care services, and the extent to which these services could 
be strengthened to serve the displaced or refugee population. Factors that 
are likely to reduce access and treatment-seeking behaviour signifi cantly in 
emergencies include poor security, culturally inappropriate services, prefer-
ences for alternative sources of health care, and charging partially or fully 
(cost recovery) for consultation, diagnosis and treatment. It should be kept 
in mind that, in most refugee camps supported by humanitarian agencies, 
access to health care is usually free of charge.
Drugs and insecticides
National policies and regulations govern the use of drugs and insecticides 
in all countries, so it is important to fi nd out: 
— what antimalarial drugs (see Chapter 5) are currently recommended 
by the ministry of health for treatment of uncomplicated malaria and 
for management of severe malaria, as well as what other drugs are 
used locally;
— whether potential emergency drug options are registered or whether 
this will need to be negotiated and introduced;
— what insecticides (see Chapter 6) are recommended and used;
— what evidence is available for the effi cacy of drugs and insecticides 
being used under national protocols.
Information to be collected after initial assessment
After the initial emergency assessment, suffi cient basic information should 
be available to allow immediate priority interventions to be started. How-
ever, to develop the emergency response and improve the impact of control 
activities, additional information should be collected to inform planning.
Health policy, planning and services
Information on the treatment-seeking behaviour of the population and 
on health care provision by traditional healers and private practitioners is 
critical in order to ensure that planned interventions will actually deliver 
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effective treatment to those in need. Planning should include working with 
private treatment providers if these are commonly used by the population 
that will be served. 
Information is needed on current health sector reforms and fi nancial 
mechanisms, health service logistics, and responsibilities for planning and 
implementation at national, regional, provincial and district levels.
Malaria control programme
It is important to fi nd out about the national malaria control programme 
– goals, objectives, targets and action plans; structure, management and 
staff; guidelines, including those on dealing with malaria in emergencies 
and epidemics; and current control efforts.
Other priority programmes and activities 
Information should be gathered on the national essential drugs list; drug 
stocks, supply and distribution systems; environmental health activities (e.g. 
vector control, insecticide stocks and supply lines); mother and child health 
initiatives, such as Making Pregnancy Safer, and Integrated Management 
of Childhood Illness (IMCI); and information management systems.
Displaced or refugee and host populations 
Other information that is essential is related to: population movement, 
settlement patterns and occupations; knowledge, attitudes and beliefs 
among different ethnic groups about malaria and its causes, prevention 
and treatment; and current level of usage of protective measures such as 
insecticide-treated materials, types of shelter and, where possible, family 
sleeping arrangements. 
Important considerations in complex emergencies
In addition to factors that increase the vulnerability of the affected popula-
tions to malaria, such as malnutrition, anaemia, co-infections, and limited 
housing facilities, it is also important to investigate the following situa-
tions, which can result in high rates of malaria mortality and morbidity:
— movement from areas of high transmission to areas of low or no ma-
laria transmission
— movement from areas of low or no transmission to areas of high ma-
laria transmission
— movement to areas with different malaria species.
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Movement from areas of high transmission to areas of low or no 
malaria transmission
If the refugee or displaced population has moved from or through an area 
of high malaria transmission to an area of low or no malaria transmission, 
there may be explosive outbreaks in the non-immune host population, de-
pending on the malaria receptivity status (possibility of transmission) of 
the region (see Box 2.2). In this situation, all patients with fever should be 
checked for malaria using either microscopic examination or RDTs, other-
wise malaria cases will be missed and misdiagnosed. 
Careful analysis is essential: the risk to the host population is sometimes 
overestimated because of the large number of malaria episodes in the arriv-
ing population. It is equally important not to discount the risk to the host 
population given its lack of immunity. The arriving population may have 
a higher incidence of disease episodes than they had been used to at home, 
simply as a result of the stress of displacement.
Box 2.2 High malaria prevalence in an area of low transmission
Over two months in 1994, some 500 000 refugees from Rwanda settled in 
Ngara camp in the United Republic of Tanzania. Although the camp was 
in an area of low malaria transmission, the prevalence of malaria among 
refugees was very high and many people died from the disease. This was 
because the refugees had passed through an endemic region of Rwanda 
on their way to Ngara and became sick only once they had arrived at the 
camp. The proportion of febrile patients with falciparum parasites reached 
a peak prevalence of 35% after the fi rst 4 weeks of resettlement and 
subsequently declined, stabilizing at 11%.
Over time, the proportion of the refugee or displaced population that is 
infected – and related malaria mortality and morbidity – will decline unless 
the introduction of infected anopheline mosquitoes into the area leads to 
an outbreak. However, it is important to remember that malaria parasites 
can stay in the blood for a considerable time. Their persistence depends on 
the species: P. falciparum parasites usually remain in the blood for less than 
one year, while P. malariae and P. vivax may persist for years.
If refugees or displaced people return to their area of origin after a pe-
riod of more than a year, it should be assumed that they have lost most of 
their semi-immune status. Children born in the camp will be especially at 
risk once they return “home”. 
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Movement from areas of low or no transmission to areas of high 
malaria transmission
If the refugee or displaced population has moved from an area of low or no 
malaria transmission to an area of high malaria transmission, all age groups 
are at risk. Mortality rates may be high (see Box 2.3). In this context, and af-
ter the exclusion of other prevalent infectious diseases, all fever cases should 
be considered as potentially due to malaria and should, wherever possible, 
be confi rmed by laboratory diagnosis and then treated (see Chapter 5). 
Movement to areas with different malaria species
Populations may be immune to species of malaria parasite that are preva-
lent in their areas of origin, but they will be at increased risk if they move to 
an area where a different species, to which they have little or no immunity, 
predominates.
Epidemiological investigation methods
Epidemiological investigation is required to determine whether malaria is, 
or may become, a signifi cant problem and to monitor trends. This is par-
ticularly important when the local malaria situation is not clearly defi ned 
(see Figure 2.2). For example, a high proportion of fever cases and associ-
ated deaths during the acute phase of an emergency suggests that malaria 
may be an important problem. If the malaria burden is very high in all age 
groups, this may either indicate that the refugee or displaced or host popu-
lations have developed little or no immunity, or signal the beginning of an 
outbreak (see Chapter 4). 
 Note: There is no specifi c epidemiological threshold for a malaria out-
break; thresholds must be adjusted to each epidemiological situation. 
However, the early stage of an outbreak is usually characterized by a 
high and rapidly increasing number of people who are sick with fever 
due to malaria, and a high proportion (usually >50%) of febrile patients 
who are infected with malaria parasites. 
Rapid surveys
Rapid surveys are essential to:
— estimate the proportion of the population, both symptomatic and 
asymptomatic, infected with P. falciparum and other species;
— identify population groups most at risk;
— determine priorities for action, including the most appropriate case 
management and vector control measures.
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Figure 2.2 Assessing the risk of malaria 
Resettlement area
All age groups are at risk
(expected malaria outbreak)
Children and pregnant women
are at risk of (severe) malaria
Coming from non-endemic region
 (little or no immunity)
Coming from endemic areas
Immune status of refugees
Endemic region Non-endemic region
People not at risk of malaria.
Region could be prone
to malaria outbreaks
Quick epidemiological
investigation needed
NOYES
Local malaria situation is clearly defined
Box 2.3 High malaria mortality in non-immune populations moving 
 to high-transmission areas
In Rwanda in 1993, many people were forced to move from highland areas 
in the north of the country, where there is no malaria transmission, to the 
lowlands in the centre of the country, where malaria transmission is high. 
During the same year, refugees from highland areas of Burundi started to 
move to Kigoma in the United Republic of Tanzania, where malaria is highly 
endemic. In both situations, mortality rates were high in the incoming non-
immune population. 
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They include:
— clinic-based fever survey at a health facility or mobile clinic;
— cross-sectional prevalence survey across the affected population(s).
Rapid surveys assess basic clinical signs and parasite presence using mi-
croscopy or RDTs (see Box 2.4). They can be carried out at health centre 
level by confi rmatory testing of symptomatic patients (patients with febrile 
illness or a history of fever), to determine the proportion of febrile cases due 
to malaria. In acute emergencies, when caseloads are unusually high, clinic-
based surveys can provide a very useful initial indication of the relative im-
portance of malaria as a cause of morbidity at facility level. However, it is 
not enough just to survey outpatients with fever, because data from health 
facilities provide information only about people who seek treatment at 
those facilities. In well set up refugee camps where health care is provided 
free of charge, it is possible that everybody can access health care (usually 
5–10 times more than in “normal” conditions); in less well organized situa-
Box 2.4 Defi nitions
Positive RDT rate
The proportion of RDTs positive for P. falciparum malaria. Depending on 
the test used (for example with the HRP-II test), RDT results tend to stay 
positive for 1–2 weeks after completion of treatment.
Parasite rate or slide positivity rate (SPR) or positive RDT rate in 
patients presenting with febrile disease or suspected malaria
The proportion of patients presenting with fever or history of fever in the 
past 48 hours who have malaria parasites in their blood. For the purposes 
of a rapid prevalence survey, malaria disease is defi ned as fever (axillary 
temperature ≥37.5 °C) or history of fever in the past 48 hours plus the 
presence of malaria parasites.
Parasite rate or SPR or positive RDT rate in the population
The proportion of blood fi lms or RDTs showing parasites in a given resident 
population (preferably in the age group 2–9 years).
Spleen rate
The proportion of enlarged spleens (splenomegaly) in a given population 
(preferably in the age group 2–9 years). In a child with a distended 
abdomen from intestinal parasitosis, the umbilicus cannot be used as a 
guide for spleen measurement. It is important to remember that there may 
be other causes of splenomegaly in the area (e.g. visceral leishmaniasis or 
schistosomiasis). It should be noted that increased access to antimalarial 
drugs has an impact on the spleen rate in the investigated population.
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tions, only a minority of the people who are actually sick may attend facili-
ties. The data will not be representative of the overall population nor will 
they provide any indication of what proportion of the overall population 
has malaria infection; cross-sectional prevalence surveys in the community 
are necessary. Depending on the population of interest, the community 
may be the displaced or refugee population and/or the host population. It 
may be necessary to repeat the community survey in different sites if there 
are reasons to suspect localized variations in malaria epidemiology and 
there is limited contact between the different populations.
Rapid clinic-based fever survey at a health facility
The purpose of a clinic survey is to fi nd out the prevalence of parasitaemia 
among symptomatic patients attending the clinic, i.e. the proportion of fe-
brile patients with malaria parasites.
Conducting the survey 
• Choose microscopy or RDTs. In an environment where there are usually 
no skilled microscopists, RDTs give reliable and quick results – always 
bearing in mind that some manufactured tests may be of poor quality, 
which will affect the sensitivity and specifi city of the malaria diagnosis. 
Microscopy through proper staining procedures and under supervision 
by skilled microscopists remains the gold standard for malaria diagno-
sis in addition to the fact that blood smears remain intact for months 
and can be checked (quality control – assurance) by supervisors outside 
the population area. Ensure that assessment team staff are adequately 
trained and skilled to use the chosen method.
• Ensure that there are suffi cient staff. 
• Select a health facility or mobile clinic(s) with high patient attendance. 
Test all patients presenting with a febrile illness, using microscopy or 
RDTs, up to at least 100 patients. If possible do this in one day. 
• Record the total number of outpatients seen at the clinic while the survey 
is being done.
• Record the age, sex and place of origin of all patients and the pregnancy 
status of female patients.
• Use the defi nition of malaria-positive described in Box 2.4 (parasite rate 
or SPR or positive RDT rate in patients presenting with febrile disease or 
suspected malaria). 
• In the fi rst few weeks of the acute phase, repeat the survey every week, 
and then at least every month to monitor trends. 
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Analysis and use of results 
• Record the total number of patients at the clinic, total number of fever 
cases, proportion of fever cases among all outpatients, and proportion of 
confi rmed malaria cases among fever cases investigated. 
• Present the results graphically by week and age group. 
In the host population
• If parasites are found in fewer than 10% of fever cases, this is an indica-
tion of low transmission (children and adults usually at risk of disease).
• If parasites are found in more than 50% of fever cases in children aged 
under 10 years and less than 50% of adult fever cases, this is an indica-
tion of high transmission (children most at risk).
• If parasites are found in more than 50% of fever cases in children aged 
over 10 years and adults, this is an indication of the possible onset of an 
outbreak. 
In the refugee population
Analysis in the refugee population is more complex, since the same results 
may refl ect different scenarios or situations (as listed below), especially in 
the fi rst few weeks of settlement. A high proportion of fever cases positive 
for malaria in refugees or displaced people may be an indication of:
• High local malaria transmission:
— If the incoming population is non-immune, high morbidity and mor-
tality rates will be recorded in all age groups.
— If the incoming population is semi-immune, children and pregnant 
women are most at risk, showing high morbidity and mortality 
rates.
• High malaria endemicity in the area of origin, regardless of the level of 
transmission in the resettlement area:
— If there is low transmission in the resettlement area, over time either 
local transmission may start on an epidemic scale if receptivity is 
high or fewer and fewer people will become sick until there is a low 
proportion of malaria disease in health care facilities.
• High malaria endemicity in areas they travelled through regardless of 
the level of transmission in the resettlement area: 
— As above.
• The beginning of a malaria outbreak if the refugees or displaced popula-
tion have come from a low to a high transmission area. 
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Rapid cross-sectional fever and parasitological prevalence survey 
across the affected population
Guiding principles 
• Highly precise survey results are usually not needed during acute emer-
gencies. The need is rather for acceptable precision in determining the 
level of malaria endemicity, particularly to distinguish between medium/
high endemicity (more than 10% of people in the general population are 
infected) and low endemicity (well under 10% of people are infected), 
since the interventions to be planned are quite different. 
• More precise survey data may be needed for operational research and for 
evaluating the impact of interventions over time and space. 
The purpose of a community cross-sectional prevalence survey is to:
— provide pre-intervention baseline data;
— ascertain the prevalence of symptomatic and asymptomatic malaria 
(with confi rmed parasitaemia) across all age groups;
— identify groups at risk and target interventions;
— gather information on the treatment-seeking behaviour of the popu-
lation, for example, whether they received treatment in the previous 
7 days, what treatment they received and where they received it.
In general, it can take 3–6 days to carry out a rapid cross-sectional malaria 
prevalence survey and it should be planned accordingly. It is useful to col-
lect baseline information about haemoglobin levels (for example, using the 
Haemoglobin Colour Scale) where possible, because malaria is often an 
important cause of severe anaemia (Hb <6 g/dl) in endemic areas. 
Conducting the survey
• Choose a diagnostic tool. Unless there is a team of good microscopists, 
RDTs (pre-qualifi ed, once available, or with evidence of good manufac-
turing practice; www.wpro.who.int/rdt) are the most appropriate tools 
for testing the blood for malaria parasites where rapid results are needed. 
Several RDTs are available, but the stability of all of them is affected by 
conditions of high humidity and temperature (>30 °C). Some test only 
for P. falciparum while others will test for more than one species but are 
usually more expensive and less stable than tests for P. falciparum alone. 
Cassettes and cards are simpler to use than dipsticks, but all need basic 
training and regular supervision. Microscopy can be used if suffi cient 
time, resources and trained staff are available and if there is a need to 
determine the prevalence of other species and to establish and maintain 
quality control procedures.
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• Defi ne the study population. If there are differences in malaria epidemi-
ology, it will be necessary to defi ne a study population within each type 
of ecological area or to take separate samples of the same size from each 
area. 
• Determine the sample size. The required sample size depends on the 
expected prevalence of malaria illness and parasitaemia, on how precise 
the results need to be (i.e. how “wide” the 95% confi dence interval can 
be allowed to be), on the sampling method (the “design effect”) and, to 
a lesser extent, on the size of the population. For valid comparisons, a 
smaller sample is suffi cient when the spleen or parasite rate is high in 
the investigated areas. For statistical validity of results, however, a large 
sample is required; see example in Table 2.2. The StatCalc program 
on EpiInfo, which can be downloaded free from http://www.cdc.gov/
epiinfo, can be used to help in the calculation of sample size. 
 For example: 
 The prevalence is assumed to be 50%; 45% is used as the “lowest accept-
able result”; the population is 25 000; the chosen confi dence interval is 
95%. The desirable sample size using EpiInfo would be 378. With an 
assumed design effect of 2 (depending on the sampling method), the 
required sample size is 2 x 378 = 756.
Table 2.2 Confi dence interval at 95% probability level for a standardized
 sample of 100 and 500, using random sampling 
Prevalence 60 50 40 10 5
95% confi dence interval, with a 
sample size at random of 100 50–70 40–60 30–50 5–18 2–11
95% confi dence interval, with a 
sample size at random of 500 56–64 46–54 36–44 8–13 3–7
For example: 
If in a sample of 100 children parasites are found in 50, the parasite rate in the total 
population of children of the same age group lies between 40% and 60%, and this 
may be assumed with a 95% probability. With the same result in a sample of 500 
children, the 95% confi dence interval would be 46–54% (Bruce-Chwatt, 1985).
Note: These fi gures are for random sampling, not for cluster sampling. Random 
sampling selects sample units such that each possible unit has a fi xed and deter-
minate probability of selection (Last, 2001). Thus, each person has an equal chance 
of being selected out of the total study population. Random sampling should not be 
confused with haphazard assignment. Random sampling follows a predetermined 
plan that is usually devised with the aid of a table of random numbers.
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• Confi dence interval. A 95% confi dence interval is the standard bench-
mark used when analysing survey data. It means that there is a less than 
5% chance that the true values will fall outside the interval. The larger 
the sample size, the more accurate is the measured prevalence rate ex-
pected to be, and the narrower the 95% confi dence interval. Survey re-
ports should preferably provide a 95% confi dence interval in the results. 
Confi dence intervals can become fairly wide when data need to be bro-
ken down by age – which is probably adequate for purposes of planning 
malaria control programmes. However, to demonstrate a statistically 
signifi cant change in prevalence associated with a particular interven-
tion, the size of the effect would need to be very large to be detected. 
If the results from the study are to show that an intervention has been 
effective, a larger sample size may be needed. This is particularly impor-
tant for children under 5 years of age, because it is often this group that 
should be targeted by interventions and the desired changes associated 
with these interventions need to be measured.
• Choose a sampling method. There are many sampling methods. For 
malaria, everyone in the household is usually surveyed. Each house-
hold must have an equal chance of being selected. Methods of select-
ing households include random sampling, systematic sampling, and 
random cluster sampling. However, in the acute phase of emergencies, 
households may not be stable or well defi ned, and the most appropriate 
method in the fi rst few weeks of this phase may be random sampling. 
• Recruit and train survey team, selecting one person as team leader. The 
team should include:
— 1 person to explain the procedure and obtain informed consent from 
the household. Ideally this person should be a community member. 
— 1 person to register the participants, record the axillary temperature, 
the RDT result and information on treatment-seeking behaviour.
— 1 person to take the axillary temperature and perform the RDT or 
make a malaria smear on a slide.
— 1 person to measure spleen size (if this is to be done) or, more feasible 
in emergencies, to check for the presence of enlarged spleen.
— 1 person to administer treatment (if this is given on the spot) and to 
provide advice about danger signs and follow-up.
• Ensure adequate supplies. The following are essential: 
— Rapid tests or microscope slides and associated consumables (e.g. 
lancets, rubber gloves, alcohol for swabbing skin, cotton wool, suit-
able disposal facilities for sharps and contaminated materials).
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— Referral forms for the nearest suitable clinic.
— Administrative equipment, e.g. log book, consent forms (see an ex-
ample in Annex II), record forms (see Annex III), pens, pencils and 
markers.
— Funds to pay for transport to the clinic if needed.
• Repeat the survey. It can be useful to repeat the survey during a different 
season and compare the results, if malaria transmission is seasonal. For 
example, in some areas prevalence is lower at the end of the dry season 
than at the end of the wet season. In areas where malaria transmission is 
intense all year round, repeating the survey several months after the start 
of the emergency response can provide a good indication of the impact 
of interventions. In areas with marked seasonal peaks it may be useful 
to repeat the survey after 12 months (i.e. at the same time of year) to 
measure any impact of interventions. 
Analysis and use of results
• Prevalence of malaria. Calculate the proportion of people, out of the 
entire population, with fever or a history of fever who have a positive 
RDT (or slide) result. This will provide an estimate of the prevalence of 
malaria in the study population at that specifi c point in time. Analyse 
the data by sex and by age group. The number of pregnant women in the 
sample will probably be too low to be statistically signifi cant.
• Endemicity. Calculate the proportion of people who have a positive 
RDT or slide result and the proportion who have splenomegaly (bearing 
in mind that widespread use of drugs may affect splenomegaly rate). Use 
the parasite rates – or spleen rates if microscopy or RDTs are not pos-
sible – to estimate the underlying endemicity of malaria (see Table 2.3). 
Table 2.3 Malaria endemicity according to spleen and parasite rates
Malaria endemicity Spleen rate (SR)  Parasite rate (PR)
 Under 5 years Over 5 years Under 5 years Over 5 years
Meso- and hyper- Very high Low or   High (>50%),  Low
endemic (usually   zero but lower 
linked to high    than spleen 
transmission)   rate
Hypoendemic  Low (<10%)  ≤10%, always higher 
(usually linked to    than spleen rate
low transmission)  
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In cross-sectional surveys, parasite and spleen rates are normally deter-
mined in children aged 2–9 years. In areas where malaria transmission is 
high, parasite and spleen rates are highest in children aged under 5 years and 
decline above that age. In areas where malaria transmission is low, parasite 
and spleen rates are low and are equally distributed over all age groups.
• Representativeness of the sample. Check the survey data to see whether 
there are many absentees, whether the sex and age of absentees are 
statistically different from the group sampled, and whether particular 
groups (e.g. children aged under 5 years) are underrepresented. Also re-
view the sex and age groups of the sample to see whether the proportions 
are similar to those in the whole community (see Chapter 3, Table 3.1).
• Enter the data into a software program (e.g. EpiInfo) to help with analysis.
• Calculate to 95% confi dence interval, if possible.
Important aspects of planning
Selecting resettlement sites 
In the initial phase of complex emergencies, refugees and internally dis-
placed people move quickly to the nearest safe place outside the confl ict 
area. Subsequently, international organizations and the host government 
may resettle the refugee or displaced population in more permanent sites. 
Whether or not this happens depends on the local situation; for example, 
some host governments may be reluctant to encourage the establishment of 
long-term settlements. 
If refugees and displaced populations are to be resettled, criteria for 
selecting a site include the availability of water and land, means of trans-
port, access to fuel, security and, where relevant, distance from borders. 
However, areas that meet these criteria are usually already occupied by the 
resident population, so refugees and displaced populations are often reset-
tled in less desirable sites. 
If there is a choice, it may be necessary to consider more specifi c criteria 
that may affect the risk of malaria (see Box 2.5). When selecting a site:
• Assess the epidemiological characteristics of the area, if this information 
is available. 
• Investigate potential vector breeding sites and make use of local exper-
tise and knowledge of local vectors. 
• Avoid sites close to major breeding places of local vectors. In Africa, 
such sites often include marshy areas and fl at, low-lying land at risk of 
CHAPTER 2. INITIAL ASSESSMENT AND PLANNING
MALARIA CONTROL IN COMPLEX EMERGENCIES
34
fl ooding. If possible, sloping, well-drained sites with tree cover, sheltered 
from strong winds, should be chosen. In south-east Asia, thick forest 
should be avoided.
Box 2.5 Malaria and resettlement sites
In 1994, around 1 million people fl ed from Rwanda to eastern DRC in a 
short period of time. Four refugee camps were established around the 
town of Goma. One of these camps was sited close to lowland marshes. 
Malaria prevalence in this camp was 30–40%, compared with 5–15% in the 
other three camps, resulting in high rates of mortality.
Selecting vector control activities
If malaria transmission is very high, rapid prescriptive standardized ap-
proaches, may be necessary, such as indoor residual spraying (IRS), or 
provision of blankets or other materials that have been treated with insec-
ticide (see Chapter 6). However, costly activities such as IRS require a clear 
understanding of vector behaviour and the susceptibility of the vectors to 
insecticides.
Selecting effective fi rst-line antimalarial treatment
Since early diagnosis and prompt effective treatment are the fi rst priority in 
malaria control, it is essential to select and use a fi rst-line antimalarial drug 
that is effi cacious and safe, with limited contraindications and side-effects 
(see Chapter 5). 
Managing supplies of antimalarial and other essential drugs 
After antimalarials have been selected, important steps in establishing sys-
tems to manage drug supplies are the following: 
• Establishment of a working group or interagency committee, involving 
local and international agencies and organizations, to manage the emer-
gency.
• Establishment of a subcommittee of the working group to manage sup-
plies of essential drugs, including antimalarials. It makes sense for the 
agency with the most experience and expertise in essential drug supply 
management to take the lead, with responsibility for receiving, storing 
and distributing drugs and monitoring drug supply. However, it is also 
important to respect the sovereignty of the host country and the affected 
population, regardless of the drug supply situation. 
35
• Careful attention to drug quality and sources of supply. It is important to 
check product specifi cations, expiry dates, dosage form and strengths. 
• Proper management of stocks. Drugs from different sources should be 
easily identifi able or kept separately. The system for stock management 
should be as simple as possible and within the scope of the host country. 
If the complex emergency is very severe or large scale, it may be neces-
sary to computerize the stock management system.
• Development of a clear policy for free distribution of drugs, ensuring 
that all agencies and communities are aware of this policy.
• Ensuring that all staff who provide health care are trained in rational use 
of drugs, including recommended antimalarials; provision of training if 
necessary.
• Getting the advice of the relevant authorities if donated supplies or the 
only available supplies of drugs are not approved or included in national 
protocols. If there is no other option, staff should be trained in the ra-
tional use of these drugs as a temporary measure to save lives; approved 
treatment guidelines should be used as soon as this is possible.
• Ensuring that patients are followed up where possible. This requires 
adequate staff and a good patient registration system. Patient follow-up 
may not be feasible in the acute phase of an emergency where there are 
large caseloads, but should be possible once the displaced or refugee 
population is living in stable settlements and during the chronic phase. 
If possible, the opportunity should be taken to monitor patient drug use 
behaviour, for example adherence to treatment regimens. 
• Early decision, with the host government, on whether or not the resident 
population will also have access to health care services delivered as part 
of humanitarian assistance. If so, estimates of the resident population 
must be included when drug supply requirements are calculated.
Summary
• Assess the existing capacity and data:
— pre-departure data collection (24 hours)
— general assessment in the fi eld (less than 1 week).
• Find out what proportion of people presenting to the clinic with a febrile 
illness have malaria:
— clinic-based fever survey (1 day).
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• Find out how big the problem is and who is most affected:
— rapid cross-sectional malaria prevalence survey (3–6 days).
• Defi ne intervention on the basis of the results of the rapid surveys in 
health care facilities and through household surveys, taking into account 
as well other important risk factors (such as severe malnutrition) and 
operational information gathered through the fi rst assessments.
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Finding out more
Most of the information you require for initial assessment can usually be 
obtained from:
— interviews with health authorities, government representatives, 
members of the affected community, health care personnel, donor 
and United Nations agency representatives, and health care agen-
cies;
— review of reception and registration records;
— laboratory records;
— published literature;
— reports from WHO and international partners.
Sources of information to help with planning include WHO, United 
Nations Children’s Fund (UNICEF), United Nations Development Pro-
gramme (UNDP), Offi ce of the United Nations High Commissioner for 
Refugees (UNHCR), health ministries and national malaria control pro-
grammes, research institutions, NGOs, international and national journals 
and publications and web sites (see Annex I).
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CHAPTER 3
Surveillance
This chapter:
■ outlines the information that is needed to plan and implement a 
surveillance system to monitor the ongoing malaria situation
■ describes how to establish a surveillance system, including the data 
that should be collected, how to collect them and how to use them.
Malaria surveillance in complex emergencies
Surveillance is the continual and systematic collection, analysis and in-
terpretation of health data essential to the planning, implementation and 
evaluation of health interventions. It is also a tool for measuring the health 
status of a population. In a complex emergency situation, surveillance is a 
priority and must be established quickly. It can, for example, help both to 
determine whether or not malaria is a signifi cant health problem and to 
decide on operational priorities. 
Malaria surveillance should be integrated into an overall system for sur-
veillance of all the main causes of mortality, which is usually based on the 
network of health facilities in an area. 
The purpose of malaria surveillance is to:
• Monitor trends, for example:
Are malaria cases or malaria deaths increasing or decreasing?
Is this due to new arrivals or the displacement of the population?
• Provide early warning of an outbreak, for example:
Is malaria incidence increasing?
• Monitor the effectiveness of malaria control interventions and, if neces-
sary, redefi ne priorities, for example:
Do sick people have access to health care?
 How effective is detection and treatment of malaria cases?
If no surveillance system is in place or the existing system is inadequate, it is 
essential to establish a system – but this must be done in a coordinated way 
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(see Box 3.1). Obstacles to establishing a surveillance system in a complex 
emergency situation may include:
— poor understanding at fi eld level of what a surveillance system is and 
why it is needed, resulting in poor recording, reporting and use of 
information;
— poor motivation of health workers because of lack of feedback;
— lack of diagnostic tools to confi rm clinical diagnosis, resulting in 
inaccurate and unreliable data;
— lack of representativeness of data collected because only a small per-
centage of the population use health services and security problems 
limit access for a proportion of the affected population;
— lack of coordination between agencies. 
Box 3.1 Surveillance problems in East Timor1
Following a vote for independence from Indonesia in August 1999, most 
of the population of East Timor1 was displaced, and health facilities and 
medical infrastructure were destroyed. There was no functioning 
government or ministry of health, records had been destroyed and there 
were no available data. All humanitarian and health agencies began to 
develop their own basic surveillance systems to collect baseline data 
about disease incidence, prevalence and mortality rates to enable them to 
plan health services. Coordination was poor, however, and information 
was not always shared. Eventually a standardized surveillance system 
was developed by WHO. 
1 Now Timor-Leste.
Collecting basic information
Before a surveillance system is implemented, certain basic information 
about the size and structure of the population is essential. It can also be 
useful to fi nd out about recent mortality. 
Population size 
To be able to calculate health indicators, such as the mortality rate, the to-
tal size of the population must be known. This can be determined by:
— counting households and the average number of people per house-
hold 
— mapping the site’s surface area and measuring the average population 
density
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— carrying out a census or reviewing records of camp registration, food 
distribution, etc; or
— using information from programme activities (e.g. vaccine cover-
age).
Counting households
The total size of a population is estimated by multiplying the number of 
households by the average number of people per household: this informa-
tion can be obtained by exhaustive counting or systematic sampling.
Exhaustive counting of households
1. Count the total number of households in the area. This can be done on 
foot, from a vehicle or by aerial photography. Because it is exhaustive, 
this method is most appropriate for small sites covering limited areas.
2. Calculate the average number of persons per household by conducting a 
small survey of sample households selected at random. A minimum of 30 
households should be selected.
3. Estimate the total population by multiplying the total number of house-
holds by the average number of persons per household.
Systematic sampling 
1. This technique is particularly adapted to well-organized refugee camps. 
Using interval sampling and a departure number chosen at random, 
select a sample (and thus determine each household to be visited). This 
method assumes that households are arranged in such a way that inter-
val sampling is possible and that their approximate number is known.
 For example:
 Estimated no. of household = 4000
 Convenient sample size chosen = 400
 Sample interval = 4000/400 = 10 (information on the number of person 
living in an household will be collected in every 10 habitats)
 If the randomly chosen departure point is 6 (i.e. the sixth household 
beginning at one extremity of the camp), the selected households are 
therefore number 6, then number 16 (6+10), then number 26 (16+10), 
etc.
2. Estimate the total population by multiplying:
 (total no. of households visited) x (average no. of persons per household) 
x sample interval.
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Mapping
The total size of a population is estimated by multiplying the total surface 
area of a site (m2) by the average population density per m2: this informa-
tion can be obtained by the quadrate method or the T-square method. 
Quadrate method (see Figure 3.1) 
1. Draw the camp boundary. This can be accomplished either by taking 
GPS points along the perimeter and drawing the map with software, or 
by hand with a compass and then on paper.
2. Select 30 systematically random locations within the site. This can also 
be accomplished by mapping software or by hand. In Figure 3.1, six such 
points are shown.
3. Mark off a 25 m x 25 m quadrate, or block, physically with a rope or 
using a telemeter at each point. 
4. Count the population within each quadrate, and the number of persons 
and number of households for the 30 quadrates.
5. Calculate the average population per quadrate.
6. Estimate the site population by extrapolating the average population per 
quadrate to the entire site surface. Confi dence intervals are then calcu-
lated around the estimate.
a Source: MSF/Epicentre.
Figure 3.1 Quadrate method for calculating population sizea
Site map, Beira
= 25 m x 25 m quadrate
1. Draw site boundary
2. Select 30 starting points
3. Mark 30 (25 m x 25 m) blocks
4. Count population in each block
5. Calculate average population/block
6. Estimate the total site population
25 m
25
 m
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Further details for the quadrate method are provided in Rapid health as-
sessment of refugee or displaced populations (MSF, 2005, in press).
T-square method1
The T-square method “involves sampling a number of random points, 
measuring the distance between each point and the nearest household or 
family unit, and then measuring the distance between that household and 
the next closest one, as a way of measuring population density”.2 It gives a 
more accurate evaluation of the population size, but is more complicated to 
perform than the quadrate method. 
Census or registration
Census
A census of the displaced population is the ideal method, if it is feasible. 
It involves visiting homes and counting how many people live in each. If 
security allows, it is best done early in the morning or in the evening when 
refugees or displaced people are “at home”. However, in an emergency situ-
ation, there may not be suffi cient time or human resources to carry out a 
census.
 For example:
 Following the fl oods in Mozambique, a quick census was carried out by 
an agency in two temporary accommodation centres. The census was 
done at night when people were most likely to be at home. It was found 
that, although the number of residents had been estimated at 10 000, 
the actual number of people residing in the accommodation centres was 
around 6000. The reason for this discrepancy was that many people 
who were present in the camp during the day were actually returning to 
their villages at night.
Registration
Registration of refugees or displaced people when they arrive at a site can 
provide an opportunity to collect data about population size (and struc-
ture). Registration can also be combined with other activities, such as dis-
tribution of food cards, detection of malnutrition and vaccination against 
measles.
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Data from programme activities
Information from programme activities, such as a vaccine coverage survey 
of a specifi c age group (e.g. children aged 6–59 months), can be used to 
estimate the number of children in this age group as well as the total popu-
lation. 
 For example:
 A measles vaccination survey estimates vaccination coverage among 
children aged 6–59 months in a camp to be 80% (0.8) and 5000 mea-
sles vaccines were administered in this age group. Using these data, the 
number of children aged 6–59 months can be estimated: 5000/0.8 = 
6250. If, from another survey, it is known that children in this age group 
represent 20% of the population in question, the total population can be 
estimated: 6250/0.2 = 31 250. 
Population structure
Since vulnerable groups need to be monitored, it is useful to know what 
proportion of the population are pregnant women and children under 
fi ve. The usual methods for determining the population structure include 
estimation based on the normal distribution of age groups in the general 
population (see Table 3.1).
Table 3.1 Distribution standard by age of stable populations 
 in developing countries
 Age group Proportion of total population
 0–4 years 17%
 5–14 years 28%
 15–29 years 28%
 ≥30 years 27%
 Total 100%
However, complex emergencies can affect the normal age and sex struc-
ture of populations. For example, there may be proportionally fewer men 
and proportionally more women, young children and elderly people. It will 
therefore be necessary to conduct a simple census or sample survey to fi nd 
out about the age breakdown of the population.
As a minimum it is important to estimate the expected number of chil-
dren under 5 years of age and pregnant women if the camp population were 
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of the same composition as a normal population. A quick way to estimate 
the number of pregnant women is to use the following calculation:
total pregnant women = total population x 0.51 x 0.50 x 0.20
 0.51 = 51% = proportion of women in a population.
 0.50 = 50% = proportion of women of childbearing age (15–45 years) 
among all women in the population
 0.20 = 20% = chance of any woman aged 15–45 years being pregnant at 
a given moment, assuming a total fertility rate per woman of childbear-
ing age of 8.1
Retrospective mortality
Retrospective mortality data can help to assess how the current situation 
compares with the recent situation. This is useful for determining trends 
and the seriousness of the situation (see Box 3.2 for the threshold of gravity 
based on mortality rates). Methods for estimating retrospective mortality 
include sample surveys and counting the number of recent graves.
Box 3.2 Mortality rates and threshold of gravity
During an emergency, mortality rates are expressed as the number 
of deaths per 10 000 persons per day, whatever the method of data 
collection. The threshold of gravity1:
■ of crude mortality = 1 death/10 000 persons per day
■ of mortality in children under 5 = 2 deaths/10 000 children under 5 per day.
1 MSF (1997).
Retrospective mortality survey
Death – the event being quantifi ed – is relatively rare, and the sample there-
fore needs to be adequately large. For cluster sampling, 30 clusters of 30 
families (approximately 4000 individuals) is an appropriate sample size.
The head of each family surveyed is asked about the occurrence (or not) 
of death within the household during a defi ned period of time. To avoid 
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example 5. If so, a woman is pregnant 5/30 years (16.7%) for 9/12 months (75%); 
from this, the chance of any woman aged 15–45 years being pregnant at a given time 
= 16.7% x 75% = 12.5%. At a total fertility rate of 8 children per woman of 15–45 
years, 20% of women of childbearing age can be expected to be pregnant at any given 
time.
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recall bias and to limit diffi culties in interpreting the results, this period 
of time should be as short as possible but long enough to allow a suffi cient 
number of “death events” to have occurred.
To calculate the mortality rate in the surveyed population: 
• Divide the total number of deaths that have occurred in a sample (nu-
merator) by the total number of surveyed individuals alive plus the 
number who have died (denominator) during a given period of time. 
• Multiply the result by 10 000 and relate it to a period of one day to per-
mit comparisons to be made. 
 For example:
 A survey of 5500 individuals showed that there were 49 deaths during 
the 28 days preceding the survey. The mortality rate was thus {[49/(5500 
+ 49)] x 10 000} / 28 = 3.2 deaths/10 000 population per day.
Counting recent graves
In some situations it is possible to count the number of graves dug since 
the arrival of the refugee or displaced population. Although this method is 
approximate, it provides some useful information when no other data are 
available.
 For example:
 Six months after the arrival of a large number of displaced people at 
Hoddur in Somalia, 5900 graves were counted among a population of 
25 000. Thus 5900/(5900 + 25 000) = 0.19 = 19% of the population 
died in 6 months, an average of 10.4 deaths/10 000 population per day.
Surveillance priorities in complex emergencies
In an emergency situation:
• Collect only the information that is absolutely necessary. 
• Keep data collection as simple as possible.
• Decide who will collect data and from where (see Box 3.3).
• Decide how often to collect information.
• Budget for the costs of surveillance (see Box 3.4). 
• Analyse what the information reveals about trends. 
Collecting data
In complex emergencies, it is essential to prioritize the surveillance of mor-
tality, the causes of mortality, morbidity, programme effectiveness indica-
tors, and malaria-specifi c indicators.
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Box 3.3 Collecting data
Possible approaches to collecting data include involvement of:
■ local community health workers working with the team responsible for 
coordinating health services for the affected population;
■ health personnel working in hospitals (outpatient and inpatient 
departments), health centres, the community, and mobile outreach teams;
■ special teams trained to conduct surveys.
Box 3.4 Budgeting for surveillance 
Human resources
Usually a combination of local and health ministry resources, e.g. vector 
control teams from the national malaria control programme, reinforced by 
expatriates. The minimum requirement is one epidemiologist and one 
laboratory technician. Outreach teams may also be needed, as may 
additional medical and technical staff to expand services to cope with an 
increased caseload, and community mobilizers and educators to encourage 
preventive and early treatment-seeking behaviour.
Laboratory
Costs will depend on whether or not RDTs are used. Other essential 
laboratory equipment and supplies (see Chapter 5) need to be costed. 
Transport
Requirements and costs will depend on the terrain and the accessibility of 
different areas. 
Other costs
Could include forms, equipment or materials required for analysing data, 
communication equipment, training and administration.
Mortality
Monitoring mortality is essential: death rates are high in the acute phase of 
an emergency and the immediate priority is to reduce mortality as quickly 
as possible. Mortality should be assessed across a standardized age group 
and among pregnant women.
Indicators used for mortality surveillance include: 
— number of deaths per 10 000 persons per day: crude mortality rate;
— number of deaths in children under fi ve per 10 000 per day (under-5 
mortality rate);
— mortality rate for specifi c diseases (e.g. malaria, measles, acute respi-
ratory infections, diarrhoea);
— proportion of mortality attributable to specifi c diseases.
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An active mortality surveillance system using home visits should be es-
tablished and home visitors trained to record total daily deaths and deaths 
in children under 5 years of age. Each home visitor should cover a popula-
tion of approximately 1000. Daily data should be compiled and analysed 
at the end of each week (Table 3.2 provides an example of a surveillance 
form) together with mortality data from health facilities, to ensure that all 
available data are included.
Table 3.2 Example of mortality surveillance form
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Population*
Population End of  New Departures End of  Average
 previous  arrivals  this week   population
 week (A)   (B)  (A+B)/2
<5 years old
All ages
Pregnant women
*Information about the population is needed to calculate mortality rate.
Mortality rate
 Number of deaths Rate (deaths/10 000 per day)
 Male Female Total Male Female Total
<5 years old
All ages
Pregnant women
Causes of mortality
The mortality surveillance system can also be used to collect informa-
tion about causes of death (Table 3.3 provides an example form). Possible 
sources of these data include health facility registers, home visits and in-
terviews with household heads. The head of the family is asked about the 
main symptoms before death. Simple defi nitions should be used (e.g. for 
malaria, presence of fever and shivering) and, where feasible, local names. 
“Closed” questions (requiring Yes or No answers) are preferable for this 
type of survey.
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Table 3.3 Example form: causes of mortality
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Diseases <5 years of age ≥5 years of age Total Percentage
 M F Total M F Total M F Total
Non-bloody diarrhoea
Bloody diarrhoea
Severe respiratory infections
Malaria
Measles
Malnutrition
Suspected meningitis
War injury
Others
Total
Causes of morbidity
A standardized case defi nition should be used for each disease, and morbid-
ity should be assessed across a standardized age group and among pregnant 
women.
Indicators used for morbidity surveillance include:
— incidence rate  (the number of new cases per week, expressed as a 
percentage of the population or per 1000, 10 000 or 100 000 persons).
— incidence rate by age group (e.g. the number of new cases/week in 
under-fi ves).
These data can be collected daily from health facilities providing outpa-
tient and inpatient services to the population, and from the community by 
a mobile team. Daily data should be compiled and analysed at the end of 
each week. 
Programme effectiveness indicators
Information on programme effectiveness indicators should be collected and 
analysed every week to assess how well different components are functioning. 
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Indicators that can be used to monitor programme functioning include: 
• How many home visitors are working and where?
• How many patients are treated and where?
• How many health personnel are involved?
• What kind of antimalarial drugs are available?
• How long is the delay between ordering the drugs and receiving them 
into the health facilities? 
• Are there frequent shortages of drugs? If so, how long do they last?
• Are rapid diagnostic tests available? Are there frequent shortages of di-
agnostic supplies? If so, how long do they last?
• What percentage of febrile patients are tested using blood smears or 
RDTs in outreach activities or in health facilities, and what is the delay 
(both average and extreme) before test results are known?
Monitoring case management is particularly important, to see how well 
cases are being diagnosed and treated. Indicators that can be used to moni-
tor case management include: 
— case-fatality rate (the number of deaths due to a specifi c disease/total 
number of cases of the disease per week).
Monitoring coverage is also important to ensure that vulnerable groups 
are being reached or have access to services. Indicators that can be used to 
assess coverage include:
— the proportion of sick patients with access to a health centre;
— the proportion of affected geographical areas covered by the pro-
gramme;
— the proportion of pregnant women and under fi ves covered by the 
programme.
Malaria-specifi c indicators
Malaria surveillance should include the indicators summarized in Table 3.4.
Data collected should be based on the standardized WHO defi nitions 
(see Box 3.5). Standard case defi nitions and proper confi rmation of cases 
are essential for accurate surveillance and to make informed judgements 
about progress. Relying only on clinical diagnosis is likely to provide 
inaccurate data about malaria cases, so it is important to use a suitable 
confi rmatory tool, such as RDTs or microscopy. Accurate surveillance also 
depends on good reporting and analysis of data collected. 
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The type of surveillance that is feasible will depend on the phase of 
the emergency. As discussed in Chapter 2, during a fi rst assessment in the 
acute phase, surveillance may focus on cross-sectional population surveys 
to assess the prevalence of disease, or on compiling hospital inpatient data 
to assess the ratio of malaria to other life-threatening diseases. A malaria 
survey may be carried out, covering fever incidence, malaria incidence, 
slide positivity rate and spleen rate. Once the situation stabilizes, however, 
and microscopy is established, slide positivity rates, RDT positivity rates or 
malaria incidence rates may be used to guide prioritization of settlements 
for vector control. For example, in the Afghan refugee camps in Pakistan, 
only those where incidence exceeded a certain threshold were targeted for 
vector control. Using this system, preventive interventions were limited to 
the most endemic camps.
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Table 3.4 Indicators for malaria surveillance
Rates Calculation Interpretation and decisions
Specifi c malaria  Number of malaria deaths/ Is malaria a health priority?
mortality 10 000 per day in each area 
Proportion of mortality Number of malaria deaths/ Is malaria a health priority in
caused by malaria total number of deaths the emergency context?
Malaria incidence  Number of new malaria  Is malaria increasing? 
rate cases/total population per  What action should be
 week in each area  taken? 
Case-fatality rate in  Number of confi rmed malaria  Are cases being managed
all malaria cases deaths/total number of  effectively?
 confi rmed malaria cases per 
 week in each area  
Case-fatality rate in  Number of confi rmed  How effective is the referral
severe malaria cases  malaria deaths/total number  system and hospital 
 of severe malaria cases management of cases?
Slide positivity rate Ratio between the number  How good is detection of
 of confi rmed cases and of  patients with malaria?
 clinically suspected cases Increasing rate may indicate 
  the beginning of a malaria 
  epidemic or a seasonal peak
Proportion of fever  Number of fever cases with  How important a health
caused by malaria confi rmed parasitaemia/ priority is malaria?
 total number of fevers   
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Establishing accurate surveillance requires the setting up of microscopy 
quality control: the service can be provided by technicians of a central 
reference laboratory who regularly monitor the technical accuracy of mi-
croscopists working in fi eld laboratories and clinics. In the Afghan refugee 
programme, for example, two reference laboratories monitored 45 fi eld 
laboratories which, in turn, monitored more than 200 camp clinics.
Box 3.5 Standardized malaria case defi nitions and classifi cation1
Confi rmed uncomplicated malaria
A patient with symptoms and/or signs of malaria, with laboratory 
confi rmation of parasitaemia.
Confi rmed severe malaria
A patient who requires hospitalization for symptoms and/or signs of 
severe malaria, with laboratory confi rmation of parasitaemia. 
Note: The uncomplicated and severe malaria categories are intended 
to be mutually exclusive. For example, a patient who initially presents 
with uncomplicated malaria but then develops signs or symptoms of 
severe disease should be classifi ed only as having severe malaria, and 
not counted twice. This also applies to situations where health services 
record cases as “suspected malaria” until diagnosis is confi rmed by 
microscopy or RDT, after which the cases become “confi rmed malaria”. 
Suspected and confi rmed malaria cases should be reported separately.
Treatment failure
A patient with treated confi rmed malaria who returns with sign and 
symptoms of malaria and is laboratory confi rmed as being parasite-
positive within 2–4 weeks of treatment. 
Note: Collecting data about patients who return can help to identify 
problems, for example drug resistance, poor treatment adherence or 
inadequate diagnosis.
Suspected malaria death
Death of a patient who has been diagnosed with probable severe malaria, 
with no laboratory confi rmation of parasitaemia.
Confi rmed malaria death
Death of a patient who has been diagnosed with severe malaria, with 
laboratory confi rmation of parasitaemia.
1 Adapted from: WHO (2000). 
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Resistance surveillance
If possible, it is very useful to identify at least one “sentinel site” in a health 
facility for conducting in vivo resistance surveillance (see Chapter 8). The 
WHO protocol for in vivo resistance surveillance recommends that a blood 
smear be carried out for each confi rmed malaria patient on days 0, 1, 2, 3, 
7, 14 and 28. Resistance surveillance allows the effi cacy of fi rst-line treat-
ment to be confi rmed and monitored.
Summary
Strategies for establishing an accurate and reliable surveillance system 
include:
• Liaison with local health authorities and emergency partners. Ensure 
that there is coordination. It can be useful to assign responsibility for 
organizing and supervising the surveillance system and for coordination 
to one agency or organization. Integrate the system into the national 
system as far as possible.
• Use of standardized case defi nitions. Focus on the most signifi cant 
priority diseases, especially those most likely to cause outbreaks, and 
provide appropriate training for health workers and staff working for 
emergency partners.
• Ensuring that malaria surveillance includes pregnant women.
• Rapid re-establishment of laboratory facilities with confi rmatory di-
agnostic tools (RDTs or microscopy). Provide appropriate training for 
health workers and laboratory technicians.
• Re-establishment of a reporting and analysis system. Set up standard-
ized mechanisms among all emergency partners, provide training, en-
sure that health workers receive feedback, and support communication 
between fi eld and district levels.
• Ensuring that all health facilities are included in the system. If necessary, 
set up mobile clinics to provide better coverage of the affected popula-
tion.
• Adaptation of reporting frequency to the situation. Initially – during the 
acute phase of an emergency – data should be collected weekly. Subse-
quently this can be done less frequently, e.g. monthly.
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CHAPTER 4
Outbreak preparedness 
and response
This chapter:
■ provides guidelines for investigating a malaria outbreak
■ describes how to prepare for and respond to an outbreak.
In complex emergencies there are rarely any clearly defi ned thresholds 
(mortality or morbidity rates) for a malaria outbreak, but unusual or sud-
den increases – compared with previous weeks – in malaria mortality, pro-
portional mortality or incidence rates may suggest an outbreak. It is also 
important to be aware that:
— malaria outbreaks may go on for longer than other disease out-
breaks, and can last 3–4 months or even longer depending on the 
climatic conditions;
— malaria outbreaks often have multiple underlying causes.
In stable situations, an epidemic threshold can be calculated using 5 years’ 
historical data. In a complex emergency it is unlikely that there are suf-
fi cient historical data to be useful – unless the camp or settlement area 
has been established for a long time and accurate malaria data have been 
collected at least monthly and consistently for several years, allowing com-
parisons to be made with deviations from the mean or median.
Epidemic malaria may occur in areas of normally low and seasonal ma-
laria transmission where people have little immunity to the disease. It may 
also occur in non-immune populations who have moved through or into 
endemic areas. In these cases, severe disease and death due to malaria can 
occur in all age groups; young children, pregnant women, malnourished 
individuals and people with concurrent infections (including HIV) are the 
most vulnerable. Even when malaria transmission is not excessive com-
pared with previous years, local epidemics with high mortality may occur 
among vulnerable displaced populations because of the concentration of 
people, the lack of adequate housing and preventive measures (resulting in 
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increased exposure to mosquito bites), concurrent infections and malnutri-
tion, and reduced access to effective treatment.
In the absence of historical data but where recent weekly patient data are 
available, clear indications of epidemic malaria are a rising slide positivity 
rate (i.e. increasing numbers of patients with fever have malaria) combined 
with a rise in the case-fatality rate (non-immune people can die of malaria 
in a matter of hours, even in well-equipped facilities). Where no compara-
tive data at all are available, a cluster of severe cases and deaths due to 
febrile disease warrants investigation.
Investigating an outbreak
A suspected malaria outbreak should be investigated immediately, as early 
intervention is critical. The purpose of an investigation is to:
— confi rm the cause of the outbreak with one or more rapid prevalence 
surveys (high slide positivity rate or rapid diagnosis positivity rate 
among “fever cases” – see Chapter 2);
— describe the outbreak (age groups, time and geographical distribu-
tions, epidemic curve).
Describing the outbreak
Describing the outbreak and planning an effective response require the 
following:
• Analysis of information from a rapid prevalence survey or surveys.
• Analysis of data collected through the surveillance system, including:
— retrospective data from registers (if any);
— prospective data collected using a malaria outbreak form (see 
Table 4.1); the data should be stratifi ed by population structure (age 
group, pregnant women) and geographical area (village, district, 
camp) so that the attack rate can be calculated for different groups 
and areas and interventions can be targeted to the most vulnerable 
groups;
— epidemic curve, which shows graphically (see Figure 4.1) the number 
of new cases per week and the evolution of the outbreak; regularly 
updated, the curve can show the transmission season, whether the 
epidemic has reached its peak, and whether preventive interventions 
are leading to a reduction in new cases (although variations in access 
to treatment may make interpretation diffi cult).
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Table 4.1 Example of malaria outbreak form
Place: .......................................................  Reported by: .......................................
From:....../......./......... (day/month/year) To: ....../......./......... (day/month/year)
Case defi nition “malaria” and “malaria death”:
 Date Day New malaria cases New malaria deaths
   <5  ≥5  Pregnant  <5  ≥5  Pregnant
   years years  women Total years  years  women Total
  1   
  2   
  3   
  4   
  5   
  6   
  7   
Total
         
Daily mortality rate (number of “malaria” deaths/10 000 population per day): ….......................
Weekly attack rate (number of “malaria” cases/1000 population per week): ….........................
Weekly case-fatality rate (number of “malaria” deaths/number of “malaria” cases x 100): ….........
Geographical areas affected (e.g. villages, districts, camps where malaria patients are 
currently living):
Locality Estimated total  No. of malaria cases  No. of malaria deaths
 pop. in locality from locality (specify  from locality (specify
  day, week, time period) day, week, time period)
Comments:
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Outbreak preparedness
Measures for epidemic prevention and control can be implemented ef-
fectively only if they are supported by an infrastructure of well-trained 
personnel, adequate supplies and equipment, supervision and evaluation. In 
areas and populations prone to epidemic malaria, it is essential for partners 
to agree on and put in place a preparedness plan of action covering the fol-
lowing elements:
• Supplies – suffi cient stock of essential laboratory diagnosis and treatment 
supplies for uncomplicated and severe malaria, including rapid diagnostic 
tests (see Chapter 5); and of equipment, materials, protective clothing 
and insecticide for emergency prevention activities (see Chapter 6).
• Laboratory facilities – an identifi ed laboratory that can determine para-
site species and density, and ensure safe blood transfusions.
• Staff and transport – staff and transport for mobile teams; the capacity to 
expand inpatient and outpatient care facilities, including the number of 
skilled medical and technical staff needed in these facilities (see Box 4.1) 
to cope with an increased malaria caseload; and the capacity to improve 
transport and logistics for referral of severe cases to inpatient facilities.
Figure 4.1 Malaria attack rate (cases/1000 population per week), 
 MSF mobile clinics, Wajir, Kenya, 14 February 1998–19 April 1998
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• Educational messages – messages to encourage the population to take 
preventive measures and seek early treatment, and the materials and 
equipment to get these messages across to the public.
• Training and refresher training of staff – on malaria diagnosis, case 
management, vector control, weekly disease surveillance.
• Budget – for all the above. 
Box 4.1 Medical support staff required – in addition to a doctor – 
 per site dealing with a major malaria epidemic
■ 1 triage nurse
■ 1 registration nurse
■ 2 nurses for temperature and weight
■ 1 person to perform the RDTs
■ 2 nurses for dispensing drugs
■ 2 nurses for case management of uncomplicated malaria cases
■ 24-hour coverage by 1 advanced nurse for care of severe malaria cases
■ 1 person for epidemiological surveillance
■ 1 driver (to transport referrals)
■ 2 health promoters to inform and educate the population.
Outbreak response and follow-up
Coordinate planning and implementation
If there is a confi rmed outbreak, all partners – government departments, Unit-
ed Nations agencies, humanitarian aid organizations and NGOs – need to:
• Decide together how to tackle the outbreak. Even if the actions of indi-
vidual players will be limited to certain areas or population groups or 
focus only on certain methods (e.g. surveillance, disease management/
prevention), it is essential that those actions be coordinated to maximize 
the impact of interventions. Coordination is especially important if the 
response involves multiple interventions including, for example, expand-
ing inpatient capacity at referral facilities.
• Follow good planning principles – in particular ascertaining which geo-
graphical areas and population groups are most affected.
Decide on a strategy
The fi rst priority in an epidemic is prompt and effective diagnosis and treat-
ment with artemisinin-based combination therapy (ACT) for all those who 
are sick.
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Vector control – if well planned, targeted and timely – can contribute 
signifi cantly to reducing the risk of infection and saving lives. Vector con-
trol is most cost-effective when it is implemented for prevention before 
an epidemic or for control at the very start of an epidemic, i.e. when it is 
implemented well before the epidemic peak and its subsequent natural de-
cline. High coverage is essential to achieve a “mass effect” and impact on 
transmission. However, the response to the epidemic is usually delayed and 
occurs in the middle of the epidemic, with the result that vector control is 
logistically demanding and time-consuming and its effect is poor. 
Vector control interventions should never interfere with, or drain re-
sources from the provision of life-saving treatment to all malaria cases.
The operational strategy for provision of disease management – for 
example, whether to use mobile teams or (additional) fi xed units, whether 
to focus initially on improvement of inpatient and/or on outpatient care 
– will depend on:
— the population affected and risk groups (during an outbreak, all age 
groups may be affected);
— the malaria proportional mortality rate;
— the case-fatality rate;
— the prevalence in different areas;
— access to the existing health facilities – distance to reach health facili-
ties.
A checklist for effective response to malaria epidemics is provided in An-
nex VIII.
Treatment 
It is critical to ensure that there are suffi cient treatment points to allow the 
population to access treatment easily, and that these are providing effective 
diagnosis and case management. It is also important to ensure that the most 
vulnerable groups have access to treatment (see Chapters 1 and 2).
Treat positive individuals – treat fever cases
In an outbreak, everyone with a positive parasitaemia result for malaria 
should be treated immediately, regardless of his or her symptoms. Priority 
should be given to pregnant women and children under fi ve because they 
are at particularly high risk of severe disease and death.
In a large epidemic it would be logistically impossible to confi rm each 
case by RDT or microscopy. Therefore, once malaria has been established 
as the cause of the epidemic (through an RDT survey) and agreement has 
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been reached on a clinical case defi nition of malaria, mass treatment of 
malaria/fever cases with ACT is appropriate as a strategy for reducing 
mortality.
RDTs should be performed on a proportion of patients to track the test 
positivity rate and the evolution of the epidemic. To ascertain whether the 
epidemic is still going on and to avoid over-treating, it is useful to carry out 
RDT surveys among the patients in the waiting room of the health centre 
at intervals of 2–3 weeks or to make daily RDT checks of a percentage of 
fever patients.
In an outbreak, pre-referral treatment of severe cases can be improved 
by using artesunate suppositories to cover the period of transport to a hos-
pital. Rectal artesunate is as effective as quinine during the fi rst 24 hours; 
to date, however, there is little evidence of its use in the fi eld. If there is a 
high caseload of severe cases in inpatient facilities, management can be sim-
plifi ed by using IM artemether (see Chapter 5 for more information about 
treatment and case management).
Prevention 
During a malaria outbreak, preventing new cases is also important – but 
diffi cult to achieve. The principal interventions to reduce the risk of infec-
tion are:
• indoor residual spraying (IRS)
• insecticide-treated nets (ITNs) or other insecticide-treated materials 
(ITMs).
The most cost-effect interventions are IRS and ITNs if used just before an 
epidemic or at the very start of an epidemic – that is, applied well before 
the epidemic peak and its subsequent natural decline. Programmes should 
aim at high coverage to achieve a “mass effect” and impact on transmis-
sion: IRS requires coverage of at least 85% of dwellings to be fully effective. 
Use of ITNs provides community vector control if population coverage of 
at least 60% can be achieved (although some studies indicate a fi gure of 
50%): at lower coverage rates, ITNs provide protection only for the people 
who sleep under them.
Follow-up
Follow-up involves monitoring the evolution of the outbreak and assessing 
the effectiveness of the response – in terms of how well activities are be-
ing carried out, the timing of activities and the level of coverage achieved. 
Monitoring the impact of interventions is an essential aspect of outbreak 
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follow-up. The evolution of malaria morbidity and mortality over time can 
be expressed in terms of proportional incidence and case-fatality rates (see 
Chapter 3).
Repeat prevalence surveys may be needed both to verify whether the 
outbreak has been brought under control and whenever there are major 
changes in the composition of the population (e.g. with the arrival of large 
numbers of non-immune people in endemic areas).
Further reading
WHO (2004). Malaria epidemics: forecasting, prevention, early detection 
and control. From policy to practice. Report of an informal consultation, 
Leysin, Switzerland, 8–10 December 2003. Geneva, World Health Or-
ganization (WHO/HTM/MAL/2004.1098).
• The report summarizes current knowledge and WHO guidance on pre-
vention and control of malaria epidemics. View/download the document 
at www.who.int/malaria/epidemicstechnicalnorms.html
Hook C (2004). Field guide for malaria epidemic assessment and report-
ing: draft for fi eld testing. Geneva, World Health Organization (WHO/
HTM/MAL/2004.1097).
• This guide is written to help fi eld health staff at district and provincial 
levels to identify malaria epidemics as early as possible after their emer-
gence, and to gather the appropriate information to guide the response. 
Also:
• Data entry sheet – epidemic threshold calculation based on 5 years’ 
monthly data – for use with the above document. 
• View/download these documents at 
 www.who.int/malaria/epidemicseds.html
WHO (2002). Prevention and control of malaria epidemics: 3rd meeting 
of the Technical Support Network. Geneva, World Health Organization 
(WHO/CDS/RBM/2002.40)
• View/download the document at 
 www.who.int/malaria/epidemicstechnicalnorms
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CHAPTER 5
Case management
This chapter:
■ provides guidelines for initial management, including emergency triage 
– for the rapid identifi cation and treatment of patients at greatest risk of 
dying – and clinical assessment
■ discusses confi rmatory diagnosis of malaria using microscopy and 
rapid diagnostic tests (RDTs)
■ outlines factors that determine the choice of antimalarial drug
■ describes antimalarial drug treatment for uncomplicated malaria, 
subsequent follow-up, and the management of treatment failures
■ describes the assessment and treatment of anaemia 
■ describes the treatment of severe P. falciparum malaria and its 
associated complications, including resuscitation, treatment with 
antimalarial drugs, and nursing care
■ provides guidance on the prevention and treatment of malaria in 
special groups (pregnant women, malnourished patients, returning 
refugees and displaced persons).
Initial assessment
Emergency triage
Severe malaria is a medical emergency, and patients need to be admitted 
for immediate treatment and good-quality nursing care. The risk of devel-
oping severe malaria depends on the age and immunity of the patient (see 
Box 5.1).
Many deaths during the acute phase of emergencies can be avoided 
with prompt identifi cation and effective treatment of all patients who are 
severely ill (as a result of malaria or any other condition). However, this is 
not easy in situations where there are few skilled staff and where health fa-
cilities are limited and case-loads excessive. It is therefore essential to adopt 
an emergency triage procedure that is both effective at identifying high-
risk patients and simple and quick to perform: the procedure described in 
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Box 5.2 can identify, in less than 2 minutes, those who need immediate as-
sessment and treatment (see Table 5.1).
Clinical assessment
In complex emergencies in malaria-endemic countries, malaria is respon-
sible for a large proportion of febrile disease, particularly in children. If 
patients with P. falciparum malaria do not receive appropriate treatment 
with an effective antimalarial drug, they may deteriorate and develop 
severe malaria within a few hours or days. However, it is important to 
remember that the clinical presentation of both uncomplicated and severe 
malaria is variable and nonspecifi c (see Box 5.3), so that the differential di-
agnosis of malaria from other febrile illnesses may be diffi cult. In addition, 
patients often have more than one underlying disease (for example malaria 
and meningitis, or malaria and pneumonia). Every effort must be made to 
improve the capacity to diagnose febrile illnesses by confi rmation of the 
presence of parasites. When this is not feasible, particularly in the acute 
stages of complex emergencies, the only practical approach may be to treat 
febrile patients for all suspected diseases with the inevitable consequence 
that there will be over-treatment not only of malaria but also of other dis-
eases. Knowledge of local disease epidemiology helps in determining the 
likelihood that any serious illness is due to P. falciparum. 
Box 5.1 Groups at high risk of developing severe malaria
In all areas:
■ pregnant women
■ young children
■ severely malnourished children and adults (<70% median weight-for-
height, or <-3SD1).
In areas of high transmission: 
■ young children
■ people of all ages who have been displaced from low-transmission 
areas and who have little or no immunity.
In areas of low to medium transmission: 
■ people of all ages with little or no immunity, particularly during 
outbreaks.
1 SD = standard deviation score or Z-score. A weight-for-height of –2SD indicates 
the child is at the lower end of the normal range, and <–3SD indicates severe 
wasting. A weight-for-height of –3SD is approximately equivalent to 70% of the 
weight-for-height of the average (median) child. (Source and reference values: 
http://www.who.int/child-adolescent-health/publications/referral_care/chap7/
chap7fr.htm.) 
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Box 5.2 Danger signs
Patients with any of the following features need urgent clinical assessment 
and treatment:
 
Witnessed convulsions 
Convulsions are particularly common in febrile children. Any convulsion 
that lasts more than 5 minutes requires prompt treatment with diazepam 
(see “Management of the complications of severe malaria”). Convulsions 
may present in a subtle way, and important signs include intermittent 
nystagmus (rapid, jerky eye movements), salivation, and minor twitching of 
a single fi nger or toe or of the corner of the mouth.
Prostration 
This is:
■ the inability to sit unsupported (if aged ≥1 year) or
■ the inability to drink or breastfeed (if aged <1 year).
Note: Prostration should be actively tested – it is not enough to ask the 
caregiver.
Coma 
This is:
■ the inability to localize a painful stimulus1 (if aged ≥8 months) or
■ the inability to fi x or follow objects with the eyes (if aged 2–8 months2).
Respiratory distress 
This is deep breathing and/or indrawing of the lower chest wall.
Note: Clothing should be removed so that the breathing pattern can be 
observed.
1 Rub fi rmly on the patient’s sternum with the knuckles of one hand. A patient who 
is able to localize pain will attempt to remove the examiner’s hand.
2 Babies are unable to fi x until the age of about 8 weeks.
Although none of the clinical signs listed in Box 5.3 is unique to malaria, 
those related to severe malaria are a clear indication that a patient is seri-
ously ill and needs immediate investigation and treatment (see Table 5.1 
and “Management of severe P. falciparum malaria” below). 
Confi rmatory diagnosis of malaria
Diagnosing malaria on the basis of clinical features alone can be very 
inaccurate and is likely to result in signifi cant over-treatment or under-
treatment of the disease. It is therefore important to establish, at the start 
of an emergency intervention, the capacity for confi rmatory diagnosis. 
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Table 5.1 Assessment and treatment of danger signs
Signs Check If: Treatmenta
 Duration Lasts >5 minutes Diazepam IV or per 
   rectum 
 Blood glucose <2.2 mmol/l or test not  Give 50% dextrose IV
  possible 
 Malaria slide or RDT Positive or test not  Start antimalarial drugs
  possible  
 Lumbar puncture (LP)b CSF evidence of menin- Start antibiotics for
  gitisc or LP not possible meningitis
 Circulation Any sign positive  Start rapid IV fl uids
 Capillary refi ll >3  (indicates shock) and   Give oxygen
  secondsd no evidence of
 Weak, fast pulse  severe malnutrition
 Cold hands 
 Hydration Any sign positive  Start rapid IV fl uids or
 Sunken eyes (indicates dehydration)  insert nasogastric (NG)
 Lax skin turgore and no evidence of  tube and start oral 
  severe malnutrition rehydration solution 
 Nutrition Any sign positive  Transfer to therapeutic
 Visible severe wasting (indicates severe   feeding centre
 AND/OR malnutrition)
 Flaking skin and 
  oedema of both feet   
 Blood glucose <2.2 mmol/l or test not  Give 50% dextrose IV
  possible 
 Lumbar puncture CSF evidence of  Start antibiotics for
 If none of the above  meningitisc or LP not  meningitis
 signs is present,  possible
 perform LP
 Malaria slide or RDT Positive or test not  Start antimalarials
  possible 
 Blood glucose <2.2 mmol/l or test not  Give dextrose 50% IV
  possible 
 Perform LP CSF evidence of  Start antibiotics for
  meningitisc or LP not  meningitis
  possible   
 Malaria slide Positivef or test not  Start IV or IM
 or RDT possible antimalarials 
 All comatose patients  Insert NG tube, aspirate
   stomach contents
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Table 5.1 Continued
Signs Check If: Treatmenta
 Palmar pallor Hb <5g/dl Give immediate blood
 Check Hb  transfusion 
 Hydration Any sign positive and  Start rapid IV fl uids
 Lethargy no evidence of severe 
 Sunken eyes malnutrition
 Lax skin turgore   
 Circulation Any sign positive and  Insert IV and start rapid
 Capillary refi ll >3  no evidence of severe  IV fl uids
  seconds malnutrition
 Weak, fast pulse
 Cold hands
 Listen to chest Chest crackles Verify pulmonary
   oedema;g start anti-
   biotics for pneumonia
a For treatment details see “Management of severe P. falciparum malaria”, page 85.
b Lumbar puncture should be performed if the patient is still unconscious more than 30 min-
utes after the end of a convulsion.
c CSF evidence of meningitis: CSF: blood glucose ratio <0.5, CSF protein >0.6 g/litre, bacteria 
seen on Gram stain. When measurement of glucose and protein is not possible, cloudy CSF 
should be taken as indicative of meningitis.
d Capillary refi ll: apply pressure for 3 seconds to whiten the fi ngernail; determine the capillary 
refi ll time from the moment of release to recovery of original nail colour.
e Skin turgor: pinch the skin of abdomen halfway between the umbilicus and the side for 1 
second, then release and observe; if the skin takes >2 seconds to return, this indicates dehy-
dration.
f In all cases of suspected severe malaria, parenteral antimalarial chemotherapy must be 
started immediately. If the cause of coma is in doubt, also test for (and treat) other locally 
prevalent causes of coma, e.g. bacterial, fungal or viral meningoencephalitis. If the malaria 
slide/RDT is negative it must be repeated, and the Giemsa-stained slide must be examined 
for indirect signs of parasitaemia (pigment in neutrophils).
g If pulmonary oedema is suspected, position the patient upright, give oxygen, stop IV fl uids 
and give frusemide, 1 mg/kg IV. If pulmonary oedema is associated with blood transfusion, 
give frusemide, 1 mg/kg IV, and restart transfusion at a slower rate.
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Effective confi rmatory diagnosis can help to:
— identify patients who need antimalarial treatment;
— reduce unnecessary use of antimalarial drugs for patients without 
malaria;
— identify malaria species;
— identify treatment failures. 
The need for parasitological confi rmation of diagnosis in individual patient 
management depends on the level of transmission and the age of the pa-
tient. Laboratory confi rmation is needed for:
— all patients with suspected malaria in areas of low to moderate trans-
mission;
— all adults and all children aged 5 years and over with suspected 
malaria in areas of high transmission.
Box 5.3 Clinical features of uncomplicated and severe malaria
Uncomplicated malaria Severe malaria
Clinical features of  A patient with severe falciparum malaria
uncomplicated malaria  may present with confusion or drowsiness
may include: with extreme weakness (prostration). In
 addition, the following may develop:
Fever
Headache Cerebral malaria, defi ned as unrousable
Vomiting  coma not attributable to any other cause 
Diarrhoea   in a patient with falciparum malaria
Cough  Generalized convulsions
Infl uenza-like symptoms,  Severe normocytic anaemia
 e.g. chills, muscle pains Hypoglycaemia
Febrile convulsions  Metabolic acidosis with respiratory distress
 (in children) Fluid and electrolyte disturbances
 Acute renal failure
 Acute pulmonary oedema and adult   
  respiratory distress syndrome (ARDS)
 Circulatory collapse, shock, septicaemia
  (“algid malaria”)
 Abnormal bleeding (bruising, bleeding  gums)
 Jaundice
 Haemoglobinuria secondary to haemolysis
 High fever
 Hyperparasitaemia
 Important: These severe manifestations  
 can occur singly or, more commonly, in 
 combination in the same patient.
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Laboratory confi rmation is not strictly needed for:
— children under 5 years of age with suspected malaria in high-trans-
mission areas; these children can be treated on the basis of clinical di-
agnosis (fever) alone, following the IMCI algorithm, bearing in mind 
that a child’s illness may commonly have more than one pathological 
basis and that fever does not necessarily mean malaria, even in high-
transmission areas;
— every single fever patient once malaria has been established as the 
cause of an ongoing epidemic with massive case-loads that over-
whelm the health services.
• In areas of low transmission and during epidemics, where populations 
have little immunity to malaria, malaria infection is dangerous for all 
age groups. The presence of malaria parasites in the peripheral blood 
(detected by confi rmatory diagnosis) almost always indicates that the 
patient has, or will develop, clinical malaria and therefore requires treat-
ment.
• In areas of stable moderate to high transmission, which include large parts 
of sub-Saharan Africa, people who have been regularly exposed to malaria 
since infancy have usually developed partial immunity. Where transmis-
sion is perennially high, a large proportion of the population may have 
malaria parasites in their blood, yet relatively few of them will become ill.
There are two options for confi rmatory diagnosis of malaria:
— light microscopy
— rapid diagnostic tests (RDTs).
The characteristics and potential uses of these two methods are outlined 
below.
Light microscopy
Performance
Microscopy is the “gold standard” and the most commonly used laboratory 
diagnostic tool in malaria-endemic regions. When performed by a skilled 
technician, microscopy is more sensitive than RDTs for the detection of low 
levels of P. falciparum parasitaemia (<100 parasites/µl) and can differenti-
ate between the various malaria species. When poorly performed, however, 
microscopy produces unreliable results.
Effective microscopy for malaria parasites requires good quality equip-
ment and reagents, skilled technicians who can prepare and stain fi lms, 
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identify parasites, and differentiate between Plasmodium species, and 
rigorous technical supervision and quality control. However, since these 
may not be available in complex emergency situations, it is often necessary 
for emergency partners to establish the capacity themselves. This requires 
training, investment in equipment (basic binocular microscopes that do 
not require electricity, or that can operate using electricity or natural light 
are the most appropriate option), and budgeting for recurrent costs, such 
as reagents. Once established, the direct cost of microscopy ranges from 
US$ 0.12–0.40 per test. 
When to use microscopy
• Routine confi rmatory diagnosis and patient management. Microscopy 
services, including training and supervision, should be re-established as 
an emergency situation stabilizes and used for routine confi rmation of 
malaria and for management of severe malaria.
• Investigation of suspected treatment failures. Microscopic examination 
of thick and thin peripheral blood fi lms should be carried out to confi rm 
all cases of suspected treatment failure.
• Drug effi cacy studies. Microscopy should be used for studies that assess 
the therapeutic effi cacy of antimalarial drugs.
• Quality control system for rapid diagnostic tests. Quality control of 
RDTs in the fi eld is needed to verify both batch quality and possible de-
terioration of quality during transport and storage. At least one reference 
laboratory is needed for verifi cation of RDT results against good micros-
copy, with a small percentage of RDTs being regularly compared.
Rapid diagnostic tests
Design
Rapid diagnostic tests (RDTs) for malaria use a dipstick,  cassette  or test 
card designed to detect malaria parasite antigens in the blood of an infected 
individual. The main types of commercially available RDT detect:
— histidine-rich protein II (HRP-II), a water-soluble protein produced 
only by P. falciparum;
— HRP-II plus a nonspecifi c pan-malaria antigen (detects all four 
malaria species); 
— lactate dehydrogenase (pLDH), P. falciparum-specifi c and pan-specifi c.
HRP-II kits detect only P. falciparum. Kits combining HRP-II and a pan-
malarial antigen, as well as pLDH kits,  can distinguish P. falciparum 
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from non-falciparum species, but cannot distinguish between P. vivax, 
P. ovale and P. malariae, or between P. falciparum alone and a mixed 
P.  falciparum/non-falciparum infection.  A few recently released products 
can also distinguish P. vivax from other species.  
Performance
Accuracy in the detection of P. falciparum
Initial evaluation of their performance in different epidemiological and 
clinical settings showed that, at parasite densities above 100/µl blood, 
RDTs can detect P. falciparum with >90% sensitivity of. That is, more 
than 90% of cases with malaria parasitaemia test positive on RDT, which 
is equivalent to the sensitivity that can normally be achieved with skilled 
microscopy. In cases with parasite densities below 100/µl blood, RDT sen-
sitivity decreases markedly. 
More recent reports, however, have indicated sensitivities and specifi ci-
ties for P. falciparum well below those required for operational use. It is 
thought that problems with storage and transport and a lack of quality 
control may have contributed to these results, which emphasize the need 
to ensure good quality assurance for RDTs and continued monitoring of 
their effi cacy.
Mixed species infections
In areas where two or more Plasmodium species commonly occur together, 
patients may present with mixed malaria infections. RDT kits sensitive 
to both P. falciparum and non-falciparum species cannot simultaneously 
demonstrate the presence of more than one species and are designed to 
detect P. falciparum preferentially. In the absence of P. falciparum, these 
test kits will show infection by a non-falciparum species, although their 
sensitivity in detecting P. vivax is low, especially with low parasitaemia. 
Storage and transport
Most RDT products should be stored and transported within the tempera-
ture range 4–30 °C, which is most likely to be impossible in many of the 
situations where they are used operationally. RDTs are sensitive to both 
moisture (humidity) and high temperatures. Where they are used, storage 
and transport conditions should be carefully controlled and documented.
Relative cost
In practical terms, the overall cost of using RDTs – which includes organi-
zation, personnel, supervision and quality control – is likely to be lower 
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than that of maintaining reliable, high-quality microscopy if microscopic 
diagnosis is used only infrequently. 
Box 5.4 summarizes the advantages of RDTs in emergency situations.
Box 5.4 Advantages of rapid diagnostic tests in emergency situations
Rapid diagnostic tests:
— are quick to perform (in practice, about 20 minutes for most tests)
— if of good quality, produce reliable results
— are sensitive on detecting P. falciparum, which causes severe malaria
— do not need skilled laboratory technicians, and can be used by health
 workers and non-health workers after a few hours of training
— do not need electricity or laboratory equipment
— are suitable for diagnosis when case-loads are high – a team of two
 people can process more than 200 tests a day, making RDTs particularly
 useful as a screening tool during community surveys
— cost from US$ 0.65 per test for detection of P. falciparum and from
 US$ 1.00 per test for detection of all species (although prices should be
 checked with individual manufacturers).
When to use RDTs
Confi rmatory diagnosis of suspected malaria cases
In low-transmission areas where there are relatively few malaria cases 
and/or where health staff may not be skilled in malaria microscopy, RDTs 
provide an effective alternative to microscopy for the diagnosis of malaria, 
provided that they are of assured quality.
In high-transmission settings, RDTs may be used for confi rmation of 
severe malaria until the situation is stabilized and good-quality microscopy 
services are established. They can also be used when it is impossible to es-
tablish or maintain effective microscopy services as a result, for example, 
of inadequate resources or the risk of looting. 
Rapid malaria assessments
RDTs are particularly useful for screening large numbers of people for 
malaria, particularly when combined with a record of clinical symptoms 
(actual or reported fever). They are therefore well suited to malaria surveys/
assessments (either community cross-sectional or clinic-based), especially 
when these must be completed and analysed quickly as part of an emer-
gency assessment, and when the identifi cation of non-falciparum species is 
not necessary.
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Malaria epidemics 
In epidemic situations, where patient numbers are very high, RDTs can 
enable a team of two people to accurately screen up to 200 patients per 
day. Where this is not possible, because of shortages of either staff or 
RDTs, clinical diagnosis may be the only option. RDTs can then be used to 
confi rm a proportion of clinically diagnosed cases. In an ongoing malaria 
epidemic, most fever cases presenting at health facilities will be malaria, 
and over-treatment of non-malaria cases will be minimal; however, this 
proportion will fall in the later stages of the epidemic and, if confi rmatory 
diagnostic capacity is not then established, the degree of over-treatment 
will increase signifi cantly (see Box 5.5). 
Box 5.5 Diagnosing malaria during an epidemic in Burundi
In late 2000 and early 2001, a malaria epidemic occurred in the highlands 
of Burundi, an area already affected by a long-term complex emergency. 
The epidemic threatened 2 million people – about 30% of the population. 
Accurate diagnosis of suspected malaria cases was diffi cult because of the 
large number of patients. Daily case-loads were as high as 2000 in some 
clinics. In Kayanza, one of the worst-affected provinces, RDTs were used 
initially to confi rm the epidemic. Since 80% of the people attending the 
clinics were positive for P. falciparum, it was decided to treat patients on 
the basis of clinical symptoms and to use RDTs on a sample of one in fi ve 
patients attending for treatment at sentinel sites. 
As the epidemic waned, the proportion of parasite-positive patients fell 
to 40–50% and the need for laboratory confi rmation of clinical diagnosis 
increased. However, this was extremely diffi cult to implement, because 
of severe staff shortages and the very high numbers of people attending 
health facilities. 
When not to use RDTs 
RDTs that detect HRP-II may continue to produce positive test results for 
up to 14 days after effective treatment of a malaria infection, even though 
patients no longer have detectable parasites on microscopy. These tests 
should therefore not be used for the following purposes.
Investigation of suspected treatment failures
Microscopy should be used to confi rm treatment failure. When microscopy 
is not possible, the decision to give further antimalarial treatment relies 
upon the history of fi rst-line treatment. 
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Drug effi cacy studies
Microscopy should be used for drug effi cacy studies. Microscopy can also 
provide quantitative results (parasite counts).
Treatment overview
Factors that determine the choice of antimalarial drugs
The choice of drugs to be used for the treatment of malaria will depend 
on:
— the local parasite species
— the local drug-resistance patterns of the parasites
— high therapeutic effi cacy
— acceptable human tolerance (safety)
— good adherence
— availability
— acceptability to patients and to the health authorities
— acceptability of cost to the drug provider.
Therapeutic effi cacy
Antimalarial drug resistance, the misuse of drugs, and the use of poor-
quality drugs are important causes of treatment failure. 
Global malaria control is being threatened on an unprecedented scale by 
the rapidly growing resistance of Plasmodium falciparum to conventional 
treatments such as chloroquine, sulfadoxine–pyrimethamine (SP) and 
amodiaquine. Multidrug-resistant falciparum malaria is widely prevalent 
in south-east Asia and South America. Now Africa, the continent with 
the highest burden of malaria, is also being seriously affected by drug 
resistance. Because of the risk of treatment failure due to drug resistance, 
national antimalarial drug policies normally include at least two lines of 
treatment of uncomplicated malaria.
Populations in complex emergencies are more vulnerable to malaria dis-
ease, and their fi rst-line treatment for falciparum malaria must therefore 
be of the highest possible effi cacy. In these situations, where mortality is 
high, drug combinations that include an artemisinin derivative are recom-
mended. Current choices of artemisinin-based combination therapy (ACT) 
are artemether–lumefantrine, artesunate–amodiaquine, artesunate–SP 
and artesunate–mefl oquine. The effi cacy of ACT depends on resistance 
to the artemisinin partner drug. A new ACT chosen as part of local drug 
policy in a complex emergency should have an effi cacy of at least 95%. If 
no information on local drug effi cacy patterns is available in African coun-
73
tries, the choice should be artemether–lumefantrine (Coartem®), which 
is still >95% effi cacious in Africa. In chronic-phase emergencies, 2-yearly 
therapeutic effi cacy testing of ACT should be carried out in sentinel sites to 
ascertain that it remains above 90%.
Information on antimalarial drug resistance and the testing protocol is 
available at www.who.int/malaria/resistance.html.
Once the emergency stabilizes, national authorities will be faced with 
longer-term decisions regarding drug choice, and information gained ear-
lier in the emergency may be very helpful. In countries where monotherapy 
(e.g. chloroquine, SP) is still used for fi rst- and second-line treatment but 
where the effi cacy of these drugs has been compromised by resistance, 
WHO recommends changing to ACT as fi rst-line treatment for uncompli-
cated malaria.
Availability
A coordinated approach is essential if adequate supplies of good quality 
antimalarial drugs are to be provided on a regular basis. The standardized 
purchase and supply of recommended, good-quality antimalarial drugs are 
the responsibility of all emergency partners. WHO – in collaboration with 
UNICEF – has established a system for pre-qualifi cation of manufacturers 
of artemisinin derivatives, negotiated price agreements with manufactur-
ers, undertaken international procurement, and set up systems of pharma-
covigilance. A broader service for malaria medicines and supplies has been 
established by the RBM partnership to facilitate access to high-quality, 
affordable antimalarial medicines and other essential supplies: insecticide-
treated mosquito nets, rapid diagnostic tests (RDT), and insecticides. For 
information and assistance, contact the RBM Malaria Medicines and Sup-
plies Service (MMSS), http://rbm.who.int/mmss.
Operational feasibility
Operational feasibility is determined by patient numbers, resources, and 
access to health facilities. It is best to use drugs that are effective and simple 
to administer: for example, once-daily intramuscular artemether is pref-
erable to 8-hourly intravenous infusions of quinine for the treatment of 
severe malaria. 
In emergency situations, limited access to health facilities and poor se-
curity may mean that the health worker sees a patient only once. In these 
circumstances, patient adherence to multi-day therapies may be poor and 
can lead to treatment failure. It is therefore vital that the treatment regimen 
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is properly explained, both to the clinician (who may be unfamiliar with 
the recommended therapy) and to each patient. 
Management of uncomplicated P. falciparum malaria
Supportive and ancillary treatment of young children
When an antimalarial drug is given to a young child, the chance of the 
child vomiting the medication will be lower if fever (axillary temperature 
>37.5 °C) is fi rst treated with an antipyretic and with tepid sponging. Anti-
pyretic drugs such as paracetamol or ibuprofen (an expensive but effective 
alternative to paracetamol) should be used: aspirin is not recommended in 
children because it can cause a rare but serious condition called Reye syn-
drome, which affects the liver and the brain.
Children should remain at the clinic for an hour after the fi rst dose 
of antimalarial drug (see Annex IV for information about the safety of 
antimalarial drugs in young children). Ideally, outpatient facilities should 
have a shaded area where patients and carers can wait. Carers should be 
encouraged to sponge febrile children with tepid water. If it is not possible 
for a child to wait at the clinic, the parent or carer should be told to return 
if the child vomits within the fi rst hour; the child should then be re-treated 
with a full dose of the antimalarial drug. A child who vomits the drug more 
than once should be admitted as an inpatient. It is important to watch for 
signs of dehydration and to give appropriate treatment if necessary. Carers 
should be told that it is important for infants to breastfeed frequently, and 
for older children to drink plenty of fl uid, to prevent dehydration.
Antimalarial drug treatment: choosing the most appropriate drug(s)
WHO recommends that any country experiencing resistance to antima-
larial monotherapies should adopt a policy of using combination therapies 
for fi rst-line treatment of falciparum malaria – preferably those containing 
an artemisinin derivative.1 In practice, this applies worldwide with the cur-
rent exception of Central America, the island of Hispaniola, and those few 
countries with pure vivax malaria. The increased vulnerability of popula-
tions in complex emergencies requires the use of highly effective ACTs even 
if these are not yet included in routine national treatment policies. 
In south-east Asia, ACTs have been shown to improve treatment effi cacy 
and to contain drug resistance. 
1 Position of WHO’s Roll Back Malaria Department on malaria treatment policy, 
www.rbm.who.int (accessed September 2005).
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The advantages of ACT are:
— rapid reduction of parasite numbers;
— rapid resolution of clinical symptoms;
— effective action against multidrug-resistant P. falciparum;
— as yet, no documented resistance to artemisinin and its derivatives;
— few clinical adverse reactions; and
— reduction of gametocyte carriage rates, which reduces patient infec-
tivity to mosquitoes.
Widespread use of ACT as a component of a comprehensive malaria con-
trol programme contributes to a reduction in overall malaria transmission. 
Experience to date indicates that this effect may be more apparent in areas 
of low transmission than in areas of high transmission.
Artesunate is the most commonly used oral formulation of the artemisi-
nin derivatives. Although the price is gradually falling, artesunate remains 
expensive compared with the commonly used monotherapies. 
Artesunate is highly effective against blood stages of the malaria para-
site, but 7 days of treatment are required when it is used as monotherapy – a 
3-day regime would result in recrudescence rates of up to 50%. However, 
a 3-day course of artesunate combined with another blood schizonticide as 
part of ACT is fully effective. 
The options for artemisinin-based combination therapy for uncompli-
cated falciparum malaria are listed in Box 5.6. 
Artemisinin-based combination therapy options
Fixed-dose combination 
Artemether–lumefantrine (Coartem®)
Artemether–lumefantrine is the only fi xed-dose ACT currently available. 
To date, clinical trials involving more than 3000 patients, including 600 
children under 5 years of age, have been carried out in Africa, south-east 
Asia and Europe and show high cure rates and tolerability. The combina-
tion should be taken as a 6-dose regimen. 
Artemether–lumefantrine will be the standard antimalarial included in 
the upcoming 2005 Inter-Agency Emergency Health Kit – it is particularly 
useful in complex emergency situations where there are no local data on the 
effi cacy of drugs contained in other combination options. It is essential that 
Coartem® is taken with fatty food of some kind, such as a glass of milk or 
some peanuts.
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Delivery. The absorption of lumefantrine, a hydrophobic, lipophilic com-
pound, is variable and increases when the drug is taken with food (par-
ticularly fatty foods). Drug absorption therefore increases as the appetite 
returns with clinical recovery. Absorption is increased by more than 100% 
when artemether–lumefantrine is taken with a meal rich in fat. In practice, 
therefore, the drug combination must be taken with some food. If the pa-
tient is too ill to eat, or if fi eld conditions prevent this, a glass of milk or 
similar drink should be given with each dose until the patient is able to eat 
normally. (See Annex V for dosage schedule.)
Side-effects. Although the artemether–lumefantrine combination is gener-
ally well tolerated, the following side-effects have been reported: dizziness 
and fatigue, anorexia, nausea, vomiting, abdominal pain, palpitations, 
Box 5.6 Artemisinin-based combination therapy for uncomplicated 
 falciparum malaria
Fixed combination treatment 
The two drugs are co-formulated in a single tablet:
■ artemether plus lumefantrine (Coartem®)
■ dihydro-artemisinin plus piperaquine (Artekin® – in advanced 
development)
■ artesunate plus mefl oquine (expected in 2006)
■ artesunate plus amodiaquine (expected in 2006)
Non-fi xed combination treatment
The drugs are formulated in separate tablets, which may be combined in a 
blister pack:
■ artesunate (4 mg/kg once a day for 3 days) plus mefl oquine (25 mg/kg, 
ideally as a split dose – 15 mg/kg followed after 12–24 hours by 10 mg/kg 
– to reduce the risk of vomiting, but may be given as a single dose of 
25 mg/kg where a split dose is not possible) 
■ artesunate (4 mg/kg once a day for 3 days) plus sulfadoxine–
pyrimethamine (SP) (adults: 3 tablets: 1500 mg sulfadoxine + 75 mg 
pyrimethamine; children: sulfa component 25 mg/kg + pyrimethamine 
component 1.25 mg/kg, as a single dose on day 1) 
■ artesunate (4 mg base/kg once a day for 3 days) plus amodiaquine 
(10 mg base/kg daily for 3 days: total dose 30 mg base/kg)
See Annex V for detailed dosage regimens.
Note: Due to limited or non-availability of data, the ACT treatments 
listed above are not recommended in the fi rst trimester of pregnancy. 
Nevertheless, ACT treatment should not be withheld if the infection is 
confi rmed and life-threatening and no alternative treatment is available.
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myalgia, sleep disorders, arthralgia, headache and rash. The side-effects 
are generally mild, however, and there is no indication of cardiotoxicity.
Contraindications. Artemether–lumefantrine is contraindicated in:
— persons with known hypersensitivity to either of the component 
drugs;
— persons with severe malaria.
Safety in special groups. The safety of artemether–lumefantrine has not 
yet been established in children of less than 5 kg body weight, and its use 
in this group is not recommended until further safety data are available. 
Artemether–lumefantrine is not recommended in the fi rst trimester of 
pregnancy.
Non-fi xed-dose combinations
The two drugs – artesunate plus another antimalarial – used in these com-
binations are separately formulated as tablets.
Because of the rapid development of resistance to SP and cross-resist-
ance between chloroquine and amodiaquine, which is of concern in areas 
of high chloroquine resistance, it is important to know the therapeutic ef-
fi cacy of these options before they are introduced. If data are not available 
from WHO or local experts, or have not already been obtained through 
operational research, artemether–lumefantrine is likely to be a better op-
tion. This can be reviewed once adequate drug effi cacy data for other ACT 
options have been obtained.
Contraindications to artesunate. The following contraindications apply to 
all the combinations listed below. Artesunate should not be used:
— when there is a history of allergy to artemisinin derivatives;
— for fi rst-line treatment of uncomplicated malaria in the fi rst trimester 
of pregnancy (but, in areas of multidrug resistance, artemisinin de-
rivatives may be used during the second and third trimesters).
Artesunate plus mefl oquine
The combination of artesunate plus mefl oquine can be used in areas where 
P. falciparum is resistant to chloroquine, SP and amodiaquine. It also pro-
vides an effective alternative to artemether–lumefantrine for emergency 
situations in which the effi cacy of SP and amodiaquine is unknown. 
Delivery. Many young children (particularly those aged under 5 years) and 
older patients with fever vomit the fi rst dose of mefl oquine. Vomiting can 
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be reduced if the recommended dose of 25 mg/kg is given as a split dose 
over 2 days on days 2 and 3 of treatment (15 mg/kg followed 24 hours later 
by 10 mg/kg). Artesunate is given on days 1, 2 and 3. (See Annex V for dos-
age schedule.) The absorption of mefl oquine is improved when the drug is 
taken with plenty of water or following food. There should be no re-treat-
ment with mefl oquine within 8 weeks of previous treatment. A fi xed-dose 
combination is expected to become available in 2006.
Side-effects. The commonest side-effects of mefl oquine are nausea, vomit-
ing, dizziness, sleep disorders, anxiety and other neurological symptoms. 
Serious neuropsychiatric adverse reactions have been reported in people 
treated with mefl oquine, including – rarely – psychosis, toxic encepha-
lopathy, convulsions and acute brain syndrome. The frequency of serious 
side-effects appears to be dose-related, and the risk has been reported to 
be 7-fold higher among people who have been re-treated with mefl oquine 
within 4 weeks of previous treatment. Mefl oquine has been associated with 
an increased risk of stillbirth in large observational studies in Thailand, but 
not in Malawi.
Contraindications. Mefl oquine should not be used in the following situa-
tions:
— when there is a history of allergy to mefl oquine;
— when there is a history of severe neuropsychiatric disease;
— in persons who have received mefl oquine in the previous 8 weeks;
— during the fi rst trimester of pregnancy (but, in areas of multidrug 
resistance, mefl oquine may be used in combination with artesunate 
in the second and third trimesters, for example if the risk of malaria 
is high and there are no alternative effi cacious drugs). 
Artesunate plus sulfadoxine–pyrimethamine
The combination of artesunate plus SP is an option for use in emergen-
cies in parts of the world where there is good parasite sensitivity to SP. 
However, most of south-east Asia, some of south America (particularly the 
Amazon basin), most of east Africa, and increasing areas of central Africa 
now have signifi cant SP resistance, and reports of resistance in west Africa 
are increasing. In areas of signifi cant SP resistance, an alternative artemisi-
nin-based combination should be selected. The rapid spread of resistance to 
SP means that its use as monotherapy and in ACT is now limited. 
Delivery. The practical operational advantage of SP over other combina-
tion options in that the full dose of SP is delivered as a single dose on day 1 
79
and can be given at the same time as the fi rst dose of artesunate. SP is less 
likely than mefl oquine to cause vomiting in young children. (See Annex V 
for dosage schedule.) Folic acid, if administered concurrently with SP, may 
antagonize the action of sulfadoxine; delivery of folic acid supplements 
should therefore be delayed until 1 week after SP treatment. 
Side-effects. SP is generally well tolerated when used as recommended and 
severe adverse side-effects are rare. However, allergic reactions of varying 
severity have been reported and are more common after repeated dosing. 
In practice, patients should not be treated with SP if they have received 
SP in the previous 4 weeks or if they have known hypersensitivity to sulfa 
drugs. While cutaneous reactions are quite rare, they are more common 
in patients who are HIV-positive. This should be taken into account when 
dealing with known high-risk groups, especially in long-term camp set-
tings where sexual abuse and prostitution may be major issues. 
SP should not be used for prophylaxis. Severe erythema multiforme in-
volving the skin and mucous membranes (Stevens–Johnson syndrome) and 
toxic epidermal necrolysis have been reported in between 1 in 5000 and 1 
in 8000 people taking SP for weekly chemoprophylaxis. 
Contraindications. SP should not be used in the following situations:
— when there is known hypersensitivity to sulfa drugs or pyrimeth-
amine;
— for chemoprophylaxis;
— when there is severe hepatic or renal dysfunction; 
— in children under 2 months old;
— in those who have received treatment with SP in the previous 4 weeks.
Artesunate plus amodiaquine
The combination of artesunate plus amodiaquine can be used in all regions 
where resistance to amodiaquine is still low. In practice this is limited to 
parts of Africa. Therapeutic effi cacy of amodiaquine in areas of chloro-
quine-resistant malaria may be compromised as a result of cross-resistance 
and, in the absence of in vivo effi cacy data, the therapeutic effi cacy of amo-
diaquine should not be assumed. 
Delivery. Amodiaquine tablets are more palatable than chloroquine and 
are therefore easier to administer to children. Amodiaquine is metabolized 
rapidly and extensively and does not need to be delivered with food. (See 
Annex V for dosage schedule.) A fi xed-dose artesunate–amodiaquine com-
bination will become available in early 2006.
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Side-effects. Standard treatment doses of amodiaquine produce side-effects 
similar to those observed with chloroquine. These include nausea, vomit-
ing, abdominal pain, diarrhoea and itching; bradycardia is a less common 
side-effect. Amodiaquine should not be used for chemoprophylaxis, as this 
may cause life-threatening hepatitis and agranulocytosis.
Contraindications. Amodiaquine should not be used in the following situ-
ations:
— when there is known hypersensitivity to amodiaquine;
— in persons with hepatic disorders;
— for chemoprophylaxis.
Follow-up and treatment failures
Immediate follow-up
Carers and/or patients should be instructed to return to the health facility 
for priority care if a patient repeatedly vomits treatment, has convulsions 
or becomes increasingly drowsy.
Longer-term follow-up
Carers and/or patients should be instructed to return to the health facility if 
symptoms worsen or if symptoms have not resolved by day 4 of treatment.
Treatment failures
Defi nition
Treatment failure is defi ned as the failure to effectively clear malaria para-
sites from the blood, with a recurrence of symptoms within days or weeks 
of the initial antimalarial treatment. The time at which symptoms recur 
depends partly upon the duration of action of the antimalarial drug. There 
are several clinical pictures of treatment failure:
— clinical deterioration, which may lead to severe disease;
— slow clinical response;
— apparent resolution of clinical symptoms followed by a reappearance 
of malaria-related symptoms;
— chronic anaemia secondary to repeated parasitaemic episodes. 
Causes
Treatment failure may be caused by any (or a combination) of the follow-
ing: 
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• Vomiting or poor absorption. The patient or carer may have been con-
fused about what to do when treatment has been vomited or about the 
need to take Coartem® with some fatty food.
• Drug quality. Treatment failure can result from the use of poor-quality 
or counterfeit antimalarial drugs that do not contain the recommended 
amount of active ingredient. This is a risk if patients are receiving treat-
ment from poorly-supervised public or private health facilities. The 
quality of ACTs should be ensured by always obtaining supplies through 
reputable pharmaceutical companies/agencies – and preferably directly 
from producers.
• Poor prescribing practice. The prescription of an incomplete course of 
antimalarial treatment increases the risk of treatment failure.
• Poor adherence. Poor adherence to treatment may be caused by a 
number of factors, including the following:
— The correct regimen may have been unclear to the patient or carer.
— Patients may choose to stop taking the treatment once initial symp-
toms have resolved. This is a particular problem with drugs that 
produce very rapid clearance of symptoms.
— After taking the initial antimalarial drug dose, a patient may choose 
to share the remaining treatment with family members.
— In areas with cost-recovery systems for health care, many patients 
cannot afford to buy a complete course of treatment. In these cir-
cumstances, a health worker whose salary is paid through the cost-
recovery system may be tempted to sell patients incomplete courses 
of treatment.
• Drug resistance. Drug resistance is the ability of a parasite to survive 
and/or multiply despite the administration and absorption of a drug 
given in doses equal to or higher than those usually recommended (but 
well within the tolerance of the patient). 
The management of suspected treatment failure depends upon the drug 
that was used for fi rst-line treatment.
• All patients presenting with severe malaria symptoms should be urgently 
treated with one of the drug therapies recommended in Box 5.9. 
• Repeat treatment should be carefully supervised. The following are the 
treatment options:
— Option 1: artemether–lumefantrine (Coartem®) 6-dose regimen.
— Option 2: 7-day course of oral artesunate (2 mg/kg per day).
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— Option 3: 7-day course of oral quinine (10 mg of salt/kg 3 times 
daily).
— Option 4: (for areas of multidrug resistance): 7-day course of oral 
quinine (10 mg of salt/kg 3 times daily) plus 7 days of oral doxycy-
cline (adults: 100 mg daily, with a double dose on the fi rst day) or 7 
days of oral clindamycin (5 mg/kg 3 times daily). Doxycycline (but 
not clindamycin) is contraindicated for pregnant women and chil-
dren <8 years.
The choice of drug will depend on the antimalarial drug already taken, the 
availability of alternatives, contraindications for the various medications, 
and operational feasibility. Adherence to the full course of re-treatment is 
vital, and re-treatment should be supervised where possible. Adherence to 
7-day drug regimens is improved if detailed instructions are given to pa-
tients, carers and health personnel. 
Management of non-falciparum malaria
Chloroquine
Treatment with chloroquine is the standard recommended therapy for 
malaria caused by P. vivax, P. malariae and P. ovale. In chloroquine-
sensitive areas, a 3-day course of treatment kills most stages of all the 
non-falciparum species. However, chloroquine does not kill the liver 
stages (hypnozoites) of P. vivax or P. ovale, for which an additional drug, 
primaquine, is required. 
Chloroquine resistance and alternative therapy
Chloroquine resistance of P. vivax is rare and was fi rst reported in the 
late 1980s in Indonesia and Papua New Guinea. Focal “true” chloroquine 
resistance (i.e. in patients with adequate blood levels at day of failure) or 
prophylactic and/or treatment failure have also been observed in Brazil, 
Colombia, Ethiopia, Guatemala, Guyana, India, Myanmar, Peru, the Re-
public of Korea, Solomon Islands, Thailand and Turkey. P. malariae resist-
ant to chloroquine has been reported from Indonesia. Treatment options 
for confi rmed chloroquine-resistant vivax malaria include mefl oquine, 
quinine and artesunate (see Box 5.7); SP is not recommended as it is slow 
to clear vivax parasites. 
Anti-relapse treatment for vivax malaria
The standard anti-relapse treatment for the dormant liver stage of P. vivax 
and P. ovale is primaquine, 0.5 mg base/kg per day for 14 days in south-
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Box 5.7 Oral drug treatment for non-falciparum malaria
Option 1 chloroquine: base 10 mg/kg once daily for 2 days, then 
 5 mg/kg on day 3 (in chloroquine-sensitive areas)
Option 2  mefl oquine: 15 mg/kg as a single dose
Option 3 quinine salt (dihydrochloride or sulfate): 10 mg/kg three times 
 a day for 7 days
Option 4  artesunate: 4 mg/kg in a divided loading dose on day 1, 
 followed by 2 mg/kg daily for 6 days.
east Asia and Oceania, and 0.25 mg base/kg per day for 14 days in other 
areas. 
It is not necessary to provide anti-relapse treatment to patients living in 
endemic areas with unabated transmission. In such situations a relapse can-
not be distinguished from reinfection and such patients should be treated 
with an effective blood schizonticide for each symptomatic recurrence of 
malaria. Pregnant patients in whom primaquine is contraindicated should 
not be treated until after delivery. 
Anti-relapse treatment is usually not feasible in the acute phase of emer-
gencies, but may be appropriate in the chronic phase. It may also have a 
role during resettlement and repatriation, as discussed at the end of this 
chapter. However, adherence to the required 14-day treatment course is 
likely to prove challenging. Shorter courses of anti-relapse treatment, such 
as the 5-day course adopted in many Asian countries, are ineffective and 
are not recommended. 
Primaquine may be given concurrently with an active blood schizonti-
cide such as chloroquine from the fi rst day of treatment. Primaquine should 
not be given to a patient who is pregnant or has glucose-6-phosphate 
dehydrogenase (G6PD) defi ciency (the incidence of G6PD defi ciency is 
high in Asia and some parts of Africa), because of the risk of intravascular 
haemolysis. The patient should be tested for G6PD defi ciency before treat-
ment with primaquine: kits that are relatively inexpensive and simple to use 
are available for this purpose. About 10% of Africans develop a mild, self-
limiting haemolysis with a dosage of 15 mg primaquine base per day for 14 
days. Severe, life-threatening haemolysis may occur in persons of Asian or 
Mediterranean origin with a rarer form of G6PD defi ciency.
Management of mixed Plasmodium infections
Mixed malaria infections with both P. falciparum and P. vivax occur com-
monly in many areas of the world, such as Latin America, Ethiopia, Timor-
Leste and other parts of north-east Africa and Asia. In these areas, when 
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malaria is diagnosed on clinical grounds, both P. falciparum and P. vivax 
infection should be treated. During the acute phase of an emergency, detec-
tion of life-threatening P. falciparum infection is the main priority, and use 
of an ACT (except artesunate–SP) will effectively treat both P. falciparum 
and P. vivax. If patient numbers are not excessive, microscopy is preferable 
to RDTs for diagnosis, since it provides reliable species differentiation.
Management of anaemia
Chronic anaemia is common in areas of high malaria transmission and is a 
particular problem in young children and pregnant women.
Assessment of anaemia (all ages)
• Check for palmar and conjunctival pallor. Time constraints are likely 
to necessitate oral treatment being started on the basis of clinical signs 
alone. 
• Measure blood haemoglobin (Hb) level. In remote settings, the Haemo-
globin Colour Scale (HCS)1 can be used to check Hb level. Patients with 
Hb of 10 g/dl or below require oral treatment (see below). Those with 
Hb <5 g/dl (equivalent to an HCS reading of 6 g/dl or below) who are 
symptomatic (prostration or respiratory distress) (see Box 5.2) must be 
urgently referred to an inpatient facility for further assessment and pos-
sible blood transfusion. Patients with Hb <5 g/dl who are otherwise well 
can be treated orally.
Treatment of anaemia
Children
• Give ferrous sulfate (200-mg tablet, equivalent to 60 mg elemental iron) 
once daily for 2 months: 2–12 months 1/4 tablet; 1–5 years 1/2 tablet; >5 
years 1 tablet.
• In areas of moderate and high malaria transmission, treat all cases of 
anaemia in children under 5 years of age with an effective antimalarial 
drug. 
• Treat all children over 2 years of age presumptively for intestinal worms 
with a single 500-mg dose of mebendazole or 400-mg dose of albenda-
zole (unless either of these has been given in the previous 6 months).
• Advise caregivers about good feeding practices.
1 http://www.who.int/medical_devices/publications/en/HbCS_brochure.pdf,
 http://www.who.int/medical_devices/initiatives/anaemia_control/en/
85
Non-pregnant adults
• Give ferrous sulfate (200-mg tablet, equivalent to 60 mg elemental iron): 
1 tablet 3 times a day for 2 months.
• Treat presumptively for intestinal worms with a single 500-mg dose of 
mebendazole or 400-mg dose of albendazole. The diagnosis should be 
confi rmed by microscopy, if time and facilities allow. 
Pregnant women
See “Malaria in special groups”, page 97.
Severe falciparum malaria
Management of severe P. falciparum malaria
Resuscitation
In complex emergency situations, where patient numbers are high and there 
are many late presentations, effective triage is essential to identify and treat 
immediately patients who are at highest risk of dying (see Box 5.2). All 
patients with signs of severe malaria (see Box 5.3) must receive immediate 
treatment (see Table 5.1 and Box 5.8). Prompt resuscitation of patients 
with severe malaria saves lives. 
Laboratory support 
Laboratory support for the management of severe malaria must, at a mini-
mum, include the following:
— accurate microscopy (for the detection of malaria parasites and for 
examination of cerebrospinal fl uid); RDTs can be used as an alterna-
tive to malaria microscopy;
— measurement of blood glucose;
— measurement of Hb or packed cell volume (PCV);
— blood grouping and cross-matching, and the ability to screen blood 
for HIV and hepatitis B.
Nursing care
Regular observation of the patient with severe malaria is critical, because 
the clinical situation changes quickly. The most important observations are 
pulse, respiratory rate and pattern, blood pressure, temperature, and level 
of consciousness. If there is any deterioration in consciousness, it is essen-
tial to check for hypoglycaemia and for a signifi cant fall in haemoglobin, 
because these are amenable to treatment. 
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In all patients with severe malaria:
• Check Hb and parasitaemia daily for the fi rst 3 days.
If the patient is unconscious:
• Check blood glucose every 4 hours.
• Check blood glucose and Hb if the level of consciousness deteriorates.
Antimalarial drug treatment
The two options for drug treatment of severe falciparum malaria are the 
artemisinin derivatives and quinine dihydrochloride (see Box 5.9). Artesu-
nate is the treatment of choice for adults with severe malaria, in view of a 
recent multi-centre trial in which mortality in the artesunate group was 
reduced by 34.7% compared with the quinine group.1 There are still in-
suffi cient data for children, however, particularly from high-transmission 
settings, to permit the same conclusion. An individual patient data meta-
analysis of trials comparing artemether and quinine showed no difference 
in mortality in African children. For children both options are effective if 
Box 5.8 Supportive and ancillary treatment for patients with severe malaria
■ Clear the airway and check that the patient is breathing.
■ Establish intravenous (IV) access.
■ Treat convulsions lasting 5 minutes or more (see below).
■ Take blood for malaria parasites, blood glucose and haemoglobin. Urea 
and electrolytes, blood gas and blood culture are also extremely useful, 
but are unlikely to be feasible in most complex emergency situations.
■ Treat hypoglycaemia (blood glucose <2.2 mmol/l) (see below).
■ Rapidly assess circulation, hydration and nutritional status, and 
resuscitate as necessary with normal (0.9%) saline (see below).
■ If haemoglobin is <5 g/dl and patient has respiratory distress, transfuse 
blood. 
■ For unconscious patients, insert a nasogastric tube and aspirate 
stomach contents to prevent aspiration pneumonia. Place the patient 
in the recovery position, and perform a lumbar puncture to exclude 
meningitis.
■ Start antimalarial drug treatment (see below). 
■ Start antibiotic therapy (see below).
1 South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesu-
nate versus quinine for treatment of severe falciparum malaria: a randomised trial. 
Lancet, 2005, 366:717–725.
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administered correctly, and the choice between them depends largely on 
practical considerations.
Intravenous (IV) quinine should be administered by means of a rate-
controlled infusion over a period of 4 hours. Because of the risk of fatal 
hypotension, it should never be given as a bolus IV injection. Intramuscular 
(IM) quinine can be used for emergency treatment but is associated with 
the risk of sterile abscess and sciatic nerve palsy. In a complex emergency, it 
may therefore be more practical to use IM artemether, which is given once 
daily, has minimal side-effects and clears malaria parasites rapidly. 
For the emergency treatment of severe malaria, or of a patient who can-
not tolerate oral medication, artesunate can be administered rectally before 
transport to an inpatient facility. Once the patient is able to tolerate oral 
medication, treatment must be completed with a full course of an effective 
oral antimalarial drug – severe malaria will not be cured by a single dose of 
artesunate (see Box 5.9).
Management of the complications of severe malaria
Management of hypoglycaemia, convulsions, shock, severe anaemia, coma, 
renal failure, and pulmonary oedema are outlined below:
Treatment of hypoglycaemia (blood glucose <2.2 mmol/l)
• If the patient is able to tolerate oral fl uids, give breast milk or a sugar 
solution (4 level teaspoons (20 grams) of sugar in a 200-ml cup of clean 
water).
• For unconscious patients or those unable to tolerate oral fl uids:
— Insert an IV line:
 Children: Dilute 50% glucose, 1 ml/kg, in an equal volume of any in-
fusion fl uid and give by slow IV injection over a period of 5 minutes. 
(Example: a child weighing 16 kg would receive 16 x 1 ml = 16 ml 
50% glucose diluted to 32 ml). Then follow with a continuous infu-
sion of 5% or (ideally) 10% dextrose.
 Adults: Infuse 50 ml of 50% glucose over 15 minutes.
— Recheck blood glucose 15 minutes after the end of the infusion.
— If blood glucose is still <2.2 mmol/l, repeat glucose infusion as 
above.
— If it is not possible to insert an IV line and the patient is unconscious, 
give 1 ml/kg 50% dextrose via nasogastric tube.
• Give oral fl uids (breast milk or sugar solution) and food once the patient 
regains consciousness.
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Box 5.9 Antimalarial drug treatment of severe malaria
OPTION 1: ARTEMISININ DERIVATIVES
■ Artemether IM
Loading dose: 3.2 mg/kg 
— Give IM artemether as a single dose on day 1. 
 Note: IM artemether should not be given to patients in shock, since 
absorption is unreliable.
Maintenance dose: 1.6 mg/kg 
— Give once a day starting on day 2.
— Continue until the patient is able to tolerate oral medication.
— Treatment should be completed with oral artesunate, 2 mg/kg daily 
to complete 7 days of treatment, or with a single dose of oral SP (in 
situations where the effi cacy of SP is known to be high) or mefl oquine, 
or with 3 days of Coartem®.
■ Artesunate IV or IM 
Loading dose: 2.4 mg/kg
— Give IV over 3 minutes as a single dose on day 1 at 0, 12 and 24 hours.
Maintenance dose: 2.4 mg/kg once daily
— Give IV over 3 minutes once a day beginning on day 2. 
— Continue the maintenance dose until the patient is able to tolerate oral 
medication. 
— Treatment should be completed with oral artesunate, 2 mg/kg daily 
to complete 7 days of treatment, or with a single dose of oral SP (in 
situations where the effi cacy of SP is known to be high) or mefl oquine 
(except following a coma or convulsions), or with 3 days of Coartem®.
■ Rectal artesunate 
— Artesunate suppositories should be reserved for situations in which it 
is not possible to give IV or IM therapy.
— Give 10 mg/kg of artesunate by suppository, and repeat the dose if the 
suppository is expelled within 1 hour.
— Repeat the dose after 24 hours if it is not possible to refer the patient.
 Note: Artesunate suppositories remain stable in temperatures of up to 
40 °C and therefore require cool – but not cold – transport and storage.
OPTION 2: QUININE DIHYDROCHLORIDE
■ IV administration
Loading dose: 20 mg salt/kg
— Omit the loading dose if the patient has had an adequate dose of 
quinine (>40 mg salt/kg) in the previous 2 days. Recent treatment with 
mefl oquine is not a contraindication to a loading dose of quinine.
— The loading dose should be given as an IV infusion over 4 hours (see 
below).
Maintenance dose: 10 mg salt/kg
— The maintenance dose must be given every 8 hours.
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Box 5.9 Continued
— The maintenance dose should be given as an infusion over 4 hours (see 
below).
— If IV therapy is still required after 48 hours, the maintenance dose 
should be reduced to 7 mg salt/kg to avoid the risk of accumulation.
— A minimum of 3 doses of IV quinine should be given before changing to 
oral treatment (see below).
Volume of infusion
— Quinine can be diluted in 5% dextrose, 10% dextrose, 4% dextrose–
0.18% saline, or normal (0.9%) saline.
— Dilute quinine to a total volume of 10 ml/kg (the same volume is used 
for both loading and maintenance doses) and infuse over 4 hours.
— To avoid overloading the patient with IV fl uids, the volume of the quinine 
infusion must be taken into account when calculating the total 24-hour 
fl uid requirement.
 Example:
 The 24-hour fl uid requirement for an adult weighing 50 kg is 50 ml/kg, 
i.e. 50 x 50 = 2500 ml. The patient will receive 3 x 500-ml infusions of 
quinine each day = 1500 ml. Therefore, the patient needs an additional 
1000 ml of maintenance fl uid to bring the 24-hour total to 2500 ml.
— IV quinine can cause hypoglycaemia, and blood glucose should 
therefore be monitored every 4 hours.
■ IM administration
— IM quinine may cause sterile abscesses and should be given only when 
IV therapy is not possible.
— Dilute quinine 1 part in 5 with normal (0.9%) saline.
— Divide the dose into 2 separate injections and administer by deep IM 
injection into both anterior thighs (IM quinine should not be injected 
into the buttock).
— A minimum of 3 doses of quinine should be given before changing to 
oral treatment (see below).
■ Changing to oral treatment (following IV or IM quinine)
— Once the patient is able to tolerate oral medication, treatment should 
be completed with (1) SP + 3 days of artesunate, (2) full course 
Coartem® (3 days) or (3) oral quinine 10 mg salt/kg every 8 hours to 
complete the remainder of a total of 7 days of quinine treatment. In 
areas of multidrug-resistant malaria, quinine should be combined with 
oral clindamycin, 5 mg/kg 3 times a day for 7 days. If clindamycin is 
unavailable, use oral doxycycline, 3 mg/kg once a day for 7 days, or oral 
tetracycline, 4 mg/kg 4 times a day for 7 days.
— Doxycycline and tetracycline should not be given to children under 8 
years or to pregnant women. Clindamycin, however, can safely be given 
to these groups.
— Mefl oquine should be avoided in patients recovering from coma as it 
increases the risk of post-malaria neurological syndrome.
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• If hypoglycaemia is suspected clinically in an unconscious person, and it 
is not possible to check the blood glucose, give a presumptive infusion of 
50% glucose as described above.
 Note: There is a marked risk of hypoglycaemia during the use of quinine 
in pregnant women and young children.
Treatment of convulsions 
• Maintain the airway.
• Turn the patient on his or her side to reduce the risk of aspiration.
• Do not attempt to force anything into the patient’s mouth.
• Check blood glucose and treat if <2.2 mmol/l (see above).
• Treat with:
— diazepam, 0.3 mg/kg (up to a maximum 10 mg), as a slow IV injec-
tion over 2 minutes; or
— diazepam, 0.5 mg/kg per rectum, administered by inserting a 1-ml 
syringe (without a needle) into the rectum; or
— paraldehyde, 0.2 ml/kg (up to a maximum of 10 ml) by deep IM 
injection into the anterior thigh; or
— paraldehyde, 0.4 ml/kg per rectum. 
• If the patient continues to convulse, give further doses of diazepam or 
paraldehyde every 10 minutes (up to a maximum of 3 doses of either 
drug).
• Treat patients who have multiple (3 or more) or prolonged (lasting 30 
minutes or more) convulsions with a loading dose of IM phenobarbital, 
10–15 mg/kg.
Fluids
Maintenance fl uid requirements (IV, oral, or via nasogastric tube)
Use IV fl uids, such as 4% dextrose–0.18% saline or 5% dextrose (ideally 
with added sodium chloride, 2 mmol/kg per day). Change to 10% dextrose 
if the patient becomes hypoglycaemic. The following daily maintenance 
fl uid volumes are recommended:
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 Weight Daily fl uid requirementa
 <5 kg 150 ml/kg
 5–10 kg 120 ml/kg
 11–19 kg 80 ml/kg
 20–30 kg 60 ml/kg
 Child >30 kg and adults 50 ml/kg
a The fl uid requirement is given in ml per kg body weight per day. The total daily fl uid require-
ment for a 14-kg child would therefore be 14 x 80 = 1120ml, while that for an adult weighing 
55 kg would be 55 x 50 = 2750ml.
In most complex emergencies there are large numbers of patients and lim-
ited numbers of nursing staff. Close observation of patients is usually im-
possible, and it is therefore safest to give maintenance fl uids by NG tube, in 
preference to IV infusion. The mother or carer can help to administer NG 
feeds, which also makes it possible to provide calories in addition to fl uid 
– an important advantage as many patients are likely to be malnourished. 
The daily fl uid requirement can be given as 4-hourly NG feeds (milk or 
diluted porridge). Inhalation pneumonia must be prevented.
 Example:
 The daily fl uid requirement for a 14-kg child is 80 x 14 ml = 1120ml. 
This can be given in the form of six 4-hourly NG milk feeds of 187 ml. 
Rapid administration of IV fl uids for resuscitation of patients in shock 
or with severe dehydration
• Use normal (0.9%) saline. Note that dextrose solutions, e.g. 5% dextrose, 
4% dextrose–0.18% saline, and 10% dextrose, must not be used for fl uid 
resuscitation, since this can lead to cerebral oedema (brain swelling).
• Check that the patient does not have severe malnutrition (severe wasting 
with associated oedema): patients with severe malnutrition should not 
be given large volumes of intravenous fl uids.
• Children: Infuse 20 ml/kg of normal saline over 15 minutes.
Example: 
A child weighing 15 kg would receive 15 x 20 ml = 300 ml.
• Adults: Infuse 1000 ml of normal saline over 30 minutes.
• Reassess the patient. If there is no improvement in hydration or 
circulation (i.e. pulse becomes slower, capillary refi ll improves – see 
Box 5.2), give a second infusion (children: 20 ml/kg normal saline; 
adults: 1000 ml normal saline).
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• Reassess the patient. If there is no improvement in hydration or circu-
lation, give a third infusion (children: 20 ml/kg normal saline; adults: 
1000 ml normal saline).
• Reassess the patient. If there is still no improvement in circulation or 
hydration, infuse 20 ml/kg of blood over 60 minutes.
• Give presumptive treatment with IV antibiotics (see below) to all pa-
tients who are in shock, since shock may be secondary to bacteraemia.
Blood transfusion for severe anaemia
It is essential to ensure a safe supply of blood for transfusion. Blood should 
be cross-matched and screened for HIV, malaria and hepatitis B. If a safe 
supply cannot be assured, transfusion should be restricted to patients with 
severe anaemia and signs of acute failure (shock, respiratory distress). If 
suitable donors without malaria infection cannot be found, blood should 
be administered with antimalarial treatment.
Children 
• Children with Hb <5 g/dl (PCV <15%) and respiratory distress 
— These patients need blood as an emergency.
— Give 20 ml/kg, as packed red cells or whole blood.
— Infuse the fi rst 10 ml/kg over 30 minutes and the next 10 ml/kg over 
2 hours.
— Reassess the patient at the end of the transfusion. If he or she still has 
respiratory distress and Hb <5 g/dl, repeat the transfusion.
• Children with Hb <5 g/dl (PCV <15%) but without respiratory distress 
— These patients should be transfused but, because their condition is 
less critical, can be given 20 ml/kg over 3–4 hours.
— Diuretics (furosemide) are unnecessary.
• Severely malnourished children (severe wasting plus oedema)
— Give blood much more cautiously to these patients.
— Infuse 10 ml/kg blood over 3 hours.
— Give furosemide, 1 mg/kg IV, halfway through the transfusion.
Adults
• Non-pregnant adults
— Blood transfusion is indicated in patients with Hb <7 g/dl plus symp-
toms (severe lethargy, prostration, breathlessness). Patients with Hb 
<7 g/dl who are otherwise asymptomatic and ambulant should not 
be transfused. 
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— Blood (500 ml) should be transfused over 3–4 hours. 
• Pregnant women 
Blood transfusion is indicated in the following situations:
— Women of ≥36 weeks gestation with Hb <7 g/dl, even if asymp-
tomatic (women who are severely anaemic during labour are at 
increased risk of dying). 
— Women of <36 weeks gestation with Hb <7 g/dl plus symptoms 
(severe lethargy, prostration, breathlessness).
— Transfuse 500 ml blood (packed red cells ideally) slowly over 4–6 
hours. Furosemide, 40 mg IV, should be given halfway through the 
transfusion.
— Transfusion should be avoided in the third stage of labour because 
of the risk of fl uid overload (pulmonary oedema) associated with 
placental separation.
Assessment of level of consciousness
Children aged 5 years and below
The Blantyre coma scale1 is a means of rapidly assessing and monitoring the 
level of consciousness in children. A score of 5 indicates full consciousness, 
while a score of 3 or less indicates coma. Ideally, the assessment should be 
carried out 4-hourly in all unconscious children.
Response  Score
Motor Localizes paina 2
 Withdraws in response to painb 1
 No motor response 0 
Verbal Appropriate cry 2
 Inappropriate cry 1
 No cry 0 
Eyes Gaze oriented 1
 Gaze not oriented 0
Total  Maximum 5 (fully conscious)
  Minimum 0 (deep coma)
a Apply sternal pressure (the examiner should press fi rmly on the child’s sternum using the 
knuckles of one hand). A child who is able to localize pain makes an attempt to remove the 
examiner’s hand.
b Pressure applied with pencil to nail bed.
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1989, 71(265):441–459.
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Children over 5 years of age and adults
Consciousness level should be assessed using the Glasgow coma scale:
Response  Score
Eyes open: Spontaneously 4
 To speech 3
 To pain 2
 Never 1
Best verbal response: Oriented 5
 Confused 4
 Inappropriate words 3
 Incomprehensible sounds 2
 None 1
Best motor response: Obeys commands 5
 Localizes paina 4
 Flexion to pain 3
 Extension to pain 2
 None 1
Total  Minimum 3; Maximum 14b
a Apply sternal pressure (the examiner should press fi rmly on the patient’s sternum using the 
knuckles of one hand). A patient who is able to localize pain makes an attempt to remove the 
examiner’s hand.
b Unrousable coma is defi ned as a score of <10.
Ideally, the assessment should be carried out 4-hourly in all unconscious 
patients, to monitor the level of consciousness.
Management of the unconscious patient
• Ensure that the airway is clear.
• Insert a nasogastric tube and aspirate the stomach contents into a sy-
ringe every 4 hours, to reduce the risk of aspiration pneumonia.
• Check that the patient is not hypoglycaemic, shocked, dehydrated, 
acidotic (breathing pattern) or severely anaemic, and treat any of these 
conditions urgently (as above).
• Start treatment with artemether, quinine or artesunate (see Box 5.9)
• Perform a lumbar puncture on all unconscious patients to exclude bac-
terial meningitis. If there is evidence of CSF infection (see Table 5.1) or 
lumbar puncture is not possible, treat presumptively for bacterial men-
ingitis (see below).
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• After successful correction of dehydration and shock, restrict IV fl uids to 
70% of normal maintenance fl uid requirements (described above). As-
sess fl uid balance daily if possible (daily weight gives a rough indication 
of overall fl uid balance).
• Check blood glucose every 4 hours, and Hb and parasitaemia at least 
daily.
• Treat convulsions that last for >5 minutes (see above).
• Monitor consciousness level every 4 hours with Blantyre coma scale 
(children 5 years and younger) or Glasgow coma score (children over 5 
years of age and adults). If consciousness level deteriorates, check blood 
glucose and Hb.
• Turn unconscious patients every 4 hours to prevent pressure sores.
Acute renal failure
Children
Established acute renal failure is rare in children with severe malaria, and 
poor urine output is often secondary to dehydration.
• Patients must be catheterized so that urine output can be measured ac-
curately.
• Acute renal failure is suggested by an hourly urine output of <0.5 ml/kg 
(oliguria). 
 Example: 
 For a 10-kg child, 0.5ml/kg per hour = 10 x 0.5 = 5 ml/hour. Blood con-
centrations of urea and creatinine are usually raised. 
• Check that oliguria is not due to dehydration or shock by giving test 
infusion(s) of 20 ml/kg normal (0.9%) saline (see above).
• If, despite correction of dehydration or shock (improved peripheral per-
fusion, normal blood pressure), hourly urine output is still <0.5 ml/kg, 
give IV furosemide, 3 mg/kg.
• If urine output remains <0.5 ml/kg per hour, assume that renal failure 
is established, and restrict fl uids to insensible loss (30 ml/kg per day: 
equivalent to 300 ml/day for a child weighing 10 kg) plus urine output. 
Consider peritoneal dialysis, if feasible.
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Adults
• Patients must be catheterized so that urine output can be measured ac-
curately.
• Acute renal failure is suggested by oliguria (urine output <0.4 ml/kg per 
hour).
• Check that oliguria is not due to dehydration or shock by giving test 
infusion(s) of 1000 ml normal (0.9%) saline (see above).
• Once dehydration is corrected, give a single dose of furosemide, 40 mg 
IV. If oliguria persists (<0.4 ml/kg per hour), increase furosemide dose 
in a stepwise fashion at 60-minute intervals to 100 mg, 200 mg (1-hour 
infusion), and fi nally 400 mg (2-hour infusion).
• If urine output remains <0.4 ml/kg per hour, assume that renal failure 
is established, and restrict fl uids to insensible loss (approximately 1000 
ml/day) plus urine output. Refer patient to hospital for dialysis if pos-
sible. If not, consider peritoneal dialysis, if feasible.
Pulmonary oedema
• Pregnant women are particularly prone to pulmonary oedema, espe-
cially during labour and immediately after delivery. 
• Check for increased respiratory rate, chest signs (crackles on ausculta-
tion) and hepatomegaly.
• If pulmonary oedema is suspected, position the patient upright, give 
oxygen, stop IV fl uids and give IV furosemide, 1 mg/kg.
• If pulmonary oedema is associated with blood transfusion, give IV furo-
semide, 1 mg/kg, and restart transfusion at a slower rate.
Antibiotics in the management of severe malaria
Patients with severe malaria should be treated with broad-spectrum IV 
antibiotics in the following circumstances:
• Severely ill or shocked patients. A recent study showed that 8% of all 
children (14% of those <12 months of age) admitted to an African dis-
trict hospital with severe malaria had concurrent bacteraemia. Mortality 
was increased 3-fold among those with bacteraemia. All patients who 
are shocked, or who remain severely ill following resuscitation, should 
therefore receive presumptive treatment with broad-spectrum IV antibi-
otics (e.g. ampicillin, 50 mg/kg 6-hourly, plus gentamicin, 7.5mg daily, 
or according to local patterns of antibiotic resistance).
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• Unconscious patients. A recent study from an African district hospital 
showed that 4% of all children (14% of those <12 months of age) with 
impaired consciousness and malaria parasitaemia had defi nite evidence 
of bacterial meningitis. If it is not possible to do a lumbar puncture in an 
unconscious patient with malaria, or if the CSF fi ndings are suggestive of 
meningitis, start presumptive IV treatment for meningitis (for example: 
children – benzylpenicillin, 60 mg/kg 6-hourly, plus chloramphenicol, 
25 mg/kg 6-hourly; adults – benzylpenicillin, 5 million IU (600 mg is 
equivalent to 1 million IU) 6-hourly, plus chloramphenicol, 1000 mg 
6-hourly as a standard dose). Treatment should be tailored to local pat-
terns of antibiotic resistance.
All patients with clinical evidence of bacterial infection (e.g. pneumonia, 
dysentery) should receive antibiotic therapy according to local treatment 
protocols.
Malaria in special groups
Pregnant women
Plasmodium falciparum is an important cause of maternal and perinatal 
morbidity and mortality. The clinical effects of falciparum malaria depend 
to a large extent on the immune status of the woman, which is determined 
by her previous exposure to malaria, and on her parity.
In pregnant women from areas of low malaria transmission, who have 
little pre-existing immunity, malaria usually presents as an acute illness, 
with detectable peripheral parasitaemia. Compared with non-pregnant 
women, non-immune pregnant women with P. falciparum malaria are 2–3 
times more likely to develop severe disease and approximately 3 times more 
likely to die. Women in this group are also at increased risk of miscarriage, 
stillbirth and neonatal death. Pregnant women often present with life-
threatening symptomatic disease, and the clinical course may be compli-
cated by hyperpyrexia (very high fever), hypoglycaemia, severe haemolytic 
anaemia, pulmonary oedema and cerebral malaria. 
Pregnant women living in areas of moderate to high transmission, who 
have a degree of pre-existing immunity, often develop malaria with few if 
any symptoms and few if any parasites in the peripheral blood on micros-
copy, although the placenta may be heavily infected. An RDT may give a 
positive result, and the woman should be treated. The main maternal ef-
fect of malaria infection in these circumstances is anaemia, which is often 
severe and may be life-threatening when not recognized and treated effec-
tively. The main effect on the baby is low birth weight, a major risk factor 
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for infant death. Pregnant women who are HIV-positive have a higher 
prevalence and density of malaria parasitaemia than those without HIV 
infection.
Pregnancy reduces the degree of partial immunity to P. falciparum that 
most women from settings with moderate to high transmission will have 
acquired during childhood and subsequently; this effect is particularly 
acute in women in their fi rst and second pregnancies and HIV-positive 
women during all pregnancies, who are thus at increased risk of malaria 
infection. 
P. vivax infection in pregnancy has less serious consequences than falci-
parum malaria, and is not associated with severe maternal disease. Howev-
er, fever can cause miscarriage, stillbirth, and premature delivery. P. vivax 
infection in pregnancy can cause mild maternal anaemia and low birth 
weight, resulting in increased infant mortality. Pregnant women living in 
areas with transmission of vivax malaria should therefore be included in 
prevention and case management strategies. 
Options for chemoprophylaxis, intermittent preventive treatment and 
case management for non-immune and semi-immune pregnant women, as 
well as management of severe malaria and prevention and management of 
anaemia in pregnancy are described in the following sections.
Non-immune pregnant women
Chemoprophylaxis
Daily or weekly chemoprophylaxis, which is theoretically an ideal way of 
preventing malaria in this vulnerable group, is very diffi cult to achieve in 
practice. Chloroquine, pyrimethamine and proguanil have been widely 
used in the past, but adherence to the prophylactic regimens has been poor 
and resistance to these drugs is now widespread. Weekly prophylaxis with 
mefl oquine was used effectively to prevent both falciparum and vivax ma-
laria in pregnancy in long-term stable refugee camps in south-east Asia, 
but resistance became widespread by 1998. Mefl oquine is no longer a 
viable option for chemoprophylaxis in parts of this region. In addition, 
a retrospective study found an increased risk of stillbirth among women 
treated (as opposed to receiving prophylaxis) with mefl oquine compared 
with other antimalarials. 
Screening
The presence of malaria parasites in the peripheral blood of a non-immune 
adult almost always indicates that he or she has, or will eventually develop, 
clinical malaria and will require treatment. Consequently, regular screen-
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ing and prompt treatment of non-immune pregnant women with parasitae-
mia is an effective way of reducing the incidence of severe disease. Weekly 
screening of women attending antenatal clinics in refugee camps along the 
Thai–Myanmar border was associated with a signifi cant reduction in ma-
ternal and perinatal morbidity and mortality. 
In situations where, for security-related or other reasons, antenatal 
clinic services are not functioning, the provision of an outreach service 
for the screening of pregnant women (using RDTs or light microscopy for 
diagnosis) in the community should be considered. 
Intermittent preventive treatment 
At present, there are no data on the effi cacy of intermittent preventive treat-
ment (IPT) for preventing the adverse consequences of malaria in pregnant 
women with no pre-existing immunity to the disease. There is thus no 
evidence to support the use of IPT in low-transmission areas and during 
epidemics – in these situations, the focus should be on case management 
and use of insecticide-treated nets (ITNs).
Semi-immune pregnant women
Asymptomatic malaria infections are common among pregnant women 
with a partial degree of immunity. A strategy that relies only on passive de-
tection and treatment of clinical illness will therefore have little impact on 
the prevention of anaemia and low birth weight. Interventions for pregnant 
women in acute complex emergencies in areas of moderate or high P. fal-
ciparum transmission should be a combination of good case management, 
active fi nding of fever cases at community level, proactive screening with 
microscopy or RDTs of all pregnant women at any point of contact with 
the health services, priority distribution of ITNs, and provision of IPT as 
soon as antenatal care (ANC) services have been established. 
Intermittent preventive treatment
Intermittent preventive treatment with SP, provided through ANC services, 
can reduce the incidence of severe anaemia and low birth weight in semi-
immune women in areas of moderate to high P. falciparum transmission. 
It is not feasible in acute-phase emergencies unless ANC services already 
exist.
IPT is an effective, safe and operationally feasible strategy for reducing 
the burden of malaria among semi-immune pregnant women, even in situ-
ations where the health infrastructure is weak. Instead of weekly or daily 
chemoprophylaxis, IPT involves the administration of a full treatment dose 
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of an effective antimalarial drug, once in the second and once in the third 
trimester of pregnancy. IPT is given whether or not malaria parasites are 
detected in the peripheral blood fi lm. 
At present, IPT is widely implemented in several African countries (in-
cluding among refugees and refugee-affected populations in border areas 
of the United Republic of Tanzania), and is being introduced in many other 
countries. 
A one-dose antimalarial treatment is preferable for IPT, since this ena-
bles treatment to be observed at the antenatal clinic and avoids the problems 
of adherence associated with medication taken at home. Currently, the only 
drug for which there is documented evidence of effectiveness when used 
as IPT is SP. In areas where it retains therapeutic effi cacy, SP has proved 
effective in reducing placental parasitaemia, improving birth weight and 
preventing severe maternal anaemia. Women who are HIV-positive appear 
to respond less well to IPT with SP than HIV-negative women and should 
therefore be given IPT on a monthly basis (minimum of 3 doses). Monthly 
IPT should be given to all pregnant women in situations where the HIV 
seropositivity rate among women attending antenatal clinics exceeds 10%. 
IPT with SP should not be given to HIV-positive women who already re-
ceive co-trimoxazole prophylaxis. Key points on IPT of semi-immune preg-
nant women in areas of high malaria endemicity are listed in Box 5.10.
The level of sensitivity required for SP to be effective as IPT is unknown. 
Therapeutic effi cacy of antimalarial drugs is usually measured in children 
under 5 years of age, and not in semi-immune pregnant women – much 
less in the context of IPT for semi-immune pregnant women. The follow-
ing guidance for African countries with intense malaria transmission and 
ongoing complex emergencies is based on the available evidence:
• In areas with low or moderate levels of SP resistance – IPT with SP 
should be given to all semi-immune pregnant women as soon as ANC 
services are established, even if no national IPT policy is yet in place.
• In areas with known relatively high levels of SP resistance – the situa-
tion is less clear. On the one hand, malaria in pregnancy is an important 
public health problem, and it would be diffi cult to withhold a prevention 
strategy that may well still be (partially) effective. On the other hand, 
it would be diffi cult to give a (partially) ineffective drug to pregnant 
women, even if the drug has a good safety profi le. Given this dilemma, 
there is currently insuffi cient evidence to stop IPT with SP in areas where 
it is already being used or to introduce it in area where it has not yet been 
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used. As soon as there is clearer evidence on this issue, it will be available on 
the WHO web site (www.who.int/malaria/pregnantwomenandinfants.
html).
Where IPT programmes are being implemented, IPT should be part of a 
larger package of prevention and case management strategies targeting 
pregnant women.
There are insuffi cient data to allow the use of any other antimalarial 
regimen to be recommended as an alternative to SP in areas of SP resist-
ance. Further research is needed to establish whether mefl oquine is a suit-
able alternative in areas of SP resistance. 
Management of malaria in pregnancy
Non-falciparum malaria
See “Management of non-falciparum malaria” on page 82.
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Box 5.10 Intermittent preventive treatment of semi-immune pregnant 
 women in areas of high malaria endemicity
■ Give intermittent preventive treatment with SP (3 tablets) at least twice 
during pregnancy in women who are HIV-negative, once at the start of the 
second trimester and once at the start of the third trimester.
■ SP should be given monthly to HIV-positive pregnant women, who are 
at increased risk of malaria.
■ Monthly IPT should be given to all pregnant women where the HIV 
seropositivity rate among women attending antenatal clinics exceeds 10%.
Precautions
■ Do not give IPT with SP more frequently than once a month. If a woman 
develops symptomatic disease after receiving SP she should be treated 
with an alternative antimalarial. 
■ Do not give SP to women who have a history of allergy to sulfa drugs. If 
an allergic reaction is suspected after the fi rst IPT dose, do not give further 
doses.
■ Do not give IPT with SP to HIV-positive women who already receive co-
trimoxazole prophylaxis.
■ Do not give IPT with SP in the fi rst trimester.
■ Advise women to return for the next dose of IPT after a clearly defi ned 
time interval, e.g. 3 months.
■ Explain to women that they can still get clinical malaria despite IPT, and 
that they should return immediately to the clinic if they develop a fever or 
anaemia.
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Uncomplicated falciparum malaria
All pregnant women with symptomatic malaria should receive urgent treat-
ment with effective antimalarials. Quinine (and chloroquine and SP where 
these are still effective) can be used safely for treatment in any trimester, 
and artesunate, artemether and mefl oquine can be used during the second 
and third trimesters. Artemisinin derivatives should not be withheld in any 
trimester if they are considered life-saving for the mother. Artemether–
lumefantrine is not recommended in the fi rst trimester of pregnancy be-
cause of the lack of data. Amodiaquine is apparently safe during pregnancy 
but only limited published data are available. Primaquine and doxycycline 
(but not clindamycin) are contraindicated in pregnancy (see Annex IV for 
more details). It should be noted that the pharmacokinetic properties of 
most antimalarials are altered in pregnancy and that the recommended 
dosages could be inadequate, leading to insuffi cient blood concentrations.
Management of severe malaria in pregnant women
Pregnant women with severe malaria should receive the highest level of 
inpatient medical care possible because of the high risk of maternal and 
perinatal mortality. Hypoglycaemia, acute pulmonary oedema, hyperpy-
rexia, postpartum haemorrhage, premature delivery and perinatal death 
are particular risks.
Antimalarial drug treatment
Severe malaria in pregnant women should be treated with IV quinine, IM 
artemether or IV artesunate (see Box 5.9). Intravenous quinine is safe in 
all three trimesters of pregnancy but may induce hypoglycaemia. When 
available, IV artesunate is the treatment of choice in the second and third 
trimesters of pregnancy. The safety of these drugs in the fi rst trimester has 
not been established, and quinine should therefore be used during early 
pregnancy. Neither quinine nor artemisinin derivatives should be withheld 
in any trimester if they are considered life-saving for the mother.
Presentation and treatment of complications
• Hypoglycaemia. Hypoglycaemia is a signifi cant risk for all pregnant 
women with malaria. It may occur during the clinical course of uncom-
plicated malaria, may be asymptomatic, or may present with sweating, 
confusion, agitated behaviour, drowsiness, convulsions or loss of con-
sciousness. Women in the second and third trimesters of pregnancy who 
are undergoing treatment with IV quinine are at particularly high risk, 
and this risk persists for several days postpartum. 
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 In patients with cerebral malaria, hypoglycaemia may be asymptomatic 
or may cause a deterioration in the level of consciousness, extensor pos-
turing, or convulsions. Differential diagnoses include sepsis, meningitis 
and eclampsia. Hypoglycaemia may also recur after correction with IV 
glucose. 
 For these reasons, regular monitoring (at least 4-hourly) of the blood 
glucose of all pregnant women with severe malaria is extremely im-
portant, particularly if they are receiving treatment with quinine. Blood 
glucose must be checked if there is any change in the level of conscious-
ness, and immediate treatment must be given if it is <2.2 mmol/l. See 
“Treatment of hypoglycaemia”, page 87.
• Acute pulmonary oedema. Acute pulmonary oedema commonly devel-
ops immediately after delivery, but may occur at any time during the fi rst 
week postpartum. Severe anaemia and the increase in blood volume and 
peripheral resistance that follows placental separation may precipitate 
acute pulmonary oedema and heart failure. This is a medical emergency 
that requires immediate treatment. 
— Pregnant women are particularly prone to pulmonary oedema, espe-
cially during labour and immediately after delivery. 
— Check for increased respiratory rate, chest signs (crackles on auscul-
tation), and hepatomegaly.
— If pulmonary oedema is suspected, position the patient upright, give 
oxygen, stop IV fl uids, and give IV furosemide, 1 mg/kg.
— If pulmonary oedema is associated with blood transfusion, give furo-
semide, 1 mg/kg IV, and restart transfusion at a slower rate.
• Severe anaemia. Blood transfusion is indicated in the following situa-
tions:
— Women of ≥36 weeks gestation with Hb <7 g/dl, PCV <21% (even if 
asymptomatic – women who are severely anaemic during labour are 
at increased risk of dying). 
— Women of <36 weeks gestation with Hb <7 g/dl plus symptoms 
(severe lethargy, prostration, breathlessness).
— Women of <36 weeks gestation with Hb <5 g/dl (PCV <15%).
Transfuse 500 ml blood (packed red cells ideally) slowly over 4–6 hours. 
Furosemide, 40 mg IV, should be given halfway through the transfusion. 
Transfusion should be avoided in the third stage of labour because of the 
risk of fl uid overload (pulmonary oedema) associated with placental sepa-
ration.
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It is essential to ensure that the blood supply is “safe”. Local laboratory 
facilities must therefore be able to perform compatibility testing (cross-
matching) and screening for HIV, malaria and, if possible, hepatitis B. 
If suitable donors without malaria infection cannot be found, the blood 
should be administered with an antimalarial treatment.
Prevention and treatment of anaemia in pregnant women
Anaemia is a common, and potentially dangerous, complication of preg-
nancy. The prevention of anaemia should, therefore, be a priority for all 
health programmes dealing with pregnant women.
• Ferrous sulfate, 200 mg (equivalent to 60 mg elemental iron), plus folic 
acid, 0.25 mg, should be given daily throughout pregnancy.
• In areas of moderate and high malaria transmission, where there is a 
high risk of asymptomatic malaria infection in pregnancy, pregnant 
women should be given IPT with SP, once in the second and once in the 
third trimester.
• Pregnant women who are anaemic (Hb 10 g/dl or below) should be given 
ferrous sulfate, 200 mg (equivalent to 60 mg elemental iron) 3 times 
daily, and folic acid, 0.25 mg 3 times daily, for 2 months.
• Presumptive treatment for intestinal worms (using a single 500-mg dose 
of mebendazole or 400-mg dose of albendazole) can be given once in 
the second or third trimester of pregnancy. Note that these drugs should 
not be given in the fi rst trimester. The diagnosis should be confi rmed by 
microscopy, if time and facilities allow. 
Malnourished persons
Management of uncomplicated malaria
Malnutrition is a signifi cant cause of mortality and morbidity in complex 
emergencies, and is associated with an increased risk of a poor outcome 
from severe malaria. 
Diagnosis
Patients with severe malnutrition (<70% of median weight-for-height, or 
<–3SD1) may have asymptomatic malaria infection and should therefore be 
1 SD = standard deviation score or Z-score. A weight-for-height of –2SD indicates the 
child is at the lower end of the normal range, and <–3SD indicates severe wasting. A 
weight-for-height of –3SD is approximately equivalent to 70% of the weight-for-height 
of the average (median) child (source and reference values: http://www.who.int/child-
adolescent-health/publications/referral_care/chap7/chap7fr.htm).
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screened for malaria – using microscopy or RDT – on admission to a thera-
peutic feeding centre and weekly thereafter until discharge. Once a patient 
has tested positive for malaria, further weekly screening can be done only 
with microscopy. 
Treatment
The absorption and bioavailability of several antimalarial drugs, includ-
ing chloroquine and quinine, can be signifi cantly impaired in patients 
with severe malnutrition. Increasing antimalarial drug bioavailability may 
reduce the risk of treatment failure due to poor drug absorption. All oral 
antimalarial drugs should be administered together with food, as this helps 
to increase absorption.
Treatment failures should be treated with either the 7 days of IM 
artemether, or with IV quinine (see Box 5.9). Intramuscular artemether 
is the preferred option for ease of administration, rapid parasite clearance 
and minimal adverse side-effects, but it should not be given to patients in 
vascular shock. 
Management of severe malaria 
Patients with severe malaria and severe malnutrition are at very high risk 
of death and require intensive medical and nursing care. They should be 
hospitalized in a therapeutic feeding centre and treated with an effective 
IM or IV antimalarial regimen (see Boxes 5.9 and 5.11), preferably using 
an artemisinin derivative. 
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Box 5.11 Therapeutic feeding in the Republic of the Congo
MSF France established therapeutic feeding centres to treat severely 
malnourished children returning from the Republic of the Congo in May 
1999. There were large numbers of malnourished children with severe 
malaria and a shortage of qualifi ed staff. Standard management with IV 
quinine infusion 3 times a day was operationally diffi cult and potentially 
dangerous, so the following protocol was introduced: 
■ Clinical diagnosis of malaria was confi rmed by RDT (Paracheck®, 98% 
positive, n = 231). 
■ Combination therapy with IM artemether once a day for 3 days 
combined with a single dose of sulfadoxine–pyrimethamine on day 3. 
High rates of clinical recovery were achieved. Artemether was easy to use, 
and no side-effects were noted.
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Returning refugees and internally displaced populations
In general, mass population movements in geographical areas of mixed 
endemicity may result in the arrival of large numbers of people with ma-
laria parasites in areas where there is normally little transmission, and the 
arrival of non-immune populations in areas where there is moderate or 
intense transmission. It is also possible that people will bring with them dif-
ferent parasite species (notably falciparum), or strains of malaria parasites 
that are more resistant to certain antimalarial drugs than the local strains. 
These situations pose a health risk for the resident populations and/or for 
the new arrivals.
The incidence of P. falciparum malaria relative to that of P. vivax has, 
for example, increased in the border region between Afghanistan and 
Tajikistan during the past decade, partly as a result of the cross-border 
movements of Afghan refugees.
If there is a risk that organized repatriation of displaced populations 
could introduce or re-introduce malaria or drug-resistant malaria, preven-
tive measures should be considered. The most cost-effective measure is 
mass screening and selective treatment of individuals with malaria, which 
should be carried out as close as possible to the time of departure and en-
tails the following:
— screening the entire returning population with a diagnostic test;
— treating individuals with malaria with effective antimalarial drugs 
that have blood schizonticidal and gametocytocidal activity, such as 
ACT.
In areas where P. vivax and P. ovale are prevalent, treatment would need 
to include anti-relapse treatment with primaquine. However, primaquine 
treatment should be given only to individuals who test negative for G6PD, 
and needs to be continued for 14 days. This may not be operationally feasi-
ble with large population groups. 
Because of the incubation period of malaria, some individuals may 
develop parasitaemia and symptoms only once they are back home. Re-
turnees should thus receive health education messages regarding malaria 
symptoms and the need to seek treatment if they fall ill with fever back 
home. Local clinics that may be unaccustomed to seeing malaria patients 
must be instructed about timely and adequate diagnosis and treatment of 
these patients.
Partial immunity will decrease during stays of 6 months or more in 
non-endemic areas. When refugees are repatriated after a long stay in an 
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Box 5.12 Malaria management in complex emergencies – 
 summary of key points
Good triage, diagnosis and case management are among the most 
effective ways of reducing avoidable illness and death from malaria.
Triage 
■ Emergency triage is essential. The priority should be to save lives, 
and the sickest patients need to be treated fi rst. The key is the rapid 
identifi cation, assessment and treatment of emergency danger signs. 
Diagnosis 
■ Differential clinical assessment and laboratory confi rmation of 
diagnosis are essential aspects of malaria case management in complex 
emergencies. Clinical assessment alone is very inaccurate, as the clinical 
presentation of malaria (both uncomplicated and severe) is variable and 
nonspecifi c. Patients often have more than one underlying disease, and all 
conditions must be rapidly identifi ed and appropriately treated. 
■ Rapid diagnostic tests and microscopy are the two tools used for the 
diagnosis of malaria.
■ In acute emergencies, limited time and resources make rapid diagnostic 
tests preferable to microscopy for screening populations, for confi rmation 
of clinical diagnosis in low-transmission areas, and for confi rming malaria 
in severely ill patients in moderate- to high-transmission areas.
Case management
■ Factors determining the choice of antimalarial drugs include drug 
effi cacy and resistance, patient case-load, access and adherence, drug 
availability, and ease of administration.
■ Uncomplicated P. falciparum malaria in acute emergencies should be 
treated with artemisinin-based combination therapy (ACT).
■ Uncomplicated non-falciparum malaria is normally treated with 
chloroquine. In areas of chloroquine resistance, mefl oquine, quinine and 
artesunate are effective alternatives. 
■ In areas where P. falciparum and P. vivax are common, patients should 
be treated for both species, if microscopy is not possible. 
■ Severe malaria should be treated with artemisinin derivatives or 
quinine. For children, both options are effective if administered correctly; 
IM artemether is easier to administer. Artesunate is the treatment of 
choice for adults with severe malaria.
■ To reduce mortality, close monitoring and immediate treatment of 
complications of severe malaria are essential.
Continued page 108
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area with little or no transmission to an area with higher transmission, the 
entire population will be at risk of severe malaria disease and death.
When organized repatriation of displaced populations could re-expose 
previously semi-immune populations (who have now lost their immunity) 
to malaria transmission, an intense IEC (information, education and com-
munication) campaign on the new risks of malaria should be organized, 
and can be accompanied by distribution of ITNs. The focus should be on 
personal protection methods (strict use of ITNs) and the need for early 
diagnosis and prompt treatment of all fever episodes. In the receiving area, 
local health workers may be unaccustomed to the dangers of malaria in-
fection for non-immune older children and adults, and must be instructed 
about timely and adequate diagnosis and treatment of these patients.
Further reading
WHO (2000). Bench aids for the diagnosis of malaria, 2nd ed. Geneva, 
World Health Organization.
WHO (2000). Severe falciparum malaria. Transactions of the Royal Soci-
ety of Tropical Medicine and Hygiene, 94(1):S1–S90.
WHO (2004). The use of malaria rapid diagnostic tests. Manila, World 
Health Organization Regional Offi ce for the Western Pacifi c (available 
at www.wpro.who.int/rdt/docs/RDTGuidelines_fi nal.pdf
WHO (2005). Malaria treatment guidelines. Geneva, World Health 
Organization (in press). 
Box 5.12 Continued
Priority vulnerable groups for active detection of fever cases and 
screening
■ Pregnant women, children under 2 years of age, severely malnourished 
children (therapeutic feeding centres).
■ Children under 5, and people known to be HIV-positive or with strong 
clinical suspicions of AIDS.
■ Affected population in general, especially (newly) non-immune people 
arriving in endemic area.
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Finding out more
Malaria in Emergencies Network
Fax: +41 22 791 4824
E-mail: rbmemergencies@who.int
Assistance can also be obtained through: 
Dr Peter Bloland
Centers for Disease Control and Prevention
Atlanta, GA
USA
E-mail: Pbb1@cdc.gov 
and 
Dr François Nosten
Shoklo Malaria Research Unit
736/2 Intrakiri Road
P.O. Box 46
Mae Sod, 63110
Tak, Thailand
E-mail: SMRU@tropmedres.ac
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CHAPTER 6
Prevention 
This chapter
■ discusses the methods available for malaria prevention
■ outlines how to make decisions about prevention interventions and 
how to organize prevention activities
■ describes features of the mosquito life cycle relevant to malaria 
prevention.
Malaria prevention in complex emergencies
While the fi rst priorities in the acute phase of an emergency are prompt and 
effective diagnosis and treatment of people with malaria, prevention can 
make an important contribution to reducing the risk of infection and sav-
ing lives. Malaria prevention strategies include vector control and personal 
protection against mosquito bites, in addition to intermittent preventive 
treatment during pregnancy to avert severe anaemia and low birth weight. 
Chapter 4 addresses prevention during malaria outbreaks, and informa-
tion about prevention in pregnant women is included in Chapter 5. This 
chapter deals with mosquito vectors, vector control, and personal protec-
tion against mosquito bites.
In emergency situations where there is a risk of malaria, the most impor-
tant initial questions related to prevention are: 
• Is malaria prevention likely to be useful? (How great is the malaria bur-
den? Where is transmission occurring?)
• Is malaria prevention feasible? (What is the situation regarding access, 
security, population mobility, human resources, funding, logistics?)
Assessment of the situation (see Chapter 2) – and particularly fi nding out about 
the malaria control strategy in the host country or in the country of origin of 
the refugee population – should provide some of the answers to these questions. 
However, the nature of complex emergencies presents both opportunities and 
constraints (see Box 6.1) that may justify a different approach to prevention. 
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There are also unanswered questions about malaria prevention in com-
plex emergencies, such as whether vector control is an appropriate response 
to outbreaks or can be implemented quickly enough to make a difference 
(see Chapter 8).
The approach to malaria prevention will also change as a complex emer-
gency situation moves from the acute phase to the chronic phase.
• In acute-phase crises the priorities are prompt and effective treatment of 
all clinical malaria episodes, to limit avoidable malaria deaths. Where 
feasible, this can be supplemented with barrier methods of mosquito-
bite prevention for targeted individuals or priority vulnerable groups at 
high risk of severe malaria and death. Exceptionally, indoor residual 
spraying with insecticides – which requires substantial advance plan-
ning, logistics and human and material resources – may be possible to 
protect people in well-organized settings such as transit camps. 
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Box 6.1 Factors in complex emergencies that may affect 
 the approach to prevention
Opportunities
■ Readily available trained workforce and adequate supervision.
■ Concentration of population, which may facilitate access, health 
education and logistics.
■ Additional humanitarian funding provided by international donor 
organizations. 
Constraints
■ Access to the population limited by confl ict.
■ Priority for curative care and feeding the population may limit funds and 
manpower available for vector control.
■ Most malaria transmission may occur outside resettlement sites or 
camps.
■ Language barriers may make it diffi cult to provide information and 
education. 
■ Lack of expertise in vector control.
■ Rapid staff turnover. 
■ Temporary shelters differ from local housing and may make indoor 
residual spraying and the use of ITNs more problematic.
■ Unstable and unpredictable situations make longer-term planning more 
diffi cult. 
■ Evaluation of prevention strategies is more diffi cult. 
■ Problems in securing orders and importing commodities (insecticide, 
pumps, nets) quickly enough.
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• In chronic crises, as the situation stabilizes, it may be possible to pre-
vent new infections by the addition of high-coverage community vector 
control measures – covering a high percentage of the population with 
insecticide-treated materials or spraying a high percentage of dwellings 
with residual insecticide to achieve an impact on transmission. 
Acute phase
During the acute phase, decisions about whether or not to implement ma-
laria prevention and about the choice of prevention methods will depend on:
— the risk of infection;
— the behaviour of the population (e.g. mobility, sleeping arrange-
ments);
— the type of shelter available (e.g. plastic sheeting, tents, permanent 
housing);
— the behaviour of the local vector.
For example, in situations where the population is on the move, it will not 
be possible to spray houses but insecticide-treated mosquito nets or ma-
terials may be appropriate. Where people have no tradition of net use or 
shelter is very basic, insecticide-treated materials may be more acceptable 
and feasible than nets.
Chronic phase
As the situation stabilizes, longer-term approaches can be introduced. 
Different prevention methods may also be needed as the population be-
comes less mobile and temporary shelters are replaced by more permanent 
structures. For example, there may be greater opportunities for providing 
information and education to the population about personal protection 
methods.
Prevention methods
Methods that are appropriate for complex emergencies
Indoor residual spraying
Indoor residual spraying (IRS) involves spraying a persistent insecticide 
onto the inside walls and ceilings or the underside of the roof and eaves 
of houses, in order to kill mosquitoes when they come indoors to feed and 
rest. The basic preconditions for IRS are:
— an endophilic malaria vector (i.e. mosquitoes enter and rest inside 
houses for long enough to absorb the insecticide);
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— an insecticide to which the vector is susceptible; and 
— a population living in dwellings with sprayable surfaces.
To be effective as a community control measure, IRS requires coverage of 
at least 85% of dwellings, ensuring that the majority of mosquitoes are 
exposed to the insecticide. 
Indoor sleeping is not strictly a requirement for IRS success. In Afghan 
refugee camps, for example, people sleep outdoors on hot summer nights, 
but indoor spraying still provides protection against malaria because mos-
quitoes rest indoors during the day.
Given the operational requirements, IRS is most suited to areas with 
some stability where advance planning and close monitoring of campaign 
coverage are possible. In acute-phase emergencies, there may be opportuni-
ties for IRS during advance planning for refugee transit camps and other 
well-organized settings.
An IRS campaign requires substantial advance planning, logistic support, 
and human and material resources. Its effectiveness is highly dependent on 
operational factors – timely delivery of commodities, on-site expertise and 
capacity, trained staff, good organization and planning, manpower, su-
pervision, and appropriate IEC (information, education, communication). 
Timing is critical – at least 85% of the walls, ceilings, etc. must be sprayed 
with insecticide before the expected peak transmission season.
Good-quality compression sprayers that comply with WHO specifi ca-
tions must be used for IRS: mechanical pumps are prone to wear and tear. 
These may need to be imported, together with spare parts and the insec-
ticide, and this takes time and requires adequate planning. Proper main-
tenance is important to ensure that compression sprayers are effi cient and 
that their working life is maximized: IRS campaigns have been known to 
fail because of neglect of spray pump maintenance. The insecticide must be 
applied safely, and the operations must be properly supervised. Spray teams 
require at least 2 days’ intensive theoretical and practical training before 
they can start fi eld operations, which must then be closely supervised and 
monitored. In view of these various requirements, IRS campaigns are not 
always carried out well even when the required operational factors are all 
in place. 
WHO has produced an illustrated manual that can be used for training 
spray teams – Manual for indoor residual spraying: application of residual 
sprays for vector control (WHO, 2000). This manual is intended to serve 
as a model for the development of relevant training materials and proce-
dures at country level. 
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Important aspects of interactions between spray teams and target house-
holds are summarized in Box 6.2.
Table 6.1 lists the insecticides commonly used for residual spraying, 
recommended application rates (g/m2), and the residual life or persistence. 
Any of the insecticides recommended by WHO can be used if available 
locally and known to be effective. WHO specifi cations for public health 
pesticides – for quality control and international trade – are available at 
www.who.int/whopes/quality.
If malaria transmission is seasonal, it is important to spray just before 
or at the start of the season. If there is an outbreak, spraying is useful only 
if the insecticide is on the walls before the peak of the epidemic is reached. 
This requires detailed advance planning and considerable logistic capacity 
and is rarely possible in practice. Delayed IRS is a waste of resources as it 
may have little impact on malaria transmission or on a malaria outbreak 
(see Box 6.3).
Box 6.2 Household aspects of indoor residual spraying
Household preparations
■ Inform the occupants of the household of the spraying schedule and the 
reasons for spraying.
■ Allow the occupants time to prepare and vacate the living areas.
■ Remove all household items, including water, food, cooking utensils and 
toys. Items that cannot be removed should be well covered.
■ Move pets and domestic animals away from the house/hut.
■ Occupants must leave before spraying begins.
■ Areas occupied by sick people who cannot be moved must not be 
sprayed.
Household procedures after spraying
■ Advise occupants to stay outside while the spray is drying.
■ Instruct occupants to sweep or mop the fl oor before children and pets 
are allowed to re-enter.
■ Instruct occupants not to clean the sprayed surfaces.
Waste disposal
■ Put washings from sprayer into pit latrines or into pits dug for the 
purpose (away from sources of drinking-water).
■ Never pour insecticide into rivers, pools or drinking-water sources.
■ Never reuse empty insecticide containers, and do not burn them. 
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Table 6.1 WHO-recommended insecticides for indoor residual spraying 
 against malaria vectorsa
Insecticide compounds  Classc Dosage Mode of Duration of
and formulationsb  (g/m2)  action  effective action 
    (months)
Alpha-cypermethrin, WP & SC P 0.02–0.03 contact 4–6
Bendiocarb, WP C 0.1–0.4 contact &  2–6
   airborne 
Bifenthrin, WP P 0.025–0.050 contact  3–6
Cyfl uthrin, WP P 0.02–0.05 contact 3–6
DDTd, WP OC 1–2 contact >6
Deltamethrin, WP & WG P 0.020–0.025 contact 3–6
Etofenprox, WP P 0.1–0.3 contact 3–6
Fenitrothion, WP OP 2 contact &  3–6
   airborne 
Lambda-cyhalothrin, WP P 0.02–0.03 contact 3–6 
Malathion, WP OP 2 contact 2–3
Pirimiphos-methyl, WP & EC OP 1–2 contact &  2–3
   airborne 
Propoxur, WP C 1–2 contact &  3–6
   airborne 
a Source: Najera JA, Zaim M (2003). Malaria vector control: decision-making criteria and 
procedures for judicious use of insecticides. Geneva, World Health Organization (WHO/CDS/
WHOPES/2002.5 Rev.1).
b EC = emulsifi able concentrate; SC = suspension concentrate; WG = water-dispersible gran-
ules; WP = wettable powder.
c OC = organochlorine; OP = organophosphate; C = carbamate; P = pyrethroid.
d For the conditions for using DDT, see: Stockholm Convention on Persistent Organic Pollutants 
(POPs) (2001), United Nations Environment Programme (UNEP/CHEMICALS/2001/3), page 49.
Effect of the surfaces to be sprayed
The nature of the surface to be sprayed and the insecticide formulation 
chosen affect both the availability of the insecticide and the duration of 
its residual effect. Generally, surfaces of organic origin – wood, bamboo, 
leaves, thatch, etc. – and metals are not absorptive; persistence on these sur-
faces is therefore related to the volatility of the insecticide (which depends, 
in turn, on temperature and the characteristics of the formulation). In con-
trast, insecticide may be absorbed into mud surfaces, the extent of absorp-
tion depending on the particle size of the insecticide. Heat from the sun 
may inactivate insecticide deposits. Alkaline surfaces such as whitewashed 
walls will inactivate organophosphates, carbamates and pyrethroids. 
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Box 6.3 Impact of spraying on malaria incidence (per 100 person-years)1
1 Source: Rowland M (1995). Unpublished report to UNHCR on Afghan refugee ma-
laria control programme. HealthNet International.
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A. Spraying with malathion in a group of Afghan camps in July 1992 
at the start of the transmission season prevented most transmission
B. Late spraying in a group of neighbouring camps in Sept–Oct 1992 
failed to curb the outbreak (which came to a natural end in the 
winter). This illustrates the importance of correct timing of spray 
campaigns at the onset of the transmission season
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Programme monitoring 
Monitoring of programme quality should take place during the IRS appli-
cation (indicators a–d below) and 1 month afterwards (indicator e):
a) Coverage = number of dwellings sprayed/number of dwellings in tar-
geted area (%).
b) Insecticide used per dwelling = quantity of insecticide used/number of 
dwellings sprayed (a measure of effi ciency and correct use of insecticide).
c) User acceptability pre-spray = % of households refusing to be sprayed.
d) % of spray pumps properly maintained and still working during and at 
the end of the campaign.
e) User acceptability post-spray = % of dwellings replastered or washed, or 
% of householders complaining about IRS.
Insecticide-treated mosquito nets 
Sleeping under an untreated mosquito net provides a physical barrier 
against mosquitoes – but mosquitoes can still bite if there is a small hole or 
tear in the net or if any part of the body is touching the net. Treating nets 
with a suitable insecticide increases the level of protection: the insecticide 
kills or repels mosquitoes before they can enter the net or bite the person 
sleeping under the net. Insecticide treatment of nets provides personal 
protection for all those who sleep under them even when coverage is low. 
High coverage of the population (≥60%, although some studies indicate 
50%) with insecticide-treated nets (ITNs) can reduce the adult mosquito 
population and may therefore also protect people who do not use ITNs. In 
Africa, ITNs work well against all malaria vector species if used regularly 
and correctly. Distribution of untreated nets is not recommended because 
when they become torn or holed, as they inevitably will, they offer little or 
no protection against mosquitoes. 
In recent years, ITNs have been shown to be very effective in reducing 
malaria mortality and morbidity in the chronic phase of complex emergen-
cies. For example, even limited distribution of ITNs has reduced malaria 
mortality and morbidity in Afghan refugee camps: 3 years after receiving 
free nets, 65% of refugees were still using them and achieving better than 
70% protection against malaria attacks (Rowland et al., 1997). The impact 
in other refugee situations has been mixed; for example ITNs have been 
effective in Viet Nam (Cong & Schapira, 1998) but less effective in refugee 
camps on the Thai–Myanmar border (Luxemburger et al., 1996).
Nets vary in size and are made from a variety of fabrics. Long-lasting 
insecticidal nets are preferable in complex emergencies to avoid the need for 
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treating and drying nets in the fi eld, and for regular re-treatment. If long-
lasting nets are not available, insecticide treatment of conventional ITNs 
in the presence of the recipients is preferable to distribution of pretreated 
nets, because of problems in ensuring the use of good-quality insecticide 
products and proper dosing of pretreated nets. Moreover, if the presence 
of insecticide is not apparent to recipients of pretreated nets, as is often 
the case, they are less likely to seek re-treatment of their nets later. Finally, 
experience indicates that organizations that distribute pretreated nets often 
fail to provide re-treatment 6 months later. In Afghanistan, it was found 
that dipping the nets in front of the recipients was essential to stimulate ap-
propriate use and later re-treatment.
The easiest method for treating nets on the spot involves simple plastic 
bags, each large enough to contain a net plus the appropriate volume of 
water. Treatment consists of adding 500 ml (for a synthetic net) or 2 litres 
(for a cotton net) of water to a bag, plus a dose of insecticide, mixing thor-
oughly, introducing the net and making a knot in the bag. Users are then 
asked to soak the net in the solution contained in the bag and to dry it once 
they are back home or in their shelters. This method is simple, limits queu-
ing, and takes little time for either users or dippers – although subsequent 
disposal of bags may be problematic. The quantities of insecticide needed 
per treated net are listed in Table 6.2. 
Table 6.2 WHO-recommended insecticides for treatment of mosquito netsa
Insecticide Formulationb Dosec for one net
  (any size)
Deltamethrin 25% WT 1 tablet
 1% SC 40 ml
Lambda-cyhalothrin 2.5% CS 10 ml
Alpha-cypermethrin 10% SC 6 ml
 6% SC 10 ml
Cyfl uthrin 5% EW 15 ml
Etofenprox 10% EW 30 ml
Permethrin 10% EC 75 ml
a Source: WHO (2000). Instructions for treatment and use of insecticide-treated mosquito nets. 
Geneva, World Health Organization (WHO/CDS/RBM/2002.41, available at www.who.int/
malaria/cmc_upload/0/000/016/007/InstructionsITNen1.pdf).
b EC = emulsifi able concentrate; SC = suspension concentrate; CS = microencapsulated; EW = 
oil-in-water emulsion
c The dose for one net may be provided as a tablet, small bottle or sachet of liquid, or the insec-
ticide may be supplied in bulk. Mix one dose of insecticide with the recommended amount of 
water (500 ml for a synthetic net, 2 litres for a cotton net) to treat one net of any size.
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Depending on the persistence of the insecticide used, the frequency of 
net washing, and the seasonality of malaria transmission, ITNs normally 
need to be re-treated every 6–12 months. The amount of insecticide needed 
to treat enough nets for a family is less than the amount required to spray 
the walls and ceiling of a house. Net treatment thus costs less than house 
spraying – but the cost of providing nets may be higher than the cost of two 
or three rounds of IRS. 
Long-lasting insecticide-treated nets (LLINs) are increasingly avail-
able. These are factory-treated mosquito nets that are expected to retain 
their biological activity for a minimum number of standard WHO washes 
and a minimum period of time under fi eld conditions. Currently, an LLIN 
would be expected to retain biological activity for at least 20 standard 
WHO washes under laboratory conditions and 3 years of recommended 
use under fi eld conditions.1 This makes them very attractive for use in 
emergency situations despite their higher cost compared with conventional 
nets. The only LLINs currently recommended by WHO for malaria preven-
tion and control are Olyset Net® and PermaNet® 2.0; in December 2003 
PermaNet® 2.0 received an interim recommendation requiring further 
large-scale fi eld studies to confi rm long-lasting effi cacy for prevention and 
control of malaria and other vector-borne diseases in different settings. 
The wash resistance of PermaNet® 2.0 over 20 washes was recently dem-
onstrated in an Afghan refugee camp (Graham et al., 2005). More infor-
mation is available on the RBM and WHOPES web sites. LLINs made of 
polyethylene are stronger and more durable (www.who.int/whopes/qual-
ity/en/OlysetInterimSpecifi cation.pdf). Institutional buyers should follow 
the WHO 2001 guidelines Specifi cations for netting materials (available at 
www.who.int/malaria/cmc_upload/0/000/012/756/ netspex.pdf). 
Nets can be used indoors or outdoors. Indoors, they can be suspended 
from walls or ceilings using string or guy ropes. Outdoors, nets can be 
supported on poles; rounded poles should be used to avoid damaging the 
netting and care is needed to hold them fi rmly in position (Rozendaal, 
1997). Before nets are distributed, it is important to fi nd out about sleeping 
practices and consult the population on how nets can best be suspended or 
supported. Distribution of nets must be accompanied by information and, 
if necessary, materials to enable people to use them correctly. Information 
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1 Source: WHO (2005). Guidelines for laboratory and fi eld testing of long-lasting 
insecticidal mosquito nets. Geneva, World Health Organization (WHO/CDS/
WHOPES/GCDPP/2005.11).
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and pictorial leafl ets about treated nets should also emphasize the impor-
tance of not washing nets, of keeping them out of sunlight and rain, and on 
the need for timely re-treatment.
An illustrated manual – Instructions for treatment and use of insec-
ticide-treated mosquito nets – that can be used for training and health 
education messages is available at www.who.int/malaria/cmc_upload/0/
000/016/007/InstructionsITNen1.pdf. 
Because of the behavioural change needed to make ITN interventions a 
success, community distribution of treated nets in acute emergencies is an 
option only if the target community is already in the habit of using nets. 
Where community vector control interventions (IRS) are already ongoing, 
community ITN distribution in acute crises is unnecessary. Distribution of 
ITNs should initially target high-priority vulnerable groups who are bio-
logically at increased risk of severe disease and who thus benefi t most from 
the personal protection effect, as outlined in Box 6.4.
The quality and likely effectiveness of the intervention should be as-
sessed by monitoring at the time of distribution (to track coverage) and 
1 month and 6 months later (to determine appropriate use and retention), 
using the following indicators:
a) Coverage = number of ITNs distributed/target population size (%).
b) Utilization rate = number of people using ITNs/number of people given 
ITNs (%).
c) Retention rate = number of people retaining ITNs/number of people 
originally given ITNs (%).
d) Deterioration rate = average number of holes per ITN.
 Note: Even nets with some holes can be protective against mosquitoes if 
they are treated with pyrethroid insecticide – this is one of the purposes 
of the insecticide treatment. Knowing the deterioration rate allows fur-
ther purchases of ITNs to replace grossly damaged nets to be planned. 
Methods with limited evidence base, deserving further local 
research in operational settings
Conventional vector control interventions (ITN, IRS) are in general not 
feasible for acute-phase emergencies. New vector control tools for acute 
emergencies are needed that:
— place little or no extra burden on implementing agencies;
— can be stockpiled long term; and
— require little or no behavioural change among implementers and users.
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Box 6.4 ITN distribution by phase of emergency, level of transmission
Acute-phase emergencies in areas of high/moderate transmission
1. Use ITNs for all beds/patients in hospitals and therapeutic feeding 
centres (TFC), and provide ITNs to the households of TFC patients on 
discharge.
2. Distribute ITNs to pregnant women and children under 2 years of age 
provided that the following three preconditions are met:
— ITNs have been stockpiled in advance
— the community is used to using them
— no community vector control interventions (IRS) are ongoing.
3. Finally, if supplies remain after situations 1 and 2 have been taken care 
of:
— provide ITNs through supplementary feeding centres to the 
household of every enrolled child on fi rst contact;
— distribute ITNs to children under 5 years of age (provided that the 
preconditions listed under 2 above are met);
— distribute ITNs to the entire households of pregnant women and 
children under 2 of age (extend to 5 years of age if supplies allow).
Acute-phase emergencies in low-transmission areas of Africa
Use ITNs only in clinical settings (TFC beds, hospital beds); no community 
distribution schemes.
Chronic-phase emergencies in areas of high/moderate transmission
1. Ensure that ITN distribution for acute-phase emergency is met.
2. Extend ITN coverage to the entire households of pregnant women 
and children under 2 years of age, with catch-up distribution schemes 
through antenatal care, immunization programmes and primary health 
care.
3. Distribute ITNs through regular catch-up distribution schemes to 
people with known HIV infection or strong clinical suspicion of AIDS.
4. Finally, if supplies remain after 1, 2 and 3 have been completed:
— extend ITN coverage to entire households of children under 5 years 
of age with catch-up distribution schemes through immunization 
programmes and primary health care;
— extend ITN distribution to the affected population in general.
Chronic-phase emergencies in low-transmission areas of Africa
Interventions as for chronic-phase emergencies in areas of high/moderate 
transmission.
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Insecticide-treated blankets and plastic sheeting are the most promising 
tools but have not yet passed WHOPES evaluation. These methods – and 
others that have been shown to be appropriate for complex emergencies in 
certain settings (mainly Asia) but whose application in other parts of the 
world would require local operational research – are discussed in the para-
graphs that follow.
Other insecticide-treated materials
Insecticide-treated nets may not be appropriate in complex emergency situ-
ations where people have no tradition of net use, shelter is very basic, or 
obtaining suffi cient supplies of nets takes a long time or is too costly. In 
such situations, insecticide treatment of other materials – tents, blankets, 
sheets, clothing and curtains – may be more acceptable and more feasible. 
Pyrethroid treatment of these materials has been tried in a range of set-
tings, in particular among Afghan refugees and more recently in Kenya 
(Macintyre et al., 2003). Some examples are described below. Insecticide-
treated blankets and plastic sheeting are the most promising but have 
not yet passed required WHOPES evaluation. Chapter 8 provides more 
information about operational research related to insecticide treatment of 
alternative materials. 
Hammock nets
In complex emergency situations where people have to sleep outdoors or 
in rudimentary shelters, use of hammocks may be an option and mosquito 
nets that are specially designed for hammocks are available. The feasibility 
and effectiveness of treating hammock nets with pyrethroid insecticides is 
currently being evaluated in Cambodia. 
Tents
The inner surface of tents can be sprayed using compression sprayers, either 
in the same way as house spraying or by laying the tent fl at before spraying. 
Tent spraying has been tried with Afghan and Vietnamese refugees, and 
is carried out each year among nomadic refugees who migrate annually 
between the Punjab and the mountain areas of Pakistan. In the latter case, 
tent spraying has been shown to provide 60–80% protection against falci-
parum malaria (Bouma et al., 1996). The most suitable insecticides for tent 
spraying are permethrin and deltamethrin, in suspension concentrate (SC) 
formulation (Hewitt et al., 1995). Wettable powder (WP) formulation, 
which is used for house spraying, is not suitable for tent spraying. Pyre-
throid insecticide persists for more than 12 months on double-sheeted tents 
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and for up to 6 months on single-sheeted tents. A tent made of canvas inter-
woven with insecticide-impregnated polyethylene threads has recently been 
shown to be highly effective against mosquitoes (Graham et al., 2004).
Insecticide-treated plastic sheeting (ITPS)
Research is under way to determine the effectiveness of insecticide treat-
ment of the plastic sheeting that is increasingly being provided as shelter in 
emergencies in Africa (Allan, 2001). The laminated polyethylene tarpaulin 
is impregnated with deltamethrin during manufacture and the insecticide 
migrates slowly to the surface to replace that which is lost. Entomological 
trials in refugee camps in Pakistan showed that the insecticide is present for 
at least a year and kills mosquitoes that come into contact with it (Graham 
et al., 2002a). The mode of action of ITPS (approx. size: 4 m x 5 m) would 
be comparable to indoor residual spraying, with a potential community 
protective effect at high coverage but no personal protection effect.
Results from an initial fi eld trial in Sierra Leone into the effectiveness 
of ITPS against malaria are currently being analysed by the Centre for In-
ternational Emergency, Disaster and Refugee Studies/Johns Hopkins Uni-
versity. The potential of ITPS is likely to depend on local vector resistance 
patterns and the ratio of ITPS to other mosquito resting sites in a given situ-
ation. Evidence from other countries and modes of use (e.g. as roofi ng, wall, 
and tent) is still needed. In situations where commercially available ITPS is be-
ing used, the duration of effectiveness against malaria, and safety under fi eld 
conditions should be monitored and reported to build up the evidence base. 
Blankets, top sheets and clothing
Permethrin treatment of top sheets, blankets and chaddars (the veil or wrap 
worn by many Muslim women) has been tried among Afghan refugees. 
Compared with a placebo, insecticide treatment was shown to provide 62% 
protection against falciparum malaria and 46% protection against vivax 
malaria (Rowland et al., 1999). A trial in Kabul, Afghanistan, showed that 
treated bedding provided a level of protection against cutaneous leishma-
niasis (a disease that is transmitted by sandfl ies) equivalent to that provided 
by treated nets (Reyburn et al., 2000). Permethrin is the preferred insecti-
cide because of its low toxicity, at a target dose of 0.5–1 g/m2 (Graham et 
al., 2002b). The good personal protection afforded by insecticide-treated 
blankets is due mostly to the repellent effect of the permethrin. Effective-
ness is comparable to, but shorter-lived than, that of ITNs.
Treated blankets, top sheets and chaddars could play an important 
role in malaria prevention in emergencies because they are easily available 
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– blankets are often included as a standard item in emergency relief kits, 
and top sheets and chaddars are widely used in some cultures – and because 
they can be used regardless of whether people sleep indoors or outdoors 
and of the type of shelter. In addition, providing protection by treating 
these materials is cheaper than providing protection with treated nets, since 
the only cost involved is that of the insecticide. The duration of effective-
ness of pretreated blankets (either stockpiled or in fi eld use) still needs to 
be evaluated. Further research is also required to fi nd out whether treated 
blankets can provide protection against malaria in endemic conditions in 
Africa: a recent study of permethrin-treated sheets among Kenyan nomads 
indicates a protective effect (Macintyre et al., 2003) (see also Chapter 8). 
Curtains
In areas where mosquitoes bite early in the evening, before people go to 
sleep under nets, use of insecticide-treated curtains over openings such 
as windows, doors and eave gaps may provide some protection. Treated 
curtains can be very cheap if shelters or houses have a limited number of 
openings. They have been shown to have an impact in some settings, for 
example in west Africa (Habluetzel et al., 1999) and in Afghanistan, where 
people have been encouraged to use treated nets as curtains when they 
move indoors after the summer.
Long-lasting treatment
A number of new long-lasting insecticidal products are expected to reach 
the market in the near future. Long-lasting formulations that could be used 
to treat conventional nets in the fi eld may be particularly useful in emer-
gencies, helping to overcome the current delays in supply of long-lasting 
insecticidal nets, or may be used to improve conventional nets that have al-
ready been distributed. It will be important to use products that conform to 
WHOPES specifi cations for safety, effi cacy and operational acceptability. 
Insecticide zooprophylaxis
Insecticide zooprophylaxis could be used in settings where vectors bite 
domestic animals as well as humans, for example in south and south-west 
Asia where A. culicifacies and A. stephensi feed on cattle 90% of the time 
and humans 10% of the time. Rather than being applied to houses, the in-
secticide – usually deltamethrin – is applied to the hair and skin of domestic 
livestock, such as cattle, goats and sheep, using a sponge or animal dip. 
Mosquitoes pick up a lethal dose of insecticide when they attempt to feed 
on a “treated” animal.
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Trials of this method in Afghan refugee camps have shown its effect on 
malaria to be comparable to that of IRS but at 20% of the cost, since less 
insecticide is required (Rowland et al., 2001). Although still at the devel-
opment stage, insecticide zooprophylaxis has been widely used in Afghan 
refugee settlements in Pakistan. However, it will not work against anthro-
pophilic vectors such as A. gambiae in Africa.
Home-use products 
Home-use products include coils, insecticide aerosols, mosquito repellents 
and vaporizing mats. Like treated curtains, these products may be of some 
use in areas where mosquitoes bite early in the evening. However, vapor-
izing mats require electricity, which is unlikely to be available in most reset-
tlement sites or camps. 
These methods are needed every evening and may therefore be too costly, 
although social marketing of mosquito repellents in Afghanistan did have 
reasonable success and indicated protection against malaria (Rowland et 
al., 2004a). In acute emergencies repellents may have logistic advantages 
(e.g. less bulk) over other methods, and a recent trial in an Afghan refugee 
camp demonstrated up to 50% protective effi cacy against falciparum ma-
laria (Rowland et al., 2004b). Repellents may provide a good temporary 
solution provided that recipients are disciplined about applying them.
Methods that are usually not appropriate in complex emergencies
Larval control
Larval control is most practicable where vector breeding sites are limited 
in number and relatively permanent. It is thus not feasible in much of rural 
Africa, where the breeding sites of the major vectors are numerous and 
temporary, or in south-east Asia, where breeding sites are in inaccessible 
forest areas. It has not been widely used in complex emergencies and is not 
advised unless there is professional entomological expertise available to 
provide support.
In areas where it is a viable option, larval control must be carried out 
thoroughly if it is to have an impact. The target area must be large enough 
to include all breeding sites contributing to the local adult mosquito popu-
lation. Not all water bodies are breeding sites, and many others produce 
few mosquitoes, so good local knowledge and entomological expertise are 
required to target the most productive breeding sites. There are three meth-
ods of larva control – chemical, biological and environmental. 
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Chemical methods
Chemical methods of larviciding include the use of oils and chemical and 
bacterial insecticides. 
Few chemical insecticides are safe enough for use in water that is used 
for drinking and bathing. The most commonly used is the organophosphate 
temephos, which is effective and safe in drinking-water at a concentration 
of 1 part per million. In most parts of the world, Anopheles species remain 
fully susceptible to temephos, although resistance is common in nuisance-
biting Culex quinquefasciatus. Pyrethroid insecticides are highly toxic to 
fi sh and are therefore unsuitable in many places. 
Bacillus thuringiensis H-14 (BTI), a bacterial insecticide, is specifi cally 
toxic to mosquitoes and blackfl ies. BTI can be very effective but it is costly; 
moreover, most formulations have a short residual action against surface-
feeding Anopheles, necessitating weekly re-treatment. 
Insecticide can be delivered in dilute liquid form using spray pumps or 
in granular form. Granular formulations are easier to handle and penetrate 
better into water that is covered with vegetation.
Biological methods
Biological control is safe but can be diffi cult to apply, and there are few 
examples of effective malaria control using biological methods. Fish are 
the most widely used method, specifi cally the minnow Gambusia affi nis 
and the guppy Poecilia reticulata. In an area of Somalia, for example, ma-
laria was controlled successfully by stocking concrete tanks (the only local 
source of surface water) with larva-eating fi sh.
Environmental methods
Environmental control methods include removing breeding sites (by fi lling 
or draining them) and avoiding the creation of breeding sites. However, 
good local knowledge and entomological expertise are required to target 
the most productive breeding sites and to avoid wasting time and resources 
on unimportant sites. 
Scrub removal
There is no evidence that the widely advocated practice of cutting down 
grass and scrub around houses, to reduce the number of mosquito resting 
sites, has any impact on malaria transmission. 
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Aerosol spraying 
Outdoor aerosol spraying from a vehicle or using a motorized sprayer looks 
impressive but there is little evidence that it has any impact on malaria and 
it is not recommended. 
Selecting and implementing prevention methods
Once it is decided that malaria prevention is likely to be useful and feasible, 
the next consideration is the methods of prevention that are appropriate 
and how malaria prevention activities can be organized.
Selecting prevention methods
The main criteria for selection of methods of prevention, and the informa-
tion required for decision-making are:
• Need – the burden of malaria; geographical distribution; seasonality; 
risk of an outbreak.
• Effi cacy – trials measuring impact; vector prevalence, distribution and 
behaviour; experience with existing/previous use of ITNs, IRS or other 
vector control in the area.
• Effectiveness relative to other malaria control methods – impact in 
operational conditions.
• Costs – cost-effectiveness; resources; affordability.
• Feasibility of implementation – health system logistics and information 
systems; access to high-risk groups; population movement, behaviour 
and housing; budget available; availability of human (trained workforce) 
and material resources; possibilities for supervision and monitoring of 
activities.
Two of the most diffi cult decisions to be made are whether to start and when 
to stop applying preventive interventions; gathering the information above 
can guide such decisions. When selecting malaria prevention methods for 
complex emergencies, it is also important to be aware that emergency situ-
ations change. The situation needs to be reviewed on a regular basis, using 
relevant data, to ensure that prevention methods are still appropriate.
Table 6.3 summarizes the characteristics of malaria in different parts of 
the world, to help guide selection of appropriate prevention measures.
Organizing malaria prevention activities
Information collected during the initial assessment (see Chapter 2) should 
be used to plan and organize malaria prevention activities. Additional, 
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Table 6.3 Characteristics of different malaria situations and possible 
 actions required
Epidemiological  Characteristics Possible prevention
type of malaria activities
Savannah or grassland  • Generally present  • Insecticide-treated
(sub-Saharan Africa,   throughout the year  mosquito nets
Papua New Guinea) • Seasonal increase • Other types of 
 • Drug resistance, mainly   personal protection
  P. falciparum • Health promotion
 • Affects mainly children 
  and pregnant women  
Plains and valleys  • Moderate transmission • Spraying of houses
outside Africa (Central • Often mainly P. vivax  • Insecticide-treated
America, China, Indian  • Major seasonal variation  mosquito nets
subcontinent) • Risk of outbreaks • Other types of 
    personal protection
   • Livestock treatment
   • Health promotion
Highland and desert  • High risk of outbreaks • Spraying of houses
fringe (African and  • Major seasonal variation  may be considered
south-east Asian high- • Infl uenced by agricultural  • Localized house spray-
lands, Sahel, southern   practices  ing for prevention
Africa, south-west  • Migration may lead to   of outbreaks
Pacifi c)  outbreaks • Insecticide-treated 
    mosquito nets 
   • Health promotion
Urban and peri-urban  • Highly variable  • Insecticide-treated
(Africa, South America,   transmission  mosquito nets
south Asia) • Immunity of the  • Other personal
  population variable  protection
 • Specially adapted urban  • Control of breeding
  vectors responsible for   sites by larviciding or
  outbreaks in south Asia  environmental 
    planning and 
    management
   • Spraying of houses in 
    selected areas
   • Health promotion
Forest and forest fringe  • Focal intense transmission • Insecticide-treated
(south-east Asia, South  • Many risk groups, often   mosquito nets
America)  occupational • Other personal 
    protection
   • Consider siting of 
    dwellings
   • Health promotion
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more specifi c, information, for example about each particular site, may be 
needed to guide the organization and monitoring of activities. Table 6.4 
shows how information about the population, vectors and environment can 
be used in the organization of malaria prevention activities. 
Important steps in setting up prevention activities are:
1. Collect information (epidemiological, demographic, logistic, etc.) from 
local experts.
2. Choose sites for camps and rehousing of people away from vector breed-
ing sites.
3. Defi ne control objectives based on the severity of the problem, available 
resources and the level of health care in the area or host country.
4. Choose control measures.
5. Identify possible local suppliers. In selecting suppliers, keep cost and 
quality in mind – sometimes an international supplier may be prefer-
able. 
6. Identify appropriate agencies to implement programmes.
7. Plan a training programme for local staff.
8. Implement the chosen control measures.
9. Monitor and evaluate control measures in terms of cost-effectiveness 
and quality.
Mosquito life-cycle, behaviour and biological features
For the purposes of vector control, it is important to:
— understand the life-cycle and natural history of mosquitoes;
— be able to recognize different types of mosquito;
— understand mosquito behaviour; and
— know the susceptibility of mosquitoes to insecticides.
The mosquito life-cycle
There are four main stages in the life-cycle of the mosquito – egg, larva, 
pupa and adult.
• Egg. Mosquitoes lay eggs on water in batches of 70–200 every few days. 
Anopheles eggs are about 0.5 mm long and fl oat on the surface of water 
for 2–3 days until they hatch; unlike Aedes eggs, they cannot survive if 
they dry out.
• Larva. Each egg hatches into a larva, which swims and feeds. Anopheles 
larvae fl oat horizontally on the surface of the water, whereas Aedes and 
Culex larvae hang down into the water with just their breathing tubes at 
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Table 6.4 Using information to plan and organize malaria 
 prevention activities 
Type of  Why is this information  How can this information 
information important? be used?
Environment  
• Climate, rainfall, Affects potential for  To determine mosquito
 surface water,  transmission control strategies and
 temperature,   predict outbreaks.
 vegetation, 
 topography    
Host  
• Population size  Indicates the total number of  To plan amount of supplies
  people at risk. needed. 
• Distribution Indicates accessibility of  To determine the type of
  people, urban and rural  malaria control activities
  environment.  required.
• Mobility Increases possibility of 
  outbreaks. 
• Types of  Open dwellings are diffi cult 
 dwellings and to spray. Different types of 
 location in  dwellings need different net 
 relation to designs. Proximity of breeding 
 breeding sites sites increases risk. 
• Night-time If people are outside during  To protect children by
 behaviour the mosquito biting time,  sugesting when they should
  their risk of infection is higher. be protected by a net.
Vector  
• Species Different species have  To infl uence mosquito
  different behaviours. control strategy.
• Preferred  Indicates which water bodies To help determine control 
 breeding sites are important and whether  methods and
  larval control is feasible.  communication messages.
• Resting habits  House spraying and 
 (inside, outside) insecticide-treated nets may 
  be more effective against 
  indoor-resting vectors. 
• Feeding habits  House spraying and insecticide- To help determine control
 (time, host  treated nets may be more  methods and
 preference,  effective against indoor biters  communication messages.
 location) and if people are inside at  
  peak biting time.   
• Seasonal density Affects seasonal pattern of  To help determine content of
 changes disease. communication messages 
   and timing of control 
   activities.
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the surface. As the larvae grow to full size (about 1 cm long) they shed 
their skin four times. In the tropics, mosquitoes can complete the larval 
stage in only 7 days.
• Pupa. The larva develops into a pupa, which is shaped like a comma. 
The pupa does not feed but comes to the surface of the water to breathe. 
The pupa stage lasts 2–3 days. 
• Adult. The adult mosquito that emerges from the pupa has three main 
parts – head, thorax and abdomen. The head has eyes, antennae, palps 
and mouth parts or proboscis. Only the female mosquito feeds on blood. 
The easiest way to distinguish male from female mosquitoes is by look-
ing at the antennae, which are feathery in males.
Adult mosquitoes mate soon after emerging from the pupae. In most spe-
cies, the female can produce eggs only after feeding on blood from a human 
or animal. Once the blood-meal is digested and the eggs have developed, the 
female mosquito fi nds a suitable place to lay the eggs. This 2–3-day cycle of 
feeding, developing and laying eggs is called the gonotrophic cycle and it is 
repeated throughout the remaining life of the adult female mosquito. 
In favourable conditions, female adult mosquitoes live an average of 
10–14 days, although some live much longer. The lifespan of the male adult 
mosquito is shorter. The lifespan of the female is most important in malaria 
transmission, since it takes at least 10 days for the malaria parasites in the 
mosquito to become infective to humans; thus, only mosquitoes that live 
longer than this will be able to transmit malaria. Factors that affect the 
lifespan of the adult mosquito include temperature, humidity, natural en-
emies, and vector control measures. Where temperatures exceed 35 °C and 
the humidity is less than 50%, mosquitoes die much sooner. 
Different types of mosquito
Malaria is transmitted by Anopheles mosquitoes. Some Anopheles mosqui-
toes can also carry other human diseases, such as fi lariasis (elephantiasis). 
Aedes mosquitoes are important vectors of yellow fever and dengue and 
Culex mosquitoes of fi lariasis and Japanese encephalitis. There are three 
main ways to distinguish Anopheles mosquitoes from culicine mosquitoes 
such as Aedes, Culex and Mansonia (see Table 6.5). The differences in each 
stage of the life cycle of Anopheles, Aedes and Culex mosquitoes are shown 
in Figure 6.1.
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Mosquito behaviour 
Several aspects of mosquito behaviour are relevant for vector control – rest-
ing location, feeding time and location, host preference, fl ight range and 
choice of egg laying site. 
Resting location
After feeding, a female adult mosquito needs somewhere to rest while she 
digests the blood and develops the eggs. Some species remain inside, while 
others go and fi nd resting places outdoors. It is easier to control vectors that 
rest indoors with residual spraying in houses; for example, this method is 
used to control the indoor-resting vectors A. culicifacies and A. stephensi 
in the Indian subcontinent.
Feeding time and location
Most Anopheles feed at night – each species feeds at a particular time of 
night. For example, A. farauti in the Solomon Islands and A. maculatus 
near the Thai–Myanmar border bite as soon as it is dark and feed mostly in 
the early evening; by contrast, A. gambiae in Africa and A. dirus in south-
east Asia feed late at night. 
Some mosquitoes prefer to feed inside houses and others outside. It is 
easier to use residual spraying of houses to control vectors that feed in-
doors and ITNs for vectors that feed outside. However, residual spraying 
is useful for species that feed outside and then enter houses to rest, such as 
A. culicifacies in Pakistan.
Host preference
Some mosquito species prefer to feed on humans and others on animals; 
several species feed partly on humans and partly on animals. Species that 
Table 6.5 Three ways to distinguish anopheline from culicine mosquitoes 
 (see also Figure 6.1) 
Characteristic Anophelines Culicines
Resting position Normally rest at an angle  Normally rest with the body
 to the surface.  parallel to the surface.
Wings Appear to have black and  Do not appear to have black
 white spots, because the  and white spots.
 dark and pale scales on the 
 wings are arranged in blocks.    
Palps (in female  Are the same length as the  Are only a third of the length
mosquitoes) proboscis. of the proboscis.
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Figure 6.1 The life-cycles of Anopheles, Aedes and Culex mosquitoesa
a  Source: Warrell DA, Gilles HM, eds. Essential malariology, 4th ed. London, Hodder Arnold, 
2002. Reproduced by kind permission of the publisher.
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have a strong preference for feeding on humans, for example A. gambiae 
in Africa, tend to be the most dangerous vectors because they are the most 
likely to pick up and pass on malaria parasites.
Flight range
Most Anopheles mosquitoes do not fl y more than 3 km from where they 
begin their lives. Malaria risk can be reduced by siting refugee camps further 
than 3 km from breeding sites. 
Choice of egg laying site 
Anopheles mosquitoes have different preferences for breeding sites or larval 
habitats, and lay their eggs in a wide variety of water bodies. However, in-
dividual species tend to choose a narrow range of egg laying sites.
Insecticide susceptibility
Mosquitoes that become resistant to a particular insecticide (see Box 6.5) 
are less likely to be controlled by that insecticide. However, even when 
resistance is detected in a species, it may be unnecessary to change the 
insecticide or the vector control method: if the resistance frequency is low 
(only a minority of mosquitoes carry resistance) or the resistance is weak, 
the insecticide might still be used to good effect. Resistant mosquitoes that 
have lived long enough to incubate malaria parasites to maturity sometimes 
become less resistant as they grow older and hence more vulnerable to in-
secticide residues. There is evidence from west Africa that insecticide-treat-
ed nets continue to be protective against pyrethroid-resistant A. gambiae 
(Corbel, 2004), whereas IRS with pyrethroids has lost effectiveness against 
resistant A. funestus in South Africa, necessitating a return to DDT spray-
ing (Hargreaves et al., 2000). If the insecticide or vector control method is 
Box 6.5 Development of insecticide resistance
A species of mosquito that is exposed to an insecticide for many 
generations may develop physiological resistance to that type of 
insecticide. This is an evolutionary (Darwinian) process in which 
mosquitoes that carry genes for resistance survive exposure to insecticide 
and pass on these genes to the next generation of mosquitoes. The 
gene for resistance arises initially by mutation. Selection of mosquitoes 
resistant to DDT was one of the reasons for the failure of malaria 
eradication efforts in the 1950s and 1960s. In some regions, resistance 
has since developed to other types of insecticide, including malathion and 
other organophosphates, and pyrethroids. 
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no longer achieving the same level of malaria control it should be changed. 
(Chapter 8 gives more information about detecting resistance.) 
Tables 6.6–6.9 summarize the relevant biological features of some of the 
most important vectors in south-east Asia, Africa, south Asia and South 
America.
Table 6.6 Signifi cant biological features of major and some minor malaria 
 vectors in Cambodia, Lao People’s Democratic Republic, 
 Myanmar, Thailand and Viet Nama 
Anopheles  Resting  Feeding Host Breeding  Insecticide
species location time and  preferences sites susceptibility
  location    
A. dirus complex  Mainly Mainly Mainly  Small shady  Susceptible
(7 sibling species; outside late (or human  pools mainly  to DDT 
described as   20:00–  in forests and  and others
A. balabacensis    02:00 hrs)  plantations, 
in earlier      footprints, 
literature)  Outside   stream seepages,
  and inside  wheel ruts, gem 
    pits, hollow logs, 
    sometimes wells
A. minimus  Mainly  All night Human  Streams in  Susceptible
(at least 2 sibling  outside  and cows forested  to DDT
species) (previously Mainly    foothills
 inside) outside 
  (previously 
  inside)    
A. maculatus  Mainly  Peak  Mainly  Sunlit streams,  Susceptible
complex  outside 19:00– non-human sometimes  to DDT and
(8 sibling species)  20:00 or   ponds, tanks,  others
  21:00–  riverbed pools
  24.00 hrs 
  Mainly 
  outside     
A. sundaicus  Outside  All night,  Human and  Brackish or DDT
(2 sibling species  and  peak  domestic  salt water resistance
suspected) inside 20:00– animals near coast, in Indonesia 
  24:00 hrs  rock pools,  and Viet
    river mouths Nam
  Outside
  and inside      
a Source: Meek (1995). Reproduced by kind permission of the publisher.
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Table 6.7 Signifi cant biological features of major malaria vectors in Africaa 
Anopheles  Resting  Feeding Host Breeding  Insecticide
species location time and  preferences sites susceptibility
  location    
A. gambiae Mainly  Mainly  Mainly  Sunlit temporary Resistance
 inside late humans pools, rice fi elds to DDT, HCH,b
     recently to 
  Inside   pyrethroids 
     in west 
     Africa
A. arabiensis Inside and  Mainly  Humans  Temporary  Resistance 
 outside late and  pools, rice  to DDT, and
   animals fi elds to malathion
  Inside and    in Sudan
  outside   
A. melas Outside  Mainly  Animals  Saltwater 
 and inside late and  lagoons, 
   humans mangrove
  Inside and    swamps
  outside   
A. merus Outside  Mainly  Mainly  Saltwater 
 and inside late animals lagoons, 
    mangrove
  Inside and   swamps 
  outside   
A. funestus Inside Mainly  Mainly  Semipermanent  Resistance
  late humans and permanent  to DDT, 
    water, especially recently to
  Inside  with vegetation,  pyrethroids
    swamps, slow  in southern
    streams, ditch  Africa
    edges  
a Source: Mehra (1995).
b Hexachlorocyclohexane.
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Table 6.8 Signifi cant biological features of major malaria vectors 
 in south Asia
Anopheles  Resting  Feeding Host Breeding  Insecticide
species location time and  preferences sites susceptibility
  location    
A. stephensi  Mainly  Late  Mainly  Urban vector:  Resistant to
(urban “type”  inside evening  cattle and domestic water  DDT, HCH,a 
and rural   and night domestic  tanks and malathion
“mysorensis”    animals containers,  
forms)  Inside and   construction
  outside  sites 
 
    Rural vector: 
    borrow pits, 
    river margins, 
    rice fi elds  
A. culicifacies  Mainly  Late  Mainly  Rural vector:  Resistant to
(5 sibling species  inside evening  cattle and  clean water,  DDT, HCH,a 
of differing  and night domestic  river margins,  malathion
vectoral    animals rice fi elds, 
capacity)  Inside and   manmade pits 
  outside  and pools   
a Hexachlorocyclohexane.
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Table 6.9 Signifi cant biological features of major malaria vectors 
 in South America
Anopheles  Resting  Feeding Host Breeding  Insecticide
species location time and  preferences sites susceptibility
  location    
A. albimanus  Mostly outside,  Late  Domestic  Stagnant  Broad-
(Central   some inside – evening animals  water, fl ooded  spectrum
America for control  (cattle,  pasture, or  resistance
to northern  IRS is standard  Inside horses) ,  water with  to organo-
South  but ITNs    80% 25% emergent  phosphates
America) shown to be   humans vegetation  and
 effective in   20% coverage carbamates
 Nicaragua    (low level),
     pyrethroids 
     and DDT
A. darlingi  Inside and  Throughout  Humans Breeding sites  Some DDT
(Brazil to  outside – for  the night,   and epidemics  resistance
Mexico) control IRS  but with   associated with
 (DDT and  biting peaks  deforestation 
 lambdacy- at dusk and  and mining
 halothrin)   dawn.
 and ITNs 
  Mainly 
  inside     
A. aquasalis  Outside – not  Late at  Mainly  Brackish water, 
(coastal areas  controlled by  night domestic  mangrove, 
from east IRS  animals  temporary 
Venezuela  Outside (cattle,  freshwater
to south   horses, 
Brazil)   pigs)
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CHAPTER 7
Community participation 
and health education
This chapter:
■ outlines guiding principles for community participation and health 
education related to malaria control in complex emergencies
■ describes how to involve communities in malaria control activities, 
including health education
■ identifi es specifi c issues to consider when planning and implementing 
health education related to malaria control.
Community participation and health education 
in complex emergencies
Community participation and health education are often seen as being of 
low priority in complex emergencies, and there is little published informa-
tion describing practical fi eld experience of these areas of activity. How-
ever, there is growing recognition that community participation and health 
education are essential to the success of malaria control interventions in 
emergency situations (see Box 7.1), and that more attention should be paid 
to understanding community perspectives and the sociocultural factors that 
infl uence the behaviour of communities and emergency partners (Médecins 
Sans Frontières, 1997; Williams, 2001; Bloland & Williams, 2003). 
The following guiding principles are important both for effective com-
munity participation and for health education related to malaria control in 
complex emergencies: 
• Establish mechanisms that promote good communication and enable 
representatives of the displaced or affected population, the host popula-
tion, and local and international emergency partners to participate in 
malaria control.
• Find out about the affected communities. 
• Work together with community and organizational representatives to 
agree on priority needs and to decide what interventions are needed to 
address these needs. 
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• Ensure that the community is involved in collecting information and 
in planning and implementing malaria control activities. Community 
involvement can also ensure that communication activities and health 
education methods are socially and culturally appropriate. 
• Involve community and organizational representatives in monitoring 
and evaluating activities.
Before community participation or health education activities are started, 
it is also important to collect baseline data. This can be done through a 
rapid ethnographic assessment. Such an assessment can provide informa-
tion about, for example, the demographics of the population at risk, local 
terms used to describe malaria, community structures and social norms 
(see also Chapter 8). 
Promoting community participation
Establishing good communication
Good communication is essential if different organizations and community 
representatives are to work together effectively. Communication between 
the various emergency partners working in a complex emergency (see 
Chapter 1) is as important as communication between these organizations 
and the affected populations.
Box 7.1 Importance of community participation and health education 
 in malaria control
Community involvement and effective health education play a critical role 
in both treatment-seeking and malaria prevention.
Malaria treatment-seeking
The effectiveness of case management depends to some extent on 
community understanding and action. One of the reasons for high 
malaria mortality in both emergency and non-emergency situations is 
late presentation of cases to, or failure to seek treatment from, health 
facilities. Communities need to be able to recognize the signs of malaria 
illness and seek effective treatment promptly. 
Malaria prevention
The effectiveness of most prevention methods also depends on 
community understanding and action. Communities need to know why 
the use of insecticide-treated nets (ITNs) is important and to ensure 
that young children and pregnant women sleep under treated nets, and 
community cooperation is essential for indoor residual spraying (IRS) of 
insecticides.
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A working group should be set up at the start of a complex emergency 
to promote good communication between representatives of emergency 
partners, local agencies and the affected population, and to ensure effec-
tive planning and coordination of malaria control activities. The working 
group should involve:
— all agencies – including international organizations and NGOs – 
working in malaria control activities, for example case management, 
vector control, health education, water and sanitation;
— camp or resettlement offi cials;
— representatives of UNHCR and other United Nations agencies;
— representatives of the displaced or refugee population, including 
camp leaders, community elders, block or sector leaders, community 
committees;
— representatives of the host population and government.
The working group should meet regularly; it is critical that everyone in-
volved agree on malaria control priorities and strategies and the role that 
the different representatives and organizations will play. The working 
group should also communicate its activities to other organizations provid-
ing health care. This is particularly important where resources are limited 
because interventions can be planned that address several issues simultane-
ously – for example, the use of ITNs to prevent both malaria and other 
mosquito-transmitted diseases.
The active participation of community representatives in the working 
group is essential for effective communication of information from emer-
gency partners to the community and vice versa (Rifkin, 1996). This helps 
to ensure that agencies are aware of, and address, community priorities 
– which will help to give people a sense of being in control of their lives. 
Without good communication there is a risk that the community will not 
support malaria control interventions because it has different priorities; 
there is also a risk that agencies remain unaware of local beliefs and behav-
iours that may have an impact on malaria control interventions or that the 
community will fail to appreciate why these interventions are important. 
Professionals need to listen to the perspectives of those with less formal 
education and training, and to recognize that communities have their own 
knowledge and beliefs that can help or hinder malaria control activities. 
The fi rst example in Box 7.2 illustrates the importance of giving commu-
nity leaders an opportunity to express their concerns and of understanding 
these concerns. Good communication is also important to prevent misun-
derstanding: in the second example, the desired behaviour change did not 
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occur because the community did not understand, and was intimidated by, 
the measures an agency introduced for future monitoring and evaluation.
Understanding the community
Social factors (structures and organization) and cultural factors (language, 
beliefs and behaviours that are common to a group of people) play an im-
portant role in malaria control. To be able to promote effective community 
participation it is important to fi nd out about the social and cultural con-
text of the displaced or refugee population and of the host community. It 
is also important to understand the “culture” of the “humanitarian relief 
community”.
• The displaced or refugee community. Within the displaced or refugee 
population there may be numerous subgroups that are socially and cul-
Box 7.2 Importance of good communication with the community
Community concerns about research
In an African refugee camp, drug effi cacy studies were planned for children 
under 5 years old. To ensure that this was acceptable to the community, 
meetings were held with camp offi cials, community health workers and 
refugee leaders. One of the major concerns was why the studies included 
only children aged less than 5 years when adults were also suffering from 
malaria. Once it was explained that children are particularly vulnerable 
and that appropriate treatment for children would also benefi t the adult 
population, community leaders agreed to support the research, and 
messages were sent out to the residential blocks encouraging people to 
participate if they were asked to.
Community fears about “breaking the contract”
In another African refugee camp, an agency introduced an ITN programme, 
attempting to distribute one net to each household. To help with future 
monitoring and evaluation, the agency stencilled its logo onto each net 
(so that they could determine whether nets were being traded outside 
the camp) and asked each household head to sign what appeared to 
be a formal “contract” stating that the nets had been received. When 
agency representatives visited the households some weeks later, they 
were surprised to fi nd that the nets were not being used. The reason was 
that the monitoring and evaluation measures were perceived by some 
households to be highly intimidating. Fear of “breaking the contract’” if 
there were any damage to the nets meant that families were keeping the 
nets in good condition in their wrappers rather than using them for the 
intended purpose.
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turally diverse and have different priorities. For example, each subgroup 
may have its own ideas about the causes and treatment of malaria and 
will interpret health education messages in different ways. The displaced 
or refugee population may or may not share the same culture as the host 
community. This can infl uence the attitudes and perceptions of the host 
community towards the displaced or refugee population. 
• The host community. It is important to understand the social and cul-
tural context of the host community in order to address its needs; this is 
especially true of a host community living close to camps or resettlement 
areas. Providing services for the displaced or refugee population that are 
not available to the host community can cause hostility and confl ict (see 
Chapter 1).
• The “humanitarian relief community”. The different organizations 
working in an emergency situation – local and government agencies, 
international organizations, and NGOs – may share many values and 
beliefs but may also have different perspectives and priorities. Successful 
coordination depends on understanding and recognizing these differ-
ences (Watson, 1999). 
For both the displaced or refugee population and the host population, it is 
essential to understand how social organization has been changed by the 
emergency situation (see Table 7.1), and to be aware that structures similar 
to those that existed before the emergency will rapidly begin to develop. It 
is particularly important to:
 • Find out about social organization, the roles that are played by different 
groups and individuals, and who infl uences attitudes and behaviours. 
Learning how residential units are organized will provide information 
about the social structure, for example, block leaders, and about any po-
litical divisions that might affect implementation of control activities.
• Be sensitive to people’s need to regain control, self-determination, and a 
sense of meaning to their lives.
• Identify all vulnerable groups – not only those that are physiologically 
vulnerable to malaria, such as pregnant women and young children, but 
also those that may be vulnerable for political, ethnic, social or cultural 
reasons. Minority groups, for example, may be politically vulnerable 
and so unable to access health facilities or to participate fully in com-
munity education or prevention activities.
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Table 7.1 Comparing community organization before and after displacementa 
 Before After
Formal  • Government and  • May be absent or centred around
organizations  social service agencies  political, ethnic or religious groups
Semi-formal  • Schools • Schools (in later phases)
organizations • Religious organizations • Religious organizations (in later
    phases); religious leaders may be a
    signifi cant presence in all phases of
    an emergency 
 • Neighbourhoods • Residential units not organized; in 
    later phases residential blocks 
    develop and block leaders emerge
 • Social organizations • Social organizations; in later phases 
    may develop as grassroots approach 
    to meeting community needs
Opinion  • May be formal or  • May be formal or informal;
leaders  informal  community health workers may play 
    this role initially
Family, kin  • Family, kin and social  • May be widely dispersed, normal
and social   networks  channels of advice and support may
networks     be lacking; ad hoc networks may be 
    formed by individuals who fl ed 
    together
a Person & Cotton, 1996.
Working with the community to identify priority needs and activities
Priorities should be based on community needs and perspectives, but will 
also depend on the resources that are available to agencies and on what 
can be achieved in the local context. In the acute phase of an emergency, 
however, there may be immediate needs, such as dealing with a malaria 
outbreak, which are often determined by health professionals. Once the 
situation stabilizes, community priorities and other activities, such as pre-
vention, can be given more attention. 
Involving the community in defi ning priority needs and activities (see 
Box 7.3) can improve the effectiveness of malaria control activities. To do 
this, it may be helpful to adapt existing guidelines for community participa-
tion in malaria control (Meek, 1995) for use in emergency situations (see 
also ”Further reading” at the end of this chapter). 
 
Collecting information
Individuals recruited from the displaced or refugee population can be used 
to help collect information about the community and priority needs. They 
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share a common language and culture with the population, which can 
greatly facilitate communication. They can also provide useful and spe-
cifi c information, for example about community leadership, structure and 
politics. It is important to be aware that initial contact will often be with 
the most educated and infl uential people and that efforts will therefore be 
needed to collect information from other subgroups who may not be rep-
resented by community leaders. Box 7.4 provides general guidelines for use 
when gathering community-level information during a research study or 
evaluation exercise.
One way to learn about the community and to identify vulnerable sub-
groups is to walk through the residential units of a camp or resettlement 
area with community members. 
• Do not walk with the most visible or important leaders, as community 
members may be reluctant to voice concerns in front of these leaders or 
CHAPTER 7. COMMUNITY PARTICIPATION AND HEALTH EDUCATION
Box 7.3 Involving the community
■ Find out how to show respect to community leaders. 
■ Listen to the concerns of the displaced or refugee and host populations. 
■ Allow community representatives to defi ne their own concerns and 
priorities fi rst. This is important because people in some cultures will 
agree with those they perceive to be more powerful, even if they do not 
support the idea or what is being said – and community agreement to 
proposals from international agencies may therefore not be what it seems. 
■ Defi ne together the problems, their causes and the possible solutions. 
■ Involve community representatives in planning and implementing 
qualitative research to gather information, and in analysing the data 
collected (see “Collecting information” below). 
■ Relate malaria control activities to local ideas about cause, symptoms 
and cure. If feasible, involve traditional healers in case management and 
referral. 
■ Provide clear information about how and where malaria control 
activities will take place; for example, specify the location of clinics and 
outreach centres, the timing and location of spraying, net distribution and 
treatment. If possible, involve community representatives in carrying out 
prevention measures such as spraying, net distribution and re-treatment. 
■ Be sensitive to gender and ethnicity. Be aware that community 
leaders may not represent the views of women, the most vulnerable, or 
minority groups in the affected population. Try to include representatives 
from these groups. For example, link malaria control to the activities of 
women’s groups or programmes that target women: in several refugee 
camps in the United Republic of Tanzania, the Tanzanian Red Cross used 
women’s groups to sew mosquito nets, and this contributed both to 
controlling malaria and to generating income for women. 
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to reveal what is happening in their residential units. Community health 
workers or trusted volunteers are more appropriate for community 
walks. 
• Walk through the community at randomly chosen times of the day, on 
several different days and in different areas. 
• Do not tell the community of your visit in advance. In this way, people 
will be engaged in typical daily activities rather than preparing for a 
“guest”. However, if an unannounced visit violates cultural ideas of 
politeness or poses a security risk, community leaders should be alerted 
about the timing and purpose of the visit.
• During the walk, stop and hold informal conversations with community 
members. Ask them about the community – who is in need of what serv-
ices, who has been sick recently or who is frequently sick. This approach 
will help to provide information about less obvious community dynam-
ics, which some leaders may be reluctant to discuss. 
• Try to take notes as you walk, recording the actual behaviours and situ-
ations that you see, as well as what people tell you.
To identify priorities, it is also essential to collect answers from the com-
munity to the following questions:
• What is their previous experience with malaria control activities?
• What malaria control activities are in place?
Box 7.4 Collecting information from the community
■ Gather information about specifi c topics from key informants or focus 
groups.
■ Choose key informants carefully. They should be individuals who 
are well known to the community, understand the information needed, 
and can communicate freely with you and interpret the information in 
a culturally meaningful way. Be aware that key informants may not be 
representative of the majority of the community.
■ Include community members in research or evaluation teams when 
possible. This makes it easier to work with the community and also 
provides additional insights during information gathering and analysis. 
■ Give feedback on your fi ndings to the community during the 
information-gathering process, so that you can adjust questions and 
methods if necessary.
■ Involve the community in developing recommendations. 
■ Continue community participatory research during the implementation 
of malaria control activities to improve their effectiveness.
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• What do they think and do about febrile illnesses, including malaria?
• What local words and terms are used to describe malaria? 
• What does the community believe about the causes, symptoms and treat-
ment of malaria? 
• What sources of information are used and trusted by the community?
• When and where do people seek treatment for malaria? 
• What does the community do to prevent malaria?
• What are the community’s priorities for malaria control?
• What factors would encourage the community to take prevention meas-
ures and to seek treatment?
• What factors might stop the community from taking prevention meas-
ures or seeking treatment?
This information can be collected using qualitative methods, which focus 
on learning about what is important to the community. Box 7.5 summa-
rizes different qualitative methods. If possible, a social scientist should be 
employed to help design qualitative research tools and collect information; 
alternatively, local experts can be consulted. However, if time and resourc-
es are limited, rapid assessment techniques may have to be used to collect 
this information (see references and ”Further reading” at the end of this 
chapter). Chapter 8 and Annex VII include examples of questions that can 
be asked to guide the development of malaria control activities.
Involving the community in implementation
The affected community is a partner in, not the target of, control activities, 
and individuals who are well known and trusted by the community must 
be involved in implementation. It is important to consider how a cadre of 
community “activists” can be developed and how community organiza-
tions – women’s groups, centres of worship, etc. – can be used to mobilize 
others to participate in malaria control activities. 
Community members and community health workers can play an im-
portant role in a range of malaria control activities, including the follow-
ing.
• Case management – for example, involving traditional healers in the 
work of the clinic (see Box 7.6), or training community health workers 
to carry out surveillance for suspected malaria cases and to supervise 
treatment with antimalarials. In the United Republic of Tanzania, com-
munity health workers were assigned the task of visiting all the homes 
in their residential blocks to ensure that malaria patients had taken 
chloroquine correctly during the 3-day treatment period. Community 
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Box 7.5 Qualitative methods
■ Individual interviews – are guided by a mixture of structured and open-
ended questions to explore topics related to malaria control. People to 
be interviewed can either be selected purposively (that is, with a specifi c 
reason or topic in mind), e.g. as key informants, community leaders or 
health workers, or be selected randomly. An advantage of individual 
interviews is that questions can be fl exibly structured and related topics 
raised by the person being interviewed can be pursued.
■ Focus group discussions – involve discussions with groups of 8–15 
people with similar backgrounds. A facilitator guides the discussion 
using a checklist of questions or topics; a second person records what 
participants say and notes how they interact. Focus group discussions are 
a useful initial method for fi nding out what topics are important to people. 
They can also be used to clarify or check information collected during 
individual interviews.
■ Free listing – a method that involves people being asked to list as many 
different aspects as possible of the topic of interest. For example, the 
question ”What methods are used in this community to prevent malaria?” 
can generate a wealth of information that can be used to develop 
questions for interviews or topics for focus group discussions, as well as 
to guide the design of malaria control interventions. An advantage of free 
listing is that it provides a large amount of information in a short period of 
time – and can be carried out, for example, in the form of a game.
■ Pile sorting – uses information identifi ed through free listing to fi nd 
out how people perceive and make sense of various issues. Individuals or 
groups are asked to sort the issues they have listed into categories. For 
Example, asking them to sort a list of malaria treatments into categories 
that make sense to them may provide information about the remedies 
people use for different types of malaria. This information can help with 
the design of interventions.
■ Mapping – uses maps drawn by community members to show different 
community features, such as where clinics are located or where malaria 
is a particular problem. Mapping provides useful information about 
community perspectives on their situation.
■ Venn diagram – a participatory method that provides information about 
the social structure of a population, for example identifying community 
leaders and people with infl uence, and about the relationships between 
the community and outside agencies. This information can help to identify 
who might support or oppose malaria control activities.
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members were also used as peer role models to improve case manage-
ment (see Box 7.7).
• Prevention measures – for example, training community members as 
community health educators (see Box 7.8) or in the manufacture and 
repair of mosquito nets, or involving them in insecticide spraying or in 
setting up net distribution or re-treatment systems (see Box 7.9).
• Epidemiology – for example, training local health workers to interpret 
the routine information they collect to help in designing malaria control 
interventions (see Box 7.8).
• Environmental control – for example, participation of community mem-
bers in sanitation improvements, design of irrigation schemes, establish-
ing biological control methods.
Box 7.6 Involving traditional healers in case management in Cambodia
In the paediatric ward of a large refugee camp on the Thai–Cambodian 
border, traditional healers (Kru Khmer) were encouraged to work alongside 
health workers. Ward rounds included both clinical staff and Kru Khmer. 
Families liked this approach and the Kru Khmer provided valuable inputs 
to clinical decisions. Together, clinical staff and the Kru Khmer were 
able to provide complementary care, rather than competing treatment 
options. For example, a child might receive standard treatment for malaria 
along with a herbal potion or massage from a traditional healer. The Kru 
Khmer appreciated the recognition of their role and the health workers 
appreciated the cultural knowledge of the traditional healers.
Box 7.7 Caregivers as peer role models
One of the unexpected benefi ts of a drug effi cacy trial in a refugee camp 
in the United Republic of Tanzania was the realization that those caring 
for under-fi ves enrolled in the trial were learning easier ways to give 
antimalarial drugs to the children. The caregivers would watch carefully 
when the team administered the drug used in the trial and ask questions 
about what they were doing. This provided an excellent opportunity to 
teach caregivers – mothers, fathers, older siblings and grandparents – 
safer techniques for holding the children while giving medications, 
different ways to give the drugs (e.g. crushing tablets to mix with liquid 
in a bottle or with a spoon), and what to do if a child vomited the drug 
shortly after administration. The caregivers said that, because regular 
health workers were often too busy to offer these explanations, they had 
not always known what to do with a child who refused to take medication 
or had vomited. Now that they knew what to do, they planned to share this 
knowledge with their family, friends and neighbours. 
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Box 7.8 Involving the community in prevention in refugee camps 
 on the Thai–Myanmar border
Training community health educators
NGOs trained members of local ethnic minority groups as community 
health educators in refugee camps along the Thai–Myanmar border. 
During the mid-1990s, previously stable camp populations were forced to 
relocate because of shelling and border incursions. The community health 
educators ensured the continuity of malaria control activities: as the 
population moved to a new site, the educators were able to go from tent 
to tent and provide essential services including:
— information about the new location of health services and general 
health messages;
— active case detection for presumed cases of malaria and other 
common illnesses;
— education in the correct use of insecticide-treated nets.
Because they belonged to the same ethnic group as the displaced 
population, the community educators were able to bridge the gap between 
the refugees and the agencies working in malaria control. This was 
particularly important for some of the more isolated ethnic groups who 
had little previous exposure to or knowledge of this kind of health care.
Training community health workers 
In the same camps, NGOs also trained community health workers to 
interpret the routine data that they were collecting, to increase their 
understanding of how this information could be used to design malaria 
control activities. This method, called community-oriented primary care, 
combined elements of primary health care, public health and community 
mobilization. Meetings and workshops were held on a regular basis to 
provide training for the community health workers and to review data 
collection and analysis, implementation, monitoring and evaluation of 
activities.
The example in Box 7.10 illustrates the importance of understanding the 
local context, showing how adapting symptom control measures to local 
belief systems can improve their acceptability. 
Regular community meetings are important, to keep the community 
informed about malaria control activities, to provide them with an op-
portunity to raise concerns about malaria, and to fi nd joint solutions to 
problems. 
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Box 7.9 Community involvement in insecticide-treated 
 materials programmes
HealthNet International (HNI) has been actively involved in programmes 
to distribute insecticide-treated materials to Afghan refugees living in 
villages and resettlement camps in Pakistan (Hewitt et al., 1996; Rowland 
et al., 1996, 1999). Community involvement, and understanding of cultural 
practices, led to a creative adaptation. Instead of relying only on treated 
mosquito nets, HNI has also treated the traditional veils, or chadors, worn 
by women during the day and used by men and women as a top sheet 
at night. Treating chadors with permethrin was not only an effective 
protection measure but also culturally acceptable. This approach also 
provides protection to vulnerable groups that may not be able to afford to 
buy nets.
HNI also engaged community members in the re-treatment of nets. Village 
health workers, nominated by village committees, became responsible 
for re-treatment. This approach reduced operational costs and increased 
community participation in the ITN programme.1
1 Rowland M. Country presentations. Review of lessons learned: Afghanistan. Oral 
presentation at the WHO Roll Back Malaria and Emergency and Humanitarian 
Action Expert Group Meeting on Malaria Control in Complex Emergencies, 1–2 
December 1998.
Box 7.10 Importance of understanding the local context
Refugees from Angola have been settling in the north-west border 
area of Zambia since the late 1960s. Because both the displaced and 
host populations believe that people with fever should not drink water, 
promotion of hydration in people with febrile illness, particularly children, 
was failing. However, when food colouring and sugar were added to the 
water and the resulting solution was described as medicinal, hydration 
with this solution became acceptable.
Health education in malaria control
Establishing priorities
The goal of health education should be to inform populations at risk about 
behaviour changes that could reduce their risk of malaria infection and 
improve their management of malaria illness. Health education should spe-
cifi cally address the concerns identifi ed by the displaced or refugee and host 
communities, in addition to the following issues:
— causes of malaria and the role of mosquitoes in transmission;
— the groups that are particularly vulnerable to malaria;
— the difference between uncomplicated and severe malaria;
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— treatment of malaria;
— location and opening hours of health services;
— danger signs that mean a patient should go back to the clinic;
— measures that can be taken to protect against mosquito biting, in-
cluding use of treated nets and other forms of personal protection.
The emphasis placed on these various issues will depend on the phase of 
the emergency. In the fi rst few days of the acute phase it is essential that 
people know both how to recognize the signs of severe malaria and where 
and how to access treatment and care. As an emergency evolves and the 
situation stabilizes, more attention will be given to such issues as preventing 
transmission or sustaining preventive measures, for example by re-treating 
mosquito nets. The emphasis will also depend on the local context. For 
example, if the displaced population has moved from a non-malarious area 
to an area where malaria is a risk, health education about the risk of trans-
mission will be important.
Designing health education 
At the beginning of the acute phase of a complex emergency, when there 
are other more urgent priorities, it will not usually be possible to develop 
a “formal” health education programme. During this phase, information 
passed by word of mouth can be a useful way to publicize urgent messages 
in the community. 
Once the situation stabilizes, a health education programme can be 
designed and implemented. It is important to invest time and resources in 
doing this with the community, who should be involved in designing and 
pretesting messages and in making any revisions necessary as a result of 
pretesting. Failing to do this can waste limited time and resources on pro-
ducing ineffective messages and materials.
Health education should focus on learning (not teaching), active partici-
pation, action and behaviour change. The principles of successful health 
education include:
• Defi ning the objectives of health education – for example, the desired 
improvement in knowledge or change in behaviour, or how to build on 
existing knowledge, beliefs and behaviours.
• Identifying the target audience – for example, pregnant women, parents 
of young children, community leaders, traditional healers, drug sellers.
• Defi ning the desired behaviours and developing clear messages – in such 
a way that the target audience understands.
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• Providing information about what people can do – for example where 
they can get nets or when to seek treatment – with a limited number of 
clear, simple messages, such as “Prompt treatment for fever saves lives”, 
repeated in different ways.
• Using methods that are culturally acceptable – and appropriate for the 
target audience.
• Delivering messages through trusted and respected individuals and 
channels.
• Providing training and materials – to those who will conduct health ed-
ucation, for example, community educators, health workers, traditional 
healers.
Effective health communication depends, in part, on understanding aspects 
of the community that is being targeted with the message. Specifi c informa-
tion from the targeted community, such as knowing where and how people 
expect to receive important information, will help to inform decisions 
about the design of your communication materials (see Box 7.11).
Implementing health education
In complex emergencies it is important to plan the timing of health educa-
tion activities carefully.
• Avoid days when rations are being distributed or when cultural or reli-
gious events are taking place.
• Take advantage of occasions when people are already meeting together, 
for example meetings with block or camp leaders.
• Alert the community in advance about campaigns or activities, for ex-
ample spraying or net re-treatment.
• Use opportunities to target specifi c groups, for example pregnant 
women and mothers of young children. In many emergency situations, 
women spend a lot of time waiting in outpatient clinics or at supplemen-
tary feeding centres; this time can be used for health education about 
some aspect of malaria, for example what to do when a child has fever. 
However, it is also important to address health education messages to 
men, as recent fi eld experience indicates that, increasingly, men are also 
bringing sick children to clinics. 
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Box 7.11 Communication channels, messages and methods
Channels
Effective delivery of health education messages depends on choosing 
communication channels appropriate to the community’s culture, 
knowledge, beliefs, values and literacy level. In some cultures, community 
leaders and elders may be the best people to transmit messages, while in 
others, teachers, health workers or the media may have more credibility. 
Messages can also be relayed through other types of community workers, 
such as those who dig latrines or do other manual tasks. Other possible 
channels for disseminating messages can include:
— camp management meetings
— health and water coordination meetings
— health facilities
— community health programmes, such as vaccination campaigns
— central message boards, particularly in transit areas.
Messages
The following principles should govern the development of messages: 
■ Target the message to the lowest level of literacy.
■ Be clear about what people are expected to do and what the result of 
their action will be.
■ Ensure that messages are realistic and feasible.
■ Refl ect local language and behaviours.
■ Ensure that messages are culturally acceptable.
■ Remember that messages will need to change as the situation changes.
■ Use creative approaches in the messages. For example, promoting ITNs 
may be more successful if the messages describe the nets as a way of  
“preventing nuisance insects from disturbing your sleep” as well as a way 
to prevent malaria.
Methods 
The choice of methods must also be appropriate for the setting. Printed 
messages are fi ne for more literate populations, but oral and visual 
methods will be needed to convey messages to less literate populations. In 
most situations it is useful to use a mixture of methods. Possible methods 
include:
■ Print – posters, fl ipcharts and picture guides. These can combine words 
and pictures. Posters should be displayed in places where people will see 
them, e.g. clinics or registration centres. Flipcharts and picture guides are 
useful for teaching and health education sessions, e.g. about how to give 
an antimalarial drug to a young child.
■ Oral – talks, person-to-person communication, songs, poetry and 
informal conversations. Give talks to, for instance, religious or women’s 
groups or at times when people are waiting, for instance at the clinic.
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Monitoring and evaluation
As for other aspects of malaria control, community participation and 
health education activities must be monitored and evaluated. It is impor-
tant to check whether or not these activities have succeeded in changing 
people’s behaviour. For example, it may be necessary to assess whether 
there have been changes in use of individual protection methods – by 
monitoring and evaluating net coverage, proper net use, or re-treatment 
rates. Alternatively, it may be important to assess changes in treatment-
seeking and case management – by monitoring and evaluating the number 
of children brought for treatment, treatment compliance, the length of time 
between initial symptoms and seeking care at a health care facility, or the 
number of return visits.
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CHAPTER 8
Operational research
This chapter:
■ describes how malaria operational research can help to develop a 
more effective response in complex emergencies
■ identifi es priority areas for operational research
■ outlines how to plan, design and implement operational research 
studies.
The essential interventions for malaria control in acute complex emer-
gencies are increasingly well defi ned, with case management and the 
establishment of early warning systems for broader communicable dis-
eases outbreaks as clear priorities. Beyond that, things are less certain and 
increasingly dependent on the local context – which is where operational 
research comes in.
By addressing practical issues, operational research guides the choice of 
the best interventions for the local context, and improves programme deliv-
ery and uptake by the target population. In its most straightforward form it 
provides the intelligence for simple programme troubleshooting.
Why malaria operational research is important 
in complex emergencies 
There are many different approaches to malaria control and no approach is 
100% effective or appropriate in every situation. The purpose of operation-
al research is to improve control tools, their application and their impact. 
There is growing recognition of the need for operational research in 
complex emergencies (see Boxes 8.1 and 8.2) and of the role that research 
can play in improving malaria control. Operational research can be used to 
identify locally effective treatments, appropriate prevention methods, and 
cultural and behavioural factors that contribute to the problem or limit the 
effectiveness of control measures. Because emergencies are fl uid situations 
– moving from acute to chronic or post-confl ict phases – the feasibility 
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of approaches to malaria control may change as the situation progresses. 
Operational research can be used to identify the best approach in different 
phases of an emergency, and can help to guide necessary modifi cations as 
the situation changes. It can also help in assessing the effectiveness of case 
management and preventive measures or the impact of outbreak control. 
Integration of research with normal control activities has helped to solve 
malaria problems that have arisen in refugee camps in the complex emer-
gencies in Afghanistan and Myanmar during the past two decades; exam-
ples are given in Chapters 5 and 6.
It is hoped that the examples provided and the issues identifi ed in this 
chapter will encourage agencies working in emergencies to become involved 
in operational research, rather than to see it as the concern only of outside 
experts.
CHAPTER 8. OPERATIONAL RESEARCH
Box 8.1 Types of operational research needed in complex emergencies
■ Research that concerns locally specifi c issues – which may need to be 
investigated in each and every emergency; for example, cultural beliefs 
about disease causation and health-seeking behaviour.
■ Research that has general applicability to most emergencies – which 
may require some input from specialists; for example, development 
research on insecticide-treated plastic sheeting and blankets.
The boundary between these two types of research is not always clear 
and emergency partners may often be involved in both. For example, after 
a new control or treatment intervention is developed it may need to be 
evaluated in emergency settings with different epidemiological and social 
conditions.
Box 8.2 Research roles of RBM in complex emergencies
■ Helping to establish operational research priorities and secure funding 
from potential donors.
■ Assisting donors by screening and endorsing operational research 
proposals.
■ Strengthening research skills of implementing agencies.
■ Providing direct technical support to agencies engaged in operational 
research in complex emergencies.
■ Publishing and sharing research fi ndings through scientifi c and medical 
journals, web sites, newsletter updates and other media.
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Guiding principles
In an emergency context, where resources are stretched and reduction of 
mortality is the priority, operational research must be:
— relevant and focused on priority local problems;
— kept as simple as possible;
— short term (3–6 months maximum), because of the risk that the situ-
ation will change before outcomes can be measured;
— designed to provide practical information to enable agencies to over-
come acute operational problems and provide better control inter-
ventions;
— undertaken as far as possible by local staff, with external support if 
necessary, to build up local skills;
— planned and conducted with the involvement of the ministry of 
health (MOH) where feasible.
Strict criteria must be met before operational research is undertaken (see 
Box 8.3), and the results must be shared with government, NGOs and 
United Nations agencies with the aim of improving local malaria control 
practices and informing necessary policy changes.
The rights of individuals and communities to participate in surveys and 
studies must be protected and informed consent obtained. Approval from 
an ethics committee should be sought (see later in this chapter).
Priority research needs
In complex emergencies, the two most important areas of operational re-
search are establishing the effectiveness of 
— diagnosis and treatment 
— prevention measures.
Other important areas include social and behavioural factors, strategies for 
delivery of preventive interventions, cost and cost-effectiveness of malaria 
control, and disease burden. Priority topics for operational research that 
have general applicability to most emergencies are summarized in Box 8.4. 
Establishing accurate diagnosis and effective treatment
Operational research can help to assess the effectiveness of diagnosis and 
treatment. Prompt and accurate diagnosis is critical but often diffi cult in 
the acute phase of emergencies. The effectiveness of malaria treatment is 
affected by drug resistance and by issues related to treatment provision, 
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Box 8.3 Criteria for operational research
■ Relevance
How signifi cant or severe is the problem?
Can it be solved by other means that do not require research?
■ Avoid duplication 
Has the research already been done somewhere else? 
Was the context comparable?
■ Feasibility
How adequate are security, expertise, staff, time, and budget?
■ Political acceptability
Does the research have the interest and support of the MOH, UN agencies 
and NGO partners?
■ Applicability
Will the fi ndings be applied and necessary resources be made available?
■ Cost-effectiveness
Will the time, money and human resources invested justify the expected 
result?
What difference will the study make to existing programmes?
■ Timeliness
Will the fi ndings be available in time to inform decision-making?
■ Ethics
Is the research methodology ethical?
Can informed consent be obtained?
When should the study end and its fi ndings be put into practice?
such as access to facilities, treatment-seeking behaviour and adherence to 
treatment, quality of drugs and quality of care. 
Rapid diagnostic tests
Clinical diagnosis of malaria is inaccurate and unreliable while laboratory 
confi rmation using microscopy is not always feasible in complex emergen-
cies. Rapid diagnostic tests (RDTs) have many potential advantages in 
emergency situations. They are likely to be most useful during the acute 
phase for monitoring the accuracy of clinical diagnosis and rapidly assess-
ing malaria prevalence, and as an interim diagnostic tool before the estab-
lishment of microscopy. However, research is needed to answer questions 
about the use of RDTs in complex emergencies, including:
• Does the use of RDTs improve treatment-seeking behaviour or alter 
patient adherence to treatment?
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• Would use of RDTs change outcomes, such as morbidity and mortal-
ity?
• What is the cost-effectiveness of RDTs compared with other methods of 
diagnosis?
Drug resistance
Artemisinin-based combination therapy (ACT) must be used as fi rst-line 
treatment for falciparum malaria for all populations living in complex 
emergencies. Its effi cacy depends on resistance to the artemisinin-partner 
drug. When choosing a new ACT as local drug policy, it should have at 
least 95% effi cacy. In chronic-phase emergencies, 2-yearly therapeutic 
effi cacy testing in sentinel sites should be carried out to ascertain that the 
Box 8.4 Priority research areas with general applicability
Insecticide-treated blankets
There is scientifi c evidence for the effectiveness against malaria of in situ 
treatment of blankets/bedsheets with permethrin in camp and village 
settings. Research in Asia, and to a lesser extent in Africa, suggests that 
permethrin-treated blankets and sheets could play an important role in 
individual protection (Rowland et al., 1999). Priorities for research include 
assessing their suitability in different cultures and climatic conditions, 
their effi cacy under highly endemic conditions, especially in Africa, 
long-lasting treatment processes and formulations, and the suitability of 
different blanket materials. Operational constraints (mass dipping/spraying 
of blankets) currently limit their use in emergencies. The duration of 
effectiveness of pretreated blankets (either stockpiled or in fi eld use) still 
needs to be evaluated.
Insecticide-treated plastic sheeting (ITPS)
Treated canvas tents have been shown to provide protection (Bouma 
et al., 1996), but most agencies are moving towards provision of plastic 
sheeting rather than tents. ITPS impregnated with deltamethrin or 
permethrin during manufacture has been shown to kill mosquitoes in 
small-scale fi eld trials in Pakistan (Graham et al., 2002), and community 
trials are underway in west Africa. In situations where ITPS that is already 
commercially available is being used, its effi cacy (and duration of effi cacy) 
against malaria and its safety under fi eld conditions must be monitored 
and reported to build up the evidence base.
Burden of disease in complex emergencies 
Better information is needed about the contribution of emergencies to the 
global malaria disease burden. 
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effi cacy of the ACT remains above 90%. Where treatment failure is com-
mon, it is important to fi nd out whether there might a resistance problem 
(see Box 8.5). Information about drug resistance in countries is available 
on the WHO RBM web site (http://www.who.int/malaria/resistance.html). 
Also on this web site is the current protocol for assessing in vivo drug re-
sponse (see also Chapter 5). The standardized in vivo test includes both 
clinical and parasitological response, and is:
— applicable to all epidemiological conditions;
— feasible in emergency situations where there is adequate microscopy 
and cases can be followed up;
— suitable for evaluating treatment effi cacy in areas of intense malaria 
transmission and, if follow-up is extended, for evaluating the effi cacy 
of drugs with a longer half-life, such as mefl oquine, in areas of unsta-
ble malaria transmission. 
For the following reasons, in vivo testing has some limitations in emergency 
situations: 
— patients need to be followed up for 14 days or longer;
— tracing of defaulters may be diffi cult. 
Treatment provision
Operational research can identify both the factors that prevent people 
from receiving effective malaria treatment and what needs to be done to 
improve the quality of treatment. For example, it can help to improve access 
to treatment by fi nding out whether health facilities are easily accessible 
and located in appropriate sites, and whether different cultural and ethnic 
groups have equal access to treatment. It can reveal much about treatment-
seeking behaviour and, for example, whether all sections of the population 
are using health facilities and, if not, why not.
CHAPTER 8. OPERATIONAL RESEARCH
Box 8.5 Identifying drug resistance in Afghan refugee camps
Outpatient records in one Afghan refugee camp in Pakistan showed 
that 50% of falciparum cases were re-attending within 1–4 weeks of 
initial treatment. This suggested two possible problems – resistance to 
chloroquine or poor patient adherence. An in vivo survey was conducted 
and the results showed resistance frequency to be 62% (Shah et al., 1997). 
In vivo surveys carried out subsequently in refugee camps in other parts 
of Pakistan found that the frequency of resistance varied little and was no 
different from the frequencies found in the Pakistani population (Rowland 
et al., 1997b).
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Operational research can also be used to monitor standards of care, to 
ensure that the quality of treatment provided by MOH, NGO and private 
health facilities is adequate and that health workers adhere to recommend-
ed drug treatment protocols. Regular surveys of public- and private-sector 
coverage and prescription practices are recommended in every phase of an 
emergency. Such research, if followed up by training and accreditation of 
competent practitioners, can help to improve standards, enable the popula-
tion to make informed choices about health providers, and assist the MOH 
to regulate or maintain standards in both public and private sectors. 
Drug quality
Counterfeit artemisinin derivatives are increasingly common because of 
the high monetary value of ACT. Trademarks are easily forged and it can 
be dangerous to buy drugs in the market place or from other than offi cial 
sources. The quality of ACT treatment can be assured by obtaining supplies 
only from reputable pharmaceutical companies/agencies – and preferably 
directly from producers. Where there are doubts, operational research is 
important to assure drug quality. Generic drugs, if used, should be properly 
assayed since they often vary in quality. Some locally produced antimalar-
ials may contain insuffi cient active ingredient for effective treatment, which 
may result in patient deaths. 
Establishing effective prevention 
Operational research can help to assess the effectiveness of prevention 
measures. It can play an important role in evaluating the effectiveness of 
different transmission control and individual protection measures and of 
component elements of these measures, such as community education, be-
haviour, and intervention delivery methods. 
Indoor residual spraying
Indoor residual spraying (IRS) of insecticide is a commonly used method 
of community vector control in emergencies. It requires coverage of ≥ 85% 
of dwellings to be fully effective and is generally not feasible during acute 
emergencies, except possibly in well-organized transit camp settings (see 
Chapter 6). In IRS programmes that continue for more than one spray-
ing cycle, operational research is required to monitor the effectiveness and 
residual life of sprayed insecticide. This is most easily accomplished by 
periodic WHO cone bioassay tests (see Annex VI). Operational research 
has helped to formulate guiding principles on IRS (see Box 8.6) but more 
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research is needed to answer general questions, covering aspects that in-
clude the following:
— comparison with the cost-effectiveness of alternative control meas-
ures, because IRS is expensive and may not be fi nancially sustainable 
year after year in chronic emergency situations (Kolaczinski et al., 
2004);
— comparative trials of pyrethroids and organophosphates or car-
bamates in areas where pyrethroid resistance is emerging, as in 
A. gambiae in west Africa (Chandre et al., 1999) and in A. funestus 
in southern Africa (Hargreaves et al., 2000).
A successful IRS campaign requires good organization and can easily fail 
to produce the desired result unless well planned and monitored. Campaign 
timing in relation to transmission season is an important indicator. Moni-
toring of programme quality should take place during the IRS application 
(indicators a–d below) and 1 month afterwards (indicator e):
a) Coverage = number of dwellings sprayed/number of dwellings in tar-
geted area (%).
b) Insecticide used per dwelling = quantity of insecticide use/number of 
dwellings sprayed (a measure of effi ciency and correct use of insecti-
cide).
c) User acceptability pre-spray = % of households refusing to be sprayed.
d) % of spray pumps properly maintained and still working during and at 
the end of the campaign.
CHAPTER 8. OPERATIONAL RESEARCH
Box 8.6 Lessons learned from research into IRS in Afghan refugee camps1
■ IRS in Afghan refugee camps is most effective if campaigns are 
undertaken at/before the beginning of the transmission season.
■ Procurement and application are often too slow to control outbreaks 
when the transmission period is short or seasonal.
■ Pyrethroid insecticides should be used – they are safer to handle, 
lighter to transport, and never less effective than organophosphates or 
carbamates. 
■ IRS should become more focused after the acute phase, and targeted at 
areas selected on the basis of epidemiological indicators.
■ IRS is more effective than ITNs when applied for just one or two 
seasons.
These lessons may guide thinking in other settings but are likely to need 
adaptation and possibly additional research for different environments.
1 Rowland, 1999; Rowland et al., 1997a.
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e) User acceptability post-spray = % of dwellings replastered or washed, or 
% of householders complaining about IRS.
Additional indicators for research are the impact of IRS on malaria in-
cidence rates or prevalence; reductions in vector density; and insecticide 
quality and residual life on sprayed surfaces. (The last two require an en-
tomologist.)
Insecticide treatment of domestic animals
Insecticide treatment of domestic animals has been shown in trials in refu-
gee camps to be a very cheap and effective method of malaria control in 
areas where people keep livestock and vectors feed primarily on animals 
(Rowland et al., 2001). This method could substitute for indoor residual 
spraying in south Asia and the Middle East where vectors feed mainly on 
animals. In particular, it has the potential to control malaria in emergencies 
in Afghanistan and Tajikistan. Operational research is needed to evaluate 
its potential role and feasibility in emergencies.
Insecticide-treated nets
Insecticide-treated nets (ITNs) have been shown to provide protection in 
many settings (see Chapter 6) and are effective as a community control 
measure if population coverage in excess of 60% (some studies indicate 
50%) is achieved. At lower coverage rates, ITNs provide protection for 
each person sleeping under a net. Although ITNs are considered appropri-
ate for epidemic or outbreak control only under very specifi c conditions 
(Nájera, 1996), and their use in acute emergencies is limited mainly to 
personal protection for priority vulnerable groups, there is increasing evi-
dence of the effectiveness of ITNs in the post-acute phase of emergencies 
(Rowland et al., 2002; Kolaczinski et al., 2004).
ITNs work well in Africa against all malaria vector species if used regu-
larly and correctly, but they are not effective in every epidemiological con-
text. Among Karen refugees on the Thai–Myanmar border, for example, 
sleeping under treated nets provided limited protection because the local 
vector bites early in the evening, before people go to bed (Luxemburger et 
al., 1994). Operational research is therefore needed on vector biting cycles 
and on the disease impact of treated nets in regions where effectiveness is 
currently unknown. 
ITNs may not be the best solution in the acute phase of emergencies. 
Community distribution to vulnerable groups should be considered only 
if ITNs have been stockpiled in advance, the community is in the habit of 
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using them, and no community vector control interventions (IRS) are ongo-
ing. Before ITN coverage is expanded, basic research is needed to: 
— fi nd out the previous experience of nets among the displaced popula-
tions, whether they want or would use nets, and the importance of 
nets relative to other priorities;
— develop appropriate information materials and evaluate instructions 
on net use and care;
— fi nd out about appropriate sizes and shapes for nets;
— fi nd out what people do with the nets they are given, whether nets are 
used, who uses them, and what proportion is resold;
— monitor the frequency of net washing.
Programme monitoring for ITN programmes should take place at distribu-
tion (indicator a below), and at 1 month (indicators b and c) and 6 months 
(indicator d) after the intervention:
a) Coverage = number of ITNs distributed / target population size (%).
b) Utilization rate = number of people using ITN/number of people given 
ITNs (%).
c) Retention rate = number of people retaining ITNs/number of people 
originally given ITNs (%).
d) Deterioration rate = average number of holes per ITN.
 Note: Even nets with some holes can be protective against mosquitoes if 
they are treated with pyrethroid insecticide – this is one of the purposes 
of the insecticide treatment.
Operational research can provide important insights into issues of broader 
applicability, such as the impact of free distribution of ITNs on the private 
sector and on future willingness to buy nets, and the effectiveness of insec-
ticide treatments of nets (see Annex VI).
Alternative individual protection and community control approaches 
Insecticide-treated nets are an expensive investment to make if their accept-
ability or effectiveness is uncertain, and they may not be practical when 
populations are living in tents or under plastic sheeting. Further opera-
tional research is needed to assess the potential of alternative approaches, 
such as pyrethroid treatment of top-sheets, blankets, tents or the plastic 
tarpaulins that are increasingly being used as an alternative to tents by 
UNHCR (see Chapter 6). One potential advantage of these materials is that 
they are already being distributed in acute emergencies; if they could be 
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rendered protective against malaria there would be a dual benefi t with no 
extra demands being placed on logistics. Research in Asia indicates that in-
secticide-treated plastic sheeting (ITPS) may, like IRS, provide community 
protection through mass killing effect of the mosquito population – but no 
personal protection from mosquito bites. 
Further research is required to assess:
— the potential of treated top-sheets and blankets in different cultural, 
epidemiological and climatic settings in Africa, to determine the 
most suitable blanket materials for treatment and different methods 
of treatment (e.g. spraying or immersion);
— the potential of ITPS, which is impregnated during manufacture and 
currently being pilot-tested in west Africa. 
Protection from malaria in pregnancy
Strategies to protect pregnant women are described in Chapters 5 and 6. 
Research is needed to identify the best ways to target ITN programmes at 
pregnant women, and to evaluate the effectiveness of intermittent preven-
tive treatment (IPT) with sulfadoxine–pyrimethamine (SP) delivered as a 
part of antenatal care in complex emergencies. Information on the effec-
tiveness of IPT (measured as prevention of severe anaemia and low birth 
weight) in areas where it is being implemented is also needed to inform the 
continuing broader debate about use of IPT in areas with relatively high 
levels of SP resistance (see Chapter 5).
Understanding social and behavioural factors
Successful malaria control depends on agencies understanding communi-
ties and communities understanding and using prevention and treatment 
measures. It is crucial to understand what people know, believe and do 
about malaria. Social and behavioural research is important for designing 
effective interventions and can shed light on why a particular intervention 
fails to be accepted (see Box 8.7).
Operational research on the following social and behavioural issues 
could strengthen planning and implementation. Chapter 7 and Annex VII 
provide additional ideas for questions that may need to be asked. 
Treatment-seeking and access to care
• What local terms do people use to describe febrile illness? 
• What perceptions do people have about the causes of febrile illness?
• What infl uences treatment-seeking?
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• Where is treatment obtained? Health services, traditional healers, pri-
vate practitioners? 
• When is treatment sought? Is there a delay? How long before treatment 
is sought from a clinic?
• What access do people have to antimalarials? Does the private sector 
provide effective drugs? How is the supply of drugs regulated or main-
tained? Do traditional healers prescribe antimalarials?
• Does the population accept the recommended standard treatment for 
malaria? Is camp treatment policy different from their former experi-
ence of treatment?
• How do people feel about antimalarial safety and effi cacy?
• What are the barriers to treatment and care? Are services accessible? 
• What role is played by intermediaries, such as other family members, in 
accessing care?
• Does security affect access to care?
• Are some groups excluded on grounds of sex or ethnic origin?
Prevention
• What individual protection measures were traditionally used? 
• What measures are currently acceptable?
• What is the market value of materials treated with insecticide? Is resel-
ling or an illegal market likely to undermine the effectiveness of these 
materials?
• What items do people most value? Are nets valued or are they sold?
• Does the displaced population have employment and income? 
CHAPTER 8. OPERATIONAL RESEARCH
Box 8.7 Understanding social and behavioural factors
KAP survey in eastern Democratic Republic of the Congo
In eastern Democratic Republic of the Congo, health data showed that 
only 20–30% of the population were using health services. A knowledge, 
attitudes and practices (KAP) survey was conducted by Merlin into 
treatment-seeking practices in the community, barriers to accessing 
health care, and knowledge and beliefs about malaria. The fi ndings showed 
that the main barrier to accessing health care was economic, because of 
the cost-recovery system in place. 
Sociobehavioural research in Zambia
In Zambia, behavioural research showed that families were not bringing 
children with severe malaria for treatment because they believed that the 
cause was spiritual and that the disease therefore needed to be treated by 
a traditional healer.
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• Who makes household expenditure decisions?
• Who should be targeted with health information? 
Operational research can provide information on people’s beliefs and 
knowledge about prevention, and useful insight for ITN programmes on 
family sleeping arrangements, sex or age differences in net use, net washing 
practices, and the proportion of the population using distributed nets. 
Social information can be collected by interviewing community leaders 
or by conducting participatory community research (see Chapter 7), some-
times also called Rapid Participatory Appraisal or Rapid Ethnographic 
Assessment.
Identifying sustainable strategies to deliver preventive interventions 
It is now generally accepted that malaria services must be free of charge 
to users in complex emergencies. During the acute – and to a lesser extent 
the chronic – phase of complex emergencies, most agencies do indeed pro-
vide preventive interventions such as nets and insecticide treatment, free of 
charge to the affected population. However, as an emergency situation re-
solves, RBM partners need to consider how to move to sustainable delivery 
of preventive interventions, including cost recovery. This can be diffi cult 
when the affected population has become used to receiving services free of 
charge. 
Various strategies have been used including, for example, social mar-
keting and private-sector provision of nets and insecticide. Operational 
research is needed to identify the strategies that are most appropriate and 
to answer questions about: 
• Accessibility
 Which delivery strategies are cost-effective and achieve best coverage 
and uptake?
• Affordability
 What are people willing and able to pay?
 What is the socioeconomic status of buyers and non-buyers, and how 
can this information be used to support more effective promotion?
 How can the most vulnerable be identifi ed and protected?
 Is there is a need for subsidies or credit schemes?
 What is the best coverage achievable when nets are sold, and is this good 
enough to control malaria in the community?
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• Demand creation 
What is the best way to get the message across?
 What methods work best in emergencies – mass media or person-to-per-
son?
• Monitoring
 How can behaviour change and correct use best be monitored?
• Insecticide re-treatment
 What can be done to encourage people to retreat their nets? 
Understanding the economics of malaria control
The costs and cost-effectiveness of malaria control in the acute phase of 
complex emergencies are still poorly documented. This is an area where 
more research is needed, especially in relation to the burden of malaria dis-
ease in emergencies (see below) and cases and mortality averted by different 
control interventions. Economic analysis of malaria control in emergencies 
should be feasible, because many agencies maintain detailed expenditure 
records for fi nancial reporting to donors. 
More is known about the post-emergency economics of malaria control. 
For example, studies have compared the cost-effectiveness of IRS and ITNs 
in Africa and Asia (Curtis et al., 1999; Rowland, 1999). More research is 
needed to identify prevention and treatment approaches that will be fi nan-
cially sustainable after the withdrawal of donor funding. 
Understanding the burden of disease in complex emergencies
Current estimates of the contribution of malaria in complex emergencies to 
the global malaria burden are rough, as they are based on country popula-
tion data and assume uniform mortality across highly endemic areas in 
Africa, irrespective of local social conditions. Studies of the burden of 
malaria disease at different stages of complex emergencies are needed – 
information for various emergency settings would give insight into the true 
contribution of complex emergencies to the global malaria burden. 
As discussed in Chapter 2, cross-sectional surveys should form part of 
initial assessment and should be repeated at regular intervals as and when 
operational, social, and epidemiological conditions change, since changing 
situations will require different interventions. Surveillance (see Chapter 3) 
is a further operational research tool – without accurate surveillance it is 
impossible to make informed judgements about progress. 
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Measuring the effectiveness of outbreak control
Surveillance can also be used as an operational research tool to evaluate the 
impact of outbreak control interventions (see Chapters 3 and 4). In Afghan 
refugee camps, for example, it was suspected that IRS with the insecticide 
malathion was no longer working very effectively. In a pilot study carried 
out the following year, six refugee camps were sprayed with malathion as 
usual and a further six camps were sprayed with the pyrethroid lambda-
cyhalothrin. Cross-sectional prevalence surveys before and after spray-
ing confi rmed that lambdacyhalothrin was giving better control than 
malathion, and policy was changed (Rowland, Hewitt & Durrani, 1994). 
Other indicators that might be used for measuring control impact, depend-
ing on the resources available, include the number of clinical malaria cases 
presenting at clinics, spleen rates in children, prevalence of anaemia, and 
mosquito population density.
Understanding post-emergency restratifi cation of malaria 
Emergency situations can affect the pattern of malaria in a country. 
As discussed earlier in this handbook, P. falciparum has re-emerged in 
Afghanistan and Tajikistan as a direct result of population movement dur-
ing confl ict (Pitt et al., 1998; Rowland et al., 2002a). Other consequences of 
emergencies – changes in land use and agriculture, breakdown in irrigation 
systems, migration to cities and increased urbanization – can also affect the 
pattern of malaria. Research is important to identify these changes. 
Research using appropriate tools – sero-epidemiological surveys of malaria 
exposure, cross-sectional parasite prevalence surveys, Geographic Informa-
tion Systems and remote sensing of land use – can help to restratify malaria 
epidemiology and ensure that control resources are targeted effectively.
Operational research procedures
Research planning 
Malaria operational research and malaria control programmes are similar 
in terms of the process of planning and design, the tools and indicators 
used, and the approaches used for monitoring and evaluation. However, 
operational research differs from control programmes in that it starts from 
a position of uncertainty, or lack of knowledge, and aims to identify the 
best solution – which may involve comparing the results of a number of 
approaches. 
The steps in developing an operational research plan (see Table 8.1) are 
the same whether the aim is to improve an existing programme or to de-
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velop a new approach to malaria control. Important aspects of the design 
of operational research include:
— agreeing clear objectives;
— setting realistic targets;
— anticipating outcomes;
— planning activities according to a strict timeframe;
— establishing a system for monitoring – with appropriate technical 
and process indicators to measure progress – and evaluation.
Good organization and planning are vital: if an activity is not carried out 
properly or an output is not recorded properly, the results may be unclear 
and interpretation of the fi ndings will be diffi cult. 
It is particularly important to plan at the design stage how data will be 
collected and analysed. Planning data collection helps to clarify activities 
(quality control checks, sorting and processing, analysis), minimize errors, 
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Table 8.1 Steps in developing an operational research plan
Questions Steps Important elements
What is the problem? Statement and defi nition  
What information is  Review published  Scientifi c, medical and
already available? literature, government “grey” literature
 or agency records  
What is the purpose? Formulate objectives Research questions or   
  hypotheses
What additional  Develop research  Type of study; data collection
information or data are  methodology techniques; variables;
needed? How should   sampling; data collection
information/data be   plan; analysis plan; ethical
collected?  considerations; pilot study 
  or pretest
How will the results  Plan for use and  Involve future benefi ciaries
be used? dissemination of results in planning or execution of 
  research
Who will do what  Develop work plan Personnel scheduling;
and when?  monitoring; evaluation
What is needed? Plan resources and  Staff; equipment; material
 budget support; fi nance
How should the argu- Develop proposal
ment be presented to 
authorities, partners, 
donors? 
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avoid unnecessary delays, and organize human and material resources. 
Planning how data will be analysed helps to formulate clear and specifi c 
objectives and determine what information should be collected in the fi rst 
place.
A pretest of a particular research component or a pilot study of the en-
tire research procedure with a small sample may help to identify potential 
problems, allowing necessary revisions to be made before research is imple-
mented on a larger scale.
Deciding on the type of operational research
Study design
There are three types of study design:
— descriptive
— analytical 
— experimental.
Descriptive studies
A descriptive study is the systematic collection and presentation of data to 
describe a particular situation. Examples of descriptive studies include an 
initial assessment of malaria in an emergency, a baseline malaria prevalence 
survey, and a survey of how many families own mosquito nets. Descriptive 
studies can be qualitative or quantitative. 
• Qualitative research – may be concerned with attitudes or opinions that 
may change over time, or characteristics of particular groups; it usually 
focuses on small samples to allow variables to be explored in depth.
• Quantitative research – usually covers a larger population, but can 
involve qualitative research on a smaller sub-sample. For example, 
estimating the extent of net ownership in a population would require 
several hundred respondents to be surveyed, but discovering the reasons 
for owning or not owning a net would require in-depth interviews with 
a randomly selected sub-sample of owners and non-owners.
Analytical studies
Analytical studies try to establish causes or risk factors for malaria in a 
more rigorous way than descriptive studies; they include case–control stud-
ies (see Box 8.8) and cohort studies. 
• In a case–control study, one group with the disease (cases) is compared 
with another without the disease (controls), to look for differences be-
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tween them – for example, in ITN use, housing, proximity to breeding 
sites – that might explain the difference in disease rates. Case–control 
studies are cheap and quick, and are therefore the method of choice 
for measuring the impact of an intervention in emergency conditions. 
Such studies are informative, provided that cases and controls are well 
matched.
• In a cohort study, a group exposed to a risk factor (the study group) is 
compared with a group that is not exposed (control group) over the same 
period of time. Both groups are selected at the same time and followed 
up for an equal period of time. 
Cohort studies take longer than case–control studies and are usually la-
bour-intensive and are more expensive. In emergency situations it can be 
diffi cult to identify all cases and to ensure follow-up over time because of 
CHAPTER 8. OPERATIONAL RESEARCH
Box 8.8 Case–control study of the impact of ITNs in a complex emergency 
 in Afghanistan1
The impact and coverage of distribution of insecticide treated nets (ITNs) 
can be estimated using routine data collected by passive case detection at 
fi eld clinics. Data from the microscopy registers of Behsud clinic in eastern 
Afghanistan were as follows: 
Blood  Falciparum-positive Falciparum-negative Total
smears (cases) (controls)
ITN user  52 (a) 610 (b) 662 (e)
Non-user  439 (c) 1958 (d)  2397 (f )
Total   3059 (g)
These data were used to estimate individual effectiveness through a case–
control study. Slides that were positive for P. falciparum were considered 
to be cases, and slides that were negative were considered to be controls. 
Using the data collected, the odds ratio (ad/bc) = 0.38, so individual 
protective effectiveness = 1 – odds ratio = 0.62 or 62% (confi dence interval 
48–72%). 
The data were also used to estimate the proportion of the population 
covered with ITNs (e/g) = 0.22. 
The impact on malaria morbidity in the population, or community 
effectiveness = individual effectiveness x coverage, which in this 
community is 0.62 x 0.22 = 14%. It was therefore concluded that 14% 
(confi dence interval 11–16%) of the total malaria cases in the community 
were prevented by the ITN distribution programme.
1 Rowland et al., 2002b.
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population movement. For these reasons, cohort studies are more appropri-
ate for stable, long-term refugee camps.
Experimental studies
An experimental study is a type of cohort study in which units are ran-
domly allocated to an intervention (expected to reduce the risk of malaria) 
while other units are not. The intervention effect is measured by comparing 
the risk of malaria between the two groups. The randomized units might be 
individuals (for example, in a drug trial), families (for example, in a treated 
net protection trial) or communities (for example, in comparing indoor 
spraying campaigns of villages). 
The unit of allocation may be a group if:
— the intervention is to be applied on a community-wide basis, such as 
many educational interventions;
— it is logistically easier to administer the intervention to groups than 
to individuals;
— the purpose is to reduce transmission of malaria in an area;
— delivery systems for the intervention are being tested or compared.
A double-blind randomized controlled trial is the “gold standard” for as-
sessing effi cacy because any intervention effect will be unambiguous. Units 
are allocated randomly to eliminate potential bias due to unforeseen fac-
tors. The double-blind approach, in which neither the researcher not the 
participant is aware of who is allocated to the intervention group or who to 
the control group, eliminates potential bias in the assessment of impact of 
an intervention. Deciding what the control group receives can involve dif-
fi cult ethical issues, and these are discussed in more detail below. 
Sampling and study size
A representative sample should possess all the characteristics of the popula-
tion from which it is drawn. Approaches to sampling include: 
• Simple random sampling. Each unit in the sampling frame has an equal 
chance of being selected. It may be diffi cult to take a simple random 
sample because of logistics or problems of excluding neighbours. In 
systematic sampling, units are taken at regular intervals. Stratifi ed 
sampling selects representative subgroups or strata (for example, age or 
ethnic groups) in proportion to the population structure. 
• Cluster sampling. A random sample of villages or camps is chosen, from 
which all individuals within the particular section of the population 
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being studied (e.g. children under 5 years of age) are selected for the 
intervention. Cluster sampling is logistically easier, but more likely to be 
unrepresentative, although the risk of this can be reduced if the number 
of clusters is 20 or more.
Study size is important. If the study is too small it may fail to detect impor-
tant effects or estimate effects too inaccurately; if it is too large it will use 
more resources than necessary. The study size should have adequate power 
(typically, at least 80% chance) to detect an effect large enough to be of 
practical importance, especially when the impact of new interventions is 
being evaluated. Computer programmes, such as EpiInfo, can be used to 
calculate required sample sizes.
Losses to follow-up are likely in refugee or displaced populations or 
in chronic emergency conditions. For example, during a 1-year study of 
insecticide-treated top-sheets in Kabul, Afghanistan, more than 30% of 
the study population moved house because of security problems. In emer-
gency situations the sample size may need to be increased to allow for such 
higher losses to follow-up. For example, if sample size calculations indicate 
that 560 subjects are required and a 30% loss is predicted, the sample size 
should be increased to 800. The higher the rate of loss to follow-up, the less 
reliable the study results will be, particularly if it affects case and control 
groups unequally. 
Other factors that determine the size of a study include availability of 
staff, transport, laboratory capacity, time and money. 
Ethical considerations 
Ethical considerations are particularly important in studies of refugee and 
displaced populations and the following issues are critical:
• Any research protocol that involves people should pass formal review by 
an ethical committee. 
• Research should follow the guiding principles for research in the Hel-
sinki Declaration of 1964, which is available at http://onlineethics.org/
reseth/helsinki.html). These principles are further elaborated with re-
spect to developing countries in the International ethical guidelines for 
biomedical research involving human subjects (CIOMS, 2002).
• Research for populations affected by complex emergencies is essential, 
but these vulnerable and socially and economically deprived groups 
must not be used in research that will mainly benefi t more privileged 
groups.
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• Informed consent must be obtained from all participants; it is the inves-
tigator’s responsibility to ensure that subjects are fully informed of the 
potential risks and benefi ts of participating in a study.
• Intervention trials on refugees should be undertaken only when there 
is uncertainty about the potential benefi t. If a previous study provides 
evidence for a benefi t there is no justifi cation for a trial unless there is 
good reason to believe that the results might be different in the present 
population or locality. 
Choice of “control” interventions is a diffi cult ethical issue. The accepted 
principle is that any new intervention should be compared with the best in-
tervention currently available. Comparison with a placebo or “no interven-
tion” control group is acceptable only if no other effective intervention is 
known or if a known intervention is too expensive for general application. 
It is important to take account of the following:
• If an intervention is already being used, its withdrawal for the purposes 
of a research study would be unethical. 
• If it is not clear whether an intervention already in use is still effi cacious, 
a randomized trial comparing a promising new treatment with the exist-
ing treatment would be justifi ed. 
• If there are insuffi cient resources to meet the needs of everyone (which 
is usually the case), distribution might be randomized to enable an un-
equivocal assessment to be made (see Example 1 in Box 8.9).
• It is acceptable to try a new intervention that might be equivalent, or even 
slightly inferior, to another if it is cheaper, easier to implement, more sus-
tainable, associated with fewer adverse reactions, or more acceptable to 
the community than the existing intervention. This situation may arise 
after a confl ict when there is a need to develop interventions that can be 
sustained with limited resources by the national public health system.
Some agencies may prefer to conduct a comparative trial (see Example 2 
in Box 8.9) rather than a randomized controlled trial, as there is no risk of 
withholding a benefi cial treatment.
Community involvement 
Active community cooperation is essential in most operational research 
studies. It is important to involve community leaders in research planning 
and design from the start. Depending on the type of study, participation 
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may be passive – such as consenting to house spraying or disease monitor-
ing, or active – such as using ITNs or other behaviour-change interven-
tions. 
Outcome measures
The most commonly used outcome measures in malaria operational re-
search are:
— disease incidence
— disease prevalence
— intermediate variables, such as vector density or human behaviour 
change. 
In studies of malaria control interventions in emergency situations, the dif-
ference in incidence or prevalence of disease in the intervention and control 
groups is the most relevant outcome. Once a disease surveillance and moni-
toring system is in place (see Box 8.10), it is simpler and more defi nitive to 
measure changes in disease outcome than to attempt to measure intermedi-
ate effects (such as changes in vector-biting density, or in knowledge, at-
titudes and behaviour). However, understanding intermediate variables is 
useful for refi ning or improving an intervention or explaining how it works. 
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Box 8.9 Different approaches to researching new interventions in Pakistan
Example 1
When insecticide-treated nets were fi rst introduced in Pakistan it was 
unclear whether they would prevent malaria since there was no tradition 
of using nets. The few nets made available by donors were given to 
randomly selected families in the camp rather than to a single cluster of 
families, and a similarly randomly selected group of families served as a 
control. After 6 months, when a preventive effect had been demonstrated 
and NGOs and donors were confi dent that the nets would make an impact, 
nets were made available to other families (Rowland et al., 1996). 
Example 2
National policy in Pakistan included spraying with the insecticide 
malathion, against malaria. UNHCR felt committed to spraying with 
malathion in Afghan refugee camps in Pakistan, even though there was 
little evidence that it made any difference to malaria incidence. To evaluate 
a new candidate insecticide, it was decided that it would be more ethical 
to randomizing camps to be sprayed with either malathion or the new 
insecticide than to withdraw malathion altogether and compare camps 
sprayed with the new insecticide against camps that were not sprayed at 
all (Rowland et al., 1994).
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Where the intermediate variables are technical or require specialized ad-
vice, help should be sought from international or local experts.
The most useful method for monitoring malaria infection (see also 
Chapters 2 and 3) is a cross-sectional parasite prevalence survey, which:
— can be done even when health facilities are very basic;
— requires microscopy or rapid testing to determine parasite rates 
– supported by data on fever rates, temperature, packed cell volume, 
spleen rates and anaemia;
— will identify most infections and allow estimation of incidence rate, 
if conducted every 2 weeks. 
If clinics are well established and well used – for example, when services 
are provided free of charge – passive case detection can provide good proxy 
estimates of incidence rate, provided that the size of the catchment popula-
tion is known. 
Although entomological surveys are important in initial assessment of a 
potential malaria problem and in identifying control solutions, they require 
technical expertise that may not be available to many agencies working in 
emergency situations. Assistance can be obtained from WHO.
Using study results
Dissemination of fi ndings
Whether the results of research are positive or negative, they must be 
reported to national health offi cials in the MOH, to donor agencies, com-
munity leaders and participants, and to appropriate health and scientifi c 
Box 8.10 Organizing laboratory support for research trials
Microscopy is the most reliable method of detecting malaria parasites and 
provides the “gold standard” for assessing research trial outcome. The 
organization of a laboratory to support a research trial in the fi eld differs 
from that of a standard laboratory for clinical diagnosis, because the 
objective in a trial or in surveillance surveys is to process large numbers of 
samples. In particular:
■ Quality control procedures are essential because of the repetitive 
nature of the work. 
■ Random samples of slides should be re-examined at an external 
reference laboratory. 
■ The re-examination should be blind to the original results and 
should focus on negative smears, asexual parasite counts, and correct 
identifi cation of malaria species.
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journals. The fi ndings and any implications for policy should be discussed 
with the MOH and with disease control authorities such as WHO, UN-
HCR and leading NGOs. 
Moving from operational research to programme development
Using research fi ndings to guide programme development is critical. Suc-
cessful new interventions may have to be integrated into current control 
programmes, and strategies to do this may need to be developed. The case 
studies below – one on treatment of drug-resistant malaria in Thailand and 
the other on prevention of malaria in Afghanistan – illustrate how simple, 
practical and relevant operational research can contribute to more effi cient 
and effective malaria control programmes. 
Case Study 1. Treatment research (Nosten et al., 2000)
Background
In Karen refugee camps on the western border of Thailand, P. falciparum 
had become resistant to most of the available antimalarial drugs. 
Methods, results and lessons learned
The in vivo response of falciparum malaria to drug treatment has been 
monitored in the camps since 1985, when diagnostic and treatment facili-
ties were fi rst set up:
• Access to effective antimalarials was strictly controlled, and treatment 
given only after microscopic confi rmation of malaria, to ensure accurate 
records and reliable estimates of incidence rate. 
• In in vivo surveys, cases were monitored weekly to estimate the clinical 
and parasitological effi cacy of the drug regimens.
This research programme of resistance monitoring and clinical epidemiolo-
gy resulted in a drug treatment policy that stopped the spread of resistance. 
Using an artesunate–mefl oquine regimen, patient cure rates have remained 
stable at over 95% for the past several years, while incidence rates in the 
catchment population have fallen by more than two-thirds over the same 
period. The methods used, main results and impact are summarized in the 
following table.
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Dates Observation New treatment  Interpretation 
  response and effects
Before  Failure of  Introduction of  Mefl oquine overcomes
1984 chloroquine and    mefl oquine  resistance to
 then of sulfadoxine– (15 mg/kg), initially  chloroquine and SP and
 pyrimethamine (SP)  combined with SP  restores the cure rate
 to cure falciparum  (MSP) in late 1984 to 98%
 malaria due to 
 selection of drug-
 resistant strains       
1985–90 Cure rates decline  MSP replaced by  Mefl oquine resistance
 over the next 4 years  high-dose  developing, leading
 despite strict control  mefl oquine  to increased rates of
 of drug use; incidence  (25 mg/kg)  transmission; high-dose
 of falciparum malaria   mefl oquine restores
 rises  effi cacy temporarily 
1991–94 Failure rates with  Artesunate and  Artesunate restores the
 high-dose mefl oquine  high-dose mefl oquine cure rate;
 rise inexorably,  combinations used  recrudescence rates
 accompanied by  increasingly from  are reduced and this
 higher gametocyte  1991 and completely  lowers transmission
 carriage by 1994      
1995–99 Artesunate– Artesunate– Artesunate has
 mefl oquine  mefl oquine  prevented further
 combination retains  combination remains selection of mefl oquine 
 100% effi cacy after  the treatment of  resistance; its effect in
 4 years as fi rst-line  choice in all camps in  reducing gametocyte
 treatment; incidence  the area carriage contributed to
 of falciparum falls by   the fall in transmission
 67% over the same 
 period    
The experience in Karen refugee camps prompts the following conclu-
sions:
• Applied and operational research on different drugs and regimens is the 
only way to develop a rational treatment policy in the face of increasing 
drug resistance.
• Simple, regular monitoring of drug resistance and a disciplined drug 
policy can prevent the development of drug resistance in refugee and 
non-refugee situations. 
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• In this area of low malaria transmission, early diagnosis and treatment 
with combined artesunate and mefl oquine have reduced the incidence of 
P. falciparum malaria and halted the progression of mefl oquine resist-
ance.
Case Study 2. Prevention research (Kolaczinski et al., 2005)
Background
War, the breakdown of the health system, population displacement and 
poverty have led to a malaria epidemic in Afghanistan that has lasted for 
more than 20 years. The former, centrally managed, system of malaria con-
trol based on indoor spraying was no longer feasible or appropriate, and 
the only option possible in such unstable conditions was to help families to 
protect themselves. Questions related to the transformation from a system 
of total government provision to total self-reliance included: 
• Which protection techniques are appropriate to the new conditions?
• Which delivery systems cover the most people at least cost?
• Who pays for the programme, and how much can benefi ciaries contribute?
• What are the limitations of the strategy, what supplementary measures 
are needed to protect the poorest or to control malaria in the entire com-
munity?
A programme of operational research was needed to answer these ques-
tions, and in particular to:
• fi eld-test potential control techniques in pilot projects;
• compare alternative delivery systems in terms of accessibility, coverage, 
and cost-effectiveness;
• fi eld-test locally adapted information and promotional strategies de-
signed to stimulate uptake. 
Methods, results and lessons learned
Specifi c research studies were implemented at different stages to answer 
each of these questions, with research and control elements integrated in 
the same programme. As a result of this: 
• A new kind of control programme evolved which emphasized protecting 
families by encouraging them to use ITNs, which had been shown to be 
locally effective.
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• Treated nets were socially marketed through existing NGO clinics, 
private shops and pharmacies; this proved to be an effi cient system that 
covered a high proportion of the population. 
• Permethrin-treated top-sheets were promoted as a cheaper, but still 
effective, alternative for those unable to afford nets and for outbreak 
control.
The experience in Afghanistan prompts the following conclusions:
• Development of a malaria control programme is best guided by opera-
tional research.
• A series of fairly simple research questions and answers can lead to a 
culturally appropriate, effective, effi cient and comprehensive prevention 
programme.
• Integration of operational research within a control programme gener-
ates a spirit of dynamism and prevents programme stagnation.
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Further reading
WHO (2000). WHO Expert Committee on Malaria. Twentieth report. 
Geneva, World Health Organization (WHO Technical Report Series, No. 
TRS 892). 
• Has a useful chapter on operational research, available at www.who.int/
malaria/docs/ecr20_9.htm.
WHO (2003). Operational research for malaria control. Learner’s guide 
and Tutor’s guide (trial edition). Geneva, World Health Organization, 
2003 (WHO/HTM/RBM/2003.51 Part I and II).
• The Learner’s guide covers basic concepts and information plus a series 
of problems, with hints or partial solutions to them. The document is 
available at http://www.who.int/malaria/docs/operational_research_
lg.pdf.
Further information about operational research and ITNs can be found 
in: 
• Chavasse D, Reed C, Attawell K (1999). Insecticide-treated net projects: 
a handbook for managers. London, Malaria Consortium.
Advice about fi eld trials is available in:
• Smith PG, Morrow RH (1996). Field trials of health interventions in de-
veloping countries – a toolbox. London, Macmillan (see also Annex I).
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Finding out more
The Malaria in Emergencies Network can provide technical assistance for 
the design, implementation and evaluation of operational research. 
Malaria in Emergencies Network 
World Health Organization
1211 Geneva 27
Switzerland
Fax: +41 22 791 4824
E-mail: rbmemergencies@who.int 
Research assistance can also be obtained through the Malaria Consortium 
(www.malariaconsortium.org) or the London School of Hygiene & Tropi-
cal Medicine. 
Mark Rowland
Department of Infectious Diseases
London School of Hygiene & Tropical Medicine
Keppel Street
London WC1E 7HT
England
Tel: +44 20 7299 4719
Fax: +44 20 7299 4720
E-mail: mark.rowland@lshtm.ac.uk
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Note: The lists in this annex are provided for information only and should 
not be regarded as exhaustive, nor should the inclusion of any organization 
be construed as an endorsement.
Contributing agencies 
Centers for Disease Control and Prevention 
www.cdc.gov
HealthNet International 
www.healthnetinternational.org
London School of Hygiene & Tropical Medicine
www.lshtm.ac.uk
Malaria Consortium
www.malariaconsortium.org
Médecins Sans Frontières (MSF)
www.msf.org
Merlin
www.merlin.org.uk
Offi ce of the United Nations High Commissioner for Refugees (UNHCR)
www.unhcr.ch
Shoklo Malaria Research Unit
www.shoklo-unit.com
WHO Roll Back Malaria department 
 www.who.int/malaria 
United Nations and intergovernmental organizations 
Department for Humanitarian Affairs (DHA)
Coordinates international emergency relief in complex emergencies. 
 www.reliefweb.int
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International Organization for Migration (IOM)
Intergovernmental organization, established in 1951 to resettle displaced 
European persons, refugees and migrants. Currently working with mi-
grants and governments worldwide to provide humane responses to migra-
tion challenges.
www.iom.int
Offi ce of the United Nations High Commissioner for Refugees (UNHCR) 
Provides protection to refugees and seeks long-lasting solutions to their 
problems as well as providing essential materials and support in the coun-
try of refuge. 
www.unhcr.ch
Roll Back Malaria (RBM) Partnership Secretariat
Ensures that contributions from individual RBM partners are coordinated 
and focused on the expressed needs of countries and in line with the best 
technical approaches. All activities are driven by the principal RBM objec-
tive – a rapid scaling-up of malaria interventions within countries, particu-
larly to reach vulnerable populations.
www.rbm.who.int 
United Nations Children’s Fund (UNICEF) 
Focuses on the needs of women and children in emergencies, including 
health, mental care, food, water and sanitation. 
www.unicef.org
World Health Organization (WHO) 
United Nations specialized agency for health. 
www.who.int
• WHO Roll Back Malaria department 
Web site: www.who.int /malaria 
• WHO Health Action in Crises department
Web site: www.who.int/hac
World Food Programme (WFP) 
Initiates and coordinates food aid for populations in acute emergencies 
through to rehabilitation and reconstruction phases. 
www.wfp.org
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United Nations Development Programme (UNDP)
Promotes measures for disaster prevention and mitigation and provides ad-
ministrative support for United Nations Disaster Management Teams. 
www.undp.org 
United Nations Disaster Management Teams (UNDMT) 
Normally chaired by the UNDP resident coordinator and includes rep-
resentatives of all the above United Nations agencies. Aims to provide 
effective, coordinated United Nations response to support governments in 
emergencies.
Bilateral organizations 
Australian Agency for International Development (AUSAID)
www.ausaid.gov.au
Department for International Development (DFID)
www.dfi d.gov.uk
United States Agency for International Development (USAID)
 www.usaid.gov
International foundations and associations
International Federation of Red Cross and Red Crescent Societies (IFRC)
www.ifrc.org
International Committee of the Red Cross (ICRC) 
www.icrc.org
The Sphere Project
www.sphereproject.org
International Council of Voluntary Agencies
 www.icva.ch
International NGOs and non-profi t organizations
Africare
www.africare.org
Caritas International
www.caritas-international.de
Catholic Organisation for Relief and Development (CORDAID)
www.cordaid.nl
Epicentre
www.epicentre.msf.org
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Food for the Hungry International
www.fh.org
Health Unlimited
www.healthunlimited.org 
HealthNet International 
www.healthnetinternational.org
International Centre for Migration and Health (ICMH)
www.icmh.ch
International Medical Corps
www.imcworldwide.org
International Rescue Committee (IRC)
www.theirc.org
Malaria Consortium
www.malariaconsortium.org
Médecins du Monde (MDM)
www.medecinsdumonde.org
Medair
www.medair.org
Mentor Initiative
www.mentor-initiative.net
Merlin
www.merlin.org.uk
Médecins Sans Frontières (MSF)
www.msf.org
Oxfam
www.oxfam.org.uk 
Save the Children
www.savethechildren.org.uk
Trinity Health International
www.mercyinternational.com
US Committee for Refugees
www.refugees.org
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Research & Development and Academic
Centers for Disease Control and Prevention 
www.cdc.gov
London School of Hygiene & Tropical Medicine
www.lshtm.ac.uk
Johns Hopkins University
www.jhu.edu
Shoklo Malaria Research Unit
 www.shoklo-unit.com
Regional NGO and Civil Societies 
African Medical & Research Foundation (AMREF)
www.amref.org
Other organizations and resources
Amnesty International 
www.amnesty.org 
Center for Research on the Epidemiology of Disasters (CRED)
www.cred.be
Centro Regional de Informacion sobre Desastres (CRID)
www.crid.or.cr/crid 
European Community Humanitarian Offi ce (ECHO)
http://europa.eu.int/comm/echo
Mapping Malaria Risk in Africa 
www.mara.org.za 
Medline
www.ncbi.nlm.nih.gov/entrez/query.fcgi
Norwegian Refugee Council Global IDP Project
www.idpproject.org
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ANNEX II
Example consent form for surveys1
Location: ............................................................ Dwelling number: ............
We are from ........................................................ We are interested to know 
how much malaria there is in your community. Then we will know better how 
to stop people becoming sick and dying from malaria. 
We would like to ask some questions and take a fi nger prick blood test (and 
examine you for signs of malaria2). The interview will take about ......... min-
utes, and the blood test and examination will take ........... minutes per person. 
If the blood test is positive for malaria, we will give you malaria treatment free 
of charge. 
We cannot ask everyone in the community, so we are choosing some house-
holds at random. Your household has been selected. If you agree, we would like 
to ask you some questions, and to test you and everyone who normally sleeps in 
the house, including people who are not here right now, for malaria. We will do 
the test in your house at ................................................................................... 
Your participation is entirely voluntary. If you do not want to be part of this sur-
vey, you are free to say no. if you do not take part you are still welcome to come 
to the clinic for treatment, where services and treatment are free of charge. 
Do you have any questions at this moment?
For more information and any questions on this survey, you can always contact 
.........................................................................................................................
Thank you very much for participating in this survey.
Name: ...................................................................... Date: ..........................
Signature: ........................................................................................................
Name of offi cer requesting consent: ................................................................
1 For more information: http://www.who.int/rpc/research_ethics/informed_consent/
en/index.html.
2 If temperature and spleen size are to be measured.
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ANNEX IV
Safety of antimalarial drugs for treatment 
and/or prophylaxis during pregnancy, 
breastfeeding and early childhood1
Note: Each drug also has its own side-effects and specifi c contraindications 
that should be taken into account.
Antimalarial  Indication Pregnancy Breast- Early 
drug   feeding childhood
Amodiaquine Treatment Apparently safe  No data  Safe
  but limited data  
Artemether– Treatment Not recommended No data Not recommended
lumefantrine   in 1st trimester   <5 kg because of
  because of lack   lack of data
  of data    
Artemisinin  Treatment Not recommended Safe Safe
and   in 1st trimester
derivatives    because of lack 
  of data 
Atovaquone– Prophylaxis Very few data. Not  No data, not  Not recommended
proguanil Treatment recommended  recommended for prophylaxis in
  except as third-line   children <11 kg
  “rescue” treatment  because of lack
  for pregnant women   of data
  with multidrug-
  resistant   Apparently safe for
  P. falciparum   treatment in
  infection  children >5 kg, but 
    limited data
Chloroquine  Prophylaxis  Safe Safe Safe
 Treatment 
 (vivax only) 
Clindamycin Treatment  Safe Apparently  Apparently safe
 (used in   safe but  but limited data
 combination   limited data
 only)    
1 NB: No medication should be withheld if it is the only option available and would be 
life-saving in a laboratory-confi rmed case of falciparum malaria.
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Antimalarial  Indication Pregnancy Breast- Early 
drug   feeding childhood
Doxycycline Prophylaxis  Contraindicated Contra- Contraindicated 
 (used alone)  indicated <8 years of age
  
 Treatment 
 (used in 
 combination 
 only)   
Mefl oquine Prophylaxis  Not recommended Safe Not recommended
 Treatment in 1st trimester   <5 kg because of
  because of lack of   lack of data
  data    
Primaquine Treatment Contraindicated Safe Contraindicated 
    <4 years of age
Proguanil Prophylaxis  Safe Safe Safe
 (used in 
 combination 
 with 
 chloroquine 
 only) 
Quinine Treatment Safe Safe Safe 
Sulfadoxine– Treatment Safe Safe Safe
pyrimethamine  
Tetracycline Treatment  Contraindicated Contra- Contraindicated 
 (used in   indicated <8 years of age
 combination 
 only)   
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ANNEX V
Dosage schedules for 
oral antimalarial drugs
For children, antimalarial drugs can be crushed, diluted in water and then 
either squirted directly into the mouth using a syringe or given with a 
spoon.
Artesunate + amodiaquine
This ACT is currently available only as separate scored tablets of artesunate 
(50 mg) and of amodiaquine (153 mg base). Co-formulated tablets are un-
der development but are not yet available.
The recommended treatment is a once-daily dose of 4 mg/kg artesunate 
and 10 mg/kg amodiaquine base, given for 3 days.
Table A-V.1 Dosage schedules for artesunate + amodiaquine
Age Artesunate tablets  Amodiaquine tablets
 (50 mg)  (153 mg base)
 Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
5–11 months 1/2 1/2 1/2 1/2 1/2 1/2
≥1–6 years 1 1 1 1 1 1
≥7–13 years 2 2 2 2 2 2
≥14 years 4 4 4 4 4 4
Artemether–lumefantrine (Coartem®)
This ACT is currently available as co-formulated tablets each containing 
20 mg of artemether and 120 mg of lumefantrine.
The recommended treatment is a 6-dose regimen containing 1.5 mg/kg 
artemether and 12 mg/kg lumefantrine twice daily for 3 days.
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Table A-V.2 Dosage schedules for artemether–lumefantrine (Coartem®)
Weight No. of tablets at approx. timing (hours) of dosing
(Approx. age) 
  0 h 8 h 24 h 36 h 48 h 60 h
 5–14.9 kg 1 1 1 1 1 1
 (<3 years)
 15–24.9 kg 2 2 2 2 2 2
 (≥3–8 years)
 25–34.9 kg 3 3 3 3 3 3
 (≥9–13 years)
 >35 kg 4 4 4 4 4 4
 (≥14 years)
Simplifi cation of the artemether–lumefantrine dosage schedule for ease of 
use at programme level is as follows:
— second dose on the fi rst day to be given any time between 8 and 12 
hours after the fi rst dose;
— doses on the second and third days are given twice a day, morning 
and evening.
The 6-dose regimen of artemether–lumefantrine was previously not recom-
mended for children weighing less than 10 kg. However, recent evidence 
suggests that therapeutic response and safety profi le in young children are 
similar to those in older children, and the combination can now be given to 
children of body weight 5 kg and above.
Lumefantrine absorption is highly dependent on co-administration with 
fat. It is essential that patients or caregivers are informed of the need for 
artemether–lumefantrine to be taken with milk or other fat-containing 
food, particularly on the second and third days of treatment.
Artesunate + mefl oquine
This ACT is currently available only as separate scored tablets of artesunate 
(50 mg) and of mefl oquine (250 mg base). Co-formulated tablets are under 
development but are not yet available.
The recommended treatment is a once-daily dose of 4 mg/kg artesunate 
given for 3 days, combined with a total (split) dose of 25 mg/kg mefl oquine 
base given either on the second (and third) day or in 3 days (8 mg/kg per 
day).
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Table A-V.3 Dosage schedules for artesunate + mefl oquine
Age No. of artesunate tablets  No. of mefl oquine tablets
 (50 mg) per day  (250 mg base) per day
 Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
5–11 months 1/2 1/2 1/2 – 1/2 1/2
≥1–6 years 1 1 1 – 1 –
≥7–13 years 2 2 2 – 2 1
≥14 years 4 4 4 – 4 2
Vomiting is reduced if mefl oquine is given on Day 2. If adherence is a prob-
lem, mefl oquine can be given on Day 1.
Artesunate + sulfadoxine–pyrimethamine
This ACT is currently available only as separate scored tablets of artesunate 
(50 mg) and of pyrimethamine (25 mg) combined with sulfadoxine (500 
mg). A similar formulation containing pyrimethamine (25 mg) combined 
with sulfalene (500 mg) is considered to be equivalent to sulfadoxine–
pyrimethamine.
The recommended treatment is a once-daily dose of 4 mg/kg artesunate 
given for 3 days, combined with a single dose of sulfadoxine–pyrimeth-
amine (25 mg/kg and 1.25 mg/kg) given on day 1.
Table A-V.4 Dosage schedules artesunate + sulfadoxine–pyrimethamine (SP)
Age No. of artesunate tablets  No. of SP tablets
 (50 mg) per day  (25 mg P + 500 mg S) per day
 Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
5–11 months 1/2 1/2 1/2 1/2 – –
≥1–6 years 1 1 1 1 – –
≥7–13 years 2 2 2 2 – –
≥14 years 4 4 4 3 – –
Although sulfadoxine–pyrimethamine is a single-dose treatment, artesu-
nate must be given for 3 days to ensure satisfactory effi cacy of the ACT.
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Quinine
Oral quinine is available as scored tablets each containing either 200 mg or 
300 mg quinine salt. Dosing with either formulation – 200 or 300 mg – leads 
to relative under- or overdosing at the extremes of the weight categories.
The recommended treatment is an 8-hourly (i.e. 3 times daily) dose of 
10 mg/kg quinine salt given for 7 days.
Table A-V.5 Dosage schedules for oral quinine
If only the 200-mg quinine salt tablet is available:
 Weight  No. of 200-mg 
 (kg) tablets/dose
 <8 1/4
 8–12 1/2
 13–17 3/4
 18–25 1
 26–35 11/2
 36–44 2
 45–54 21/2
 ≥55 3
If only the 300-mg quinine salt tablet is available:
 Weight  No. of 300-mg 
 (kg) tablets/dose
 7–11 1/4
 12–23 1/2
 24–37 1
 38–52 11/2
 ≥53 2
If both 200-mg and 300-mg quinine salt tablets are available:
 Weight  No. of 200-mg  No. of 300-mg
 (kg) tablets/dose tablets/dose
 <8 1/4 –
 8–12 1/2 –
 13–17 3/4 –
 18–23 1 –
 24–37 – 1
 38–52 – 11/2
 ≥53 – 2
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Chloroquine (for P. vivax only)
Chloroquine is available as scored tablets, usually containing either 100 mg 
or 150 mg chloroquine base per tablet. If formulations of other strengths 
are used, the dosage table below should be adjusted accordingly.
The recommended treatment is 25 mg/kg chloroquine base total, over 
3 days. Chloroquine should be used only for the treatment of chloroquine-
sensitive vivax malaria.
Table A-V.6 Dosage schedules for chloroquine (for P. vivax only)
 Weight (kg) Age either or
   No. of 100-mg  No. of 150-mg 
   tablets/day tablets/day
   Day 1 Day 2 Day 3 Day 1 Day 2 Day 3
 5–6 <4 months 1/2 1/2 1/2 1/2 1/4 1/4
 7–10 4–11 months 1 1 1/2 1/2 1/2 1/2
 11–14 1–2 years 11/2 11/2 1/2 1 1 1/2
 15–18 3–4 years 2 2 1/2 1 1 1
 19–24 5–7 years 21/2 21/2 1 11/2 11/2 1
 25–35 8–10 years 31/2 31/2 2 21/2 21/2 1
 36–50 11–13 years 5 5 21/2 3 3 2
 >50 ≥14 years 6 6 3 4 4 2
Note: Chloroquine treatment for falciparum malaria is no longer accept-
able for populations living in complex emergency situations. The only 
current exception to this rule is Haiti, where P. falciparum is known still to 
be fully sensitive to chloroquine.
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ANNEX VI
Entomological investigations
This annex describes the basic methods used and the minimum informa-
tion required for entomological investigations. More information about 
test methods is given in the following publications:
• WHO (1992). Entomological fi eld techniques for malaria control. 
Part 1: Learners guide. Geneva, World Health Organization.
• WHO (1996). Report of the WHO Informal Consultation on the evalu-
ation and testing of insecticides, Geneva, 7–11 October 1996. Geneva, 
World Health Organization (CTD/WHOPES/IC/96.1).
Surveillance
Before considerable resources are invested in specialized vector control 
programmes aimed at a reduction of malaria transmission, the following 
information is required:
— anopheline vector species present;
— relevant biology and behaviour (resting habits indoors and outdoors, 
feeding preferences, seasonal changes in abundance, locations 
found);
— breeding habits;
— resistance to insecticides.
The minimum information required is confi rmation of vector species. 
Expertise in mosquito identifi cation should be sought – locally if possi-
ble. Mosquitoes should be collected indoors and outdoors. The simplest 
method is indoor “fl y spray” catches: exits are blocked off and mosquitoes 
are collected on fl oor sheets. Outdoors, mosquitoes can be collected us-
ing CDC light traps baited with CO2 (dry ice) or by man-landing-catches 
using aspirators (sucking tubes). Knowledge of breeding habits is useful if 
breeding sites are limited and larviciding is feasible.
Resistance to insecticides
The standard method for detecting resistance is to expose mosquitoes to 
insecticide-treated papers within a WHO susceptibility test kit (obtain-
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able from WHO – www.who.int/whopes/resistance/en/WHO_CDS_CPE_ 
PVC_2001.2.pdf). Field-collected mosquitoes are exposed to treated pa-
pers for 1 hour inside the kit, and the proportion killed is recorded after 
a 24-hour recovery period. Resistance testing is especially important if 
indoor residual spraying is being considered. Pyrethroid insecticides con-
tinue to work well in many regions but resistance is becoming increasingly 
common in western and southern Africa.
Effi cacy and residual life of insecticide treatments
Information on effi cacy and residual life is needed if there is any doubt 
about either the effectiveness of indoor spraying or the interval between 
spray rounds. The simplest way of obtaining this information is by WHO 
cone bioassay. A plastic cone is attached to the surface of sprayed walls. 
Batches of fi eld-caught mosquitoes are placed within the cone for 30 min-
utes, removed and transferred to a paper cup for observation; mortality is 
determined after a 24-hour recovery period. Eight weeks after spraying, a 
good insecticide should still give at least 70% mortality.
Householders who resent the intrusion of spray teams or object to spray-
ing may re-plaster sprayed surfaces. There may be little that can be done to 
counter this, but it would wise to monitor for evidence of re-plastering or 
washing down of walls (using WHO cone bioassay tests, for example) to 
guide future spraying policy. 
It may be necessary to monitor the effectiveness of insecticide treatments 
on nets. Most recommended pyrethroids give protection against mosquito 
biting for at least 12 months after treatment. Marking nets with a non-per-
manent marker pen and then carrying out spot checks in the home provides 
a means of monitoring washing rates. An alternative is to take samples of 
netting and expose batches of mosquitoes to the treated surface using a 
WHO cone bioassay test. If 50% of mosquitoes are knocked down after 10 
minutes’ exposure, the treatment can be considered to still be effective.
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ANNEX VII 
Questions to guide a rapid qualitative 
assessment of social, economic and 
cultural aspects of malaria
This annex is intended as a guide only: the questions that will need to be 
asked to understand what community members know about, and how they 
respond to, malaria will depend on the local situation and cultural norms. 
In addition, the approach used will depend on the subject group – key in-
formants, householders, focus groups, etc. In some settings you may want 
to focus just on treatment-seeking behaviours or the use of preventive meas-
ures, while in other settings you may want a more complete understanding 
of what malaria means to a community and what they are most worried 
about. You can select the questions that you think are most relevant to what 
you need to know in order to make sound programmatic decisions related 
to malaria control in general. More information on preparing and carrying 
out social surveys is provided in the following publication:
• Akua Agyepong I et al. (1995). The malaria manual – guidelines for the 
rapid assessment of social, economic, and cultural aspects of malaria. 
Geneva, World Health Organization (TDR/SER/MRS/95.1).
Community perceptions of malaria
1. What are the common illnesses in the community?
➤ Allow the person to list all illnesses, even if malaria or a malaria-like 
illness is not mentioned.
2. Which of these illnesses are considered to be the most important?
a) Why (prevalence, severity, mortality)?
3. Which of these illnesses affect children? Which affect adults?
4. What is the local name for “febrile illness”?
➤ Probe for terms for febrile illness.
5. Are there different types of febrile illness? 
a) If yes: What are the local names of these illnesses?
b) Which of the febrile illnesses that you have described to me is consid-
ered to be the most dangerous?
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c) How do you know when a child/an adult has this type of illness?
➤ Identify which of the terms used for the illness most closely resem-
bles the biomedical defi nition of malaria, then use that term for 
the questions below. In some cultures, fever with convulsions is 
considered to be a different type of malaria and one that is best 
suited for traditional or spiritual healing. If this is not mentioned, 
you could add a question such as “Is there a different illness when 
the child/adult has fever and also convulsions (shaking)?”
6. What are the signs and symptoms of [local term for malaria]?
7. Who is most at risk for [local term for malaria]?
8. What causes [local term for malaria]? 
a) Can malaria be spread? 
b) If yes: How?
➤ If mosquitoes are not mentioned, probe with questions like: “Can 
this illness be carried by mosquitoes?”
Treatment-seeking behaviours
9. How is [local term for malaria] treated?
➤ Probe to ensure that all treatments are mentioned, including use of 
self-medication.
a) Can you please tell me the steps of treatment once you notice that 
your child /an adult is sick with [malaria]?
b) If use of health care services is mentioned: I see you mentioned going 
to the [dispensary/clinic/hospital] to receive care. From the time that 
you know that your child/the adult is sick, how long do you usually 
wait before going to the health care facility?
— What do you do for treatment during times when the [dispensary/clinic/
health post] might be closed (such as weekends, nights, holidays)?
—  Is there an ambulance service to help you with a really sick person?
➤ If the answer is no: probe to fi nd out how they transfer a sick indi-
vidual to a health care facility.
c) If multiple treatments are listed: do you use some of these treatments 
at the same time (for example, see a traditional healer for herbal treat-
ments while taking antimalarials)?
d) Which of these treatments are considered to be the most effective?
e) From whom do you normally receive advice about how to treat illness 
in a child/adult?
f) If not previously mentioned: Do you use the services of traditional 
healers or spiritualists for malaria?
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— Do traditional healers ever give you antimalarial drugs?
g) Can you easily obtain drugs to treat [malaria] here in the camp/
settlement area?
— If yes: where do you get these drugs?
h) Can you please tell me about any problems you might experience when 
seeking care from a health care facility in the camp/settlement area?
➤  Probe for things such as lack of referrals, no assistance to trans-
port a sick patient, long waiting periods for care, political/cultural 
differences with health care staff, perceived poor communication 
between staff and patients or caregivers, lack of drugs or other 
supplies.
Prevention
10. Can [local term for malaria] be prevented? 
a) If yes: How can you prevent it? 
➤ Probe for use of insecticides, bednets or other insecticide-treated 
materials, coils, repellents, etc.
b) Of these methods, which ones do you personally use?
c) Why do you use these particular methods?
d) Which of the methods that you mentioned do you think are the most 
effective?
Insecticide-treated materials
11. In the residential unit that you live in, can you estimate for me how 
many households use insecticide-treated nets (ITNs)?
a) Would you say that your residential unit is similar to other parts of 
the camp/settlement area?
b) Did people bring the nets with them from their previous homes or did 
they receive them while they were in camp?
c) If a net was mentioned in response to question 10b): where and when 
did you get your net? 
— Do you know whether your net was treated with insecticide?
— Have you ever had a net while in camp/settlement area that you 
needed to sell in order to buy more food?
— If the interview is done at home and if the respondent states that 
they have a net: Could you please show me your net?
➤ Look to see what type of condition the net is in – is it dirty, is it 
very clean, does it have holes in it?
d) If a net was not mentioned in response to question 10b): “I see that 
you did not mention using a bednet. Why is this?” 
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➤ Probe for reasons of cost (cannot afford), lack of availability 
(such as distribution only to vulnerable populations), theft of 
nets, need to sell the net for food, dislike due to heat.
e) Why do people use bednets?
➤ Probe for prevention of nuisance biting, prevention of malaria, 
prestige, privacy.
f) In your house, who sleeps under the net?
— Why does that person/those persons sleep under the net?
g) Are there any times when households in this area do not use nets if 
they have them?
➤ Probe: “For example, what do people do when it is very hot out-
side? Do they sleep under the nets?”
h) Do people always sleep indoors – or outside, or in fi elds?
i) Are nets supported by poles or are they suspended from ceilings?
j) What sizes and shapes of nets would best fi t your sleeping arrange-
ments?
Indoor residual spraying (IRS)
12. Have you ever had your house sprayed?
a) If yes: what did you think about that malaria control measure?
➤ Probe: Ask whether they like the control measure; did they fear 
the insecticide being in the house.
13. Do you think that this method works to control mosquitoes?
14. Was there anything that you did not like about IRS?
15. Once your house was sprayed, when did you next replaster the walls? (How 
much time elapsed between the spraying of the walls and replastering?)
Experience with malaria control
16. Did you have [local term for malaria] in your home area?
a) If yes: what was your experience with malaria control?
➤ Probes: Ask whether they ever had indoor residual spraying done 
in their home; whether the health care facilities dispensed antima-
larials; whether there were net distribution or insecticide re-treat-
ment programmes taking place?
b) Was the community involved in trying to control malaria?
— If yes: what did they do?
17. Can you please give me some ideas for what you would like to see in 
place in the camp to improve malaria control?
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ANNEX VIII
A checklist for effectively responding 
to malaria epidemics1
1 Source: WHO (2002). Prevention and control of malaria epidemics. Third meeting of 
the Technical Support Network. Geneva, World Health Organization (WHO/CDS/
RBM/2002.40): Annex 6 (with minor editorial changes).
Predictive indicators
e.g. meteorological
reports or population
 movements
Initial assessment
Establish the situation
through phone, radio, fax
and e-mail as appropriate
Maintain field
surveillance
Rapid investigation (24–48 hours)
An investigation to determine the
cause, effect and potential magnitude
and duration of the epidemic
Provide immediate support
Design and implement a response
following the guidelines overleaf
Sentinel site data
Rumours
Press reports
Epidemic suspected
Epidemic confirmed
N
o 
ep
id
em
ic
Epidemic
alert and
reports
Weekly
surveillance
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Designing the response
At all epidemic stages
• Ensure that all clinics and health facilities are operational and have suf-
fi cient drugs, equipment and trained staff.
• Establish treatment centres (temporary clinics or mobile clinics) where 
access is a problem or health facility coverage is low.
• Ensure that the correct diagnosis and treatment is provided at all health 
facilities and at community level.
• Promote proactive clinical case detection and management/referral.
• Reinforce the referral system and consider the introduction of artesunate 
suppositories and IM artemether as a temporary measure where these 
are not already used.
• Intensify/maintain effective preventive measures for pregnant women.
• Reinforce health information systems for reporting and epidemic moni-
toring, preferably on a weekly basis.
• Conduct specifi c epidemic health education campaigns.
• Organize regular press releases/conferences/articles for public informa-
tion.
Epidemic start
In the early stages of an epidemic, in addition to reinforcing case manage-
ment (see above), it is still possible to reduce the potential impact of the 
epidemic using vector control interventions such as indoor residual spray-
ing (IRS).
Additional specifi c interventions
• If the area is in principle already protect-
ed by IRS – establish coverage and quality 
of vector control using techniques such as 
bioassays.
• If the area is not already protected, but 
the malaria epidemiology, type of housing 
and available logistics allow rapid deploy-
ment of effective IRS – implement IRS in 
target areas.
• Consider – properly timed fogging in 
highly populated areas such as refugee/displaced persons camps, espe-
cially if shelters are small and IRS is not an option.
• Consider – re-impregnation or use of ITMs (insecticide-treated materi-
✸
Time
Im
pa
ct
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als including bednets) if there is a history of ITM use in the area or if the 
capacity exists to enforce such a programme (e.g. within a concentrated 
workforce).
Epidemic acceleration
Case management (see above) is the priority at this stage. Aiming to reduce 
the potential impact of the epidemic through IRS and other vector control 
methods is an option only if (1) there is considerable operational capacity 
trained and readily available, and (2) preparedness levels have been high.
Additional specifi c interventions
• Consider – establishing coverage and 
quality of vector control, using techniques 
such as bioassays, if the area has already 
been sprayed.
• Consider – IRS if the area is not already 
protected.
• Consider – changing chemicals for IRS if 
observed susceptibility is low.
• Consider – properly timed fogging in 
highly populated areas such as refugee/
displaced persons camps, especially if shelters are small and IRS is not 
an option.
Epidemic peak
The epidemic has already begun to stabilize 
at this point and the number of new cases 
is beginning to decrease. Vector control in-
terventions to reduce the potential impact of 
the epidemic have no public health value at 
this late stage. Resources should instead be 
directed at case management to reduce ma-
laria mortality (see above).
After epidemics
Ensure lessons-learned exercise (“postmortem”) for next epidemic.
✸
Time
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Pre-season preparedness and early identifi cation provide the malaria man-
ager with an increasing number of tools to deal with an epidemic. Maintain 
surveillance, keep database up to date, think ahead – be prepared.
Post-mortem
Epidemic
Response
PreventionEarly warning
Forecasting
Preparedness
The epidemic cycle
for sustained action
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